ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001178.1|UK-68,597_1 # 137 # 1102 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.705	BGC0001178.1|UK-68,597_1 	137	1102	+	Loose	250	137.502	vanG	28.37	3002909	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGTCAGAGCTTGGCCGCGTGCTCGTGCTCGCCGGAGGGCTTTCCCCTGAGCGGGAGGTGTCGCTGCACTCCGGGCGGCGAGTGTTCGACGCGCTGCGTGGGCTCGACGTGGACGTCGAGTTCGGCGATCTGGGTCCTGACCTGATGGAAGCTCTGATCGCTGATCCGCCGTCGGTCGTGCTGCCCGTTCTGCACGGCAACACAGGCGAGGACGGCACCGTTCGGGAGGTGCTGGAGCTGGTGGGCGTGCCGTACGTCGGGGCGTCGGCCGAAGCCTGCCGGCGCGCTTTCGACAAGCCACTCGCGAAGGCGCTGATGGCCCAGGCCGGCCTTGGCACGCCGGCATCCGTGACGCTGCCGCGTGAGGCCTTCCACGACCTGGGCGCCGCCCCGTTGATCTCACTCATCCTCAAGCGGCTCGGCCTGCCCTTGTTCGTCAAGCCACGCGCCGGCGGATCGGCCTTCGGCGTCAGTCACGTCAGCGACGCGGACCAGCTGCCGGCGGCGCTGATGGCGTGCTTCGCCTACCACGACACCGCGCTCATCGAGCGGGCCGTGATCGGCGTCGAGGTCGCGGTCGGCGTAGTCGACCTGGGGGACGGGCCGGTGGCGATGCCAGCCGTCGAGATCGTTCCCCGACGGGGCATCTATGACTACGCGGCCCACTACACCGCGGGGGCGACAGAGTTCTTCTGCCCTGCCCGCCTGAGTGACCGGGCGGCAGCGGCGGTCGCGCGGGCGGCACTCACCGCGCACGCGGCGCTGGGCCTGCGCGACCTGTCGCGAACCGATCTCATCGTCGACGAGGACGACCAGGTGTTCGTCTTGGAGACGGCCGTCGCGCCCGGGCTGACCGACACCTCCACCTTCGTCATGGGCCTCGCGGCCGAGGGCTACGCCTTCGAACGCGTCTGGCTGCAACTCGCGAGGCTCGCCGAGGCGAGGGGCAGTTCAGCAGCCGGGTAG	MSELGRVLVLAGGLSPEREVSLHSGRRVFDALRGLDVDVEFGDLGPDLMEALIADPPSVVLPVLHGNTGEDGTVREVLELVGVPYVGASAEACRRAFDKPLAKALMAQAGLGTPASVTLPREAFHDLGAAPLISLILKRLGLPLFVKPRAGGSAFGVSHVSDADQLPAALMACFAYHDTALIERAVIGVEVAVGVVDLGDGPVAMPAVEIVPRRGIYDYAAHYTAGATEFFCPARLSDRAAAAVARAALTAHAALGLRDLSRTDLIVDEDDQVFVLETAVAPGLTDTSTFVMGLAAEGYAFERVWLQLARLAEARGSSAAG	MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE	91.98	gnl|BL_ORD_ID|1069|hsp_num:0	1157			12	1038	vancomycin
BGC0001178.1|UK-68,597_2 # 1135 # 2298 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.658	BGC0001178.1|UK-68,597_2 	1135	2298	-	Loose	650	414.846	vanS gene in vanO cluster	65.55	3002941	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTGGCCTGCATCGGGCGTGAGGATTGGACCGTGGATAGGGCGCCTGGTGTGAGCGTTCGCCTCAAGCTCACCCTCAGCTACGCGGGGTTCCTCATGCTTGCCGGCGCCTTGCTACTCGCCGTGGTGTGGTTGTTCCTGCTGCGTTATGTACCCGAGGTGATCCGACCCGACCCGGGACCCCCGGGGCTGAATGATGGCGGCCTGGGACCGGCGAATCCCCACATAAGGTTCATACCCGACCGCTCCGACCTGCAGCGCGCCTTCATCCCGAAGGCAGTCGCAATGCTGGCCTTCCTGCTGATGTTCGGCCTCCTGGGAGGATGGATCCTCGCCGGCCGCATGCTCGCGCCCCTGACCCGGATCACCAATGCCACCCGCCAAGCCGCGGACGGATCACTCTCCCACCGGATCCGGCTGGAAGGCCGCGAAGATGAGTTCCGCGAGCTCGCCGACGCCTTCGACACCATGCTCGCGCGGCTCGAAGCACAGGTCGCCGAGCAGCAGCGGTTCGCAGCCAACGCCTCCCACGAGCTGCGCACCCCGCTGGCGATCATGCAGACACTGCTCGATGTGGCCCGCAACGATCCGAACCACGACGCCGGTGCACTTGTCGACCGTCTCCACTTCGTCAACACCCGAGCGATCGACCTCACTGAAGCATTGCTCCTGCTCAGCCGCGCCGACCGGCGGTCCTACACCGGAGAACACATCGACCTGTCCCTGATAGCGGAAGAGGCCACCGAAACGCTCCTCCCACTCGCCGAGAAGCGCGGCCTCACTATCGAGACCTCCGGCGACCTGGCATCCACCATCGGCTCATACACGCTCCTGCTGCAGATGACTACCAACCTCGTGCAGAACGCGATCGTCCACAACCTGCCGGAAGTAGGCACGGTGTGGATCACGACCAGCGTTCACCCCGAGGGCGTGGTGCTCGCTGTCGAGAACACCGGCGAAAAGCTCACCGCACAGTCGGTTTCCACGTTCGTCGAGCCTTTCCAGCGCGGCACTGGACGGATACGCGACGGCCACGCGGGTGTCGGCCTCGGCCTGCCCATCGTCAAGAGCATCGCCCAAGCACACGACGGAGCACTCACCCTCACCCCACGCCCCGGTGGAGGGCTCTGCGTCACGGTGCGACTACCCGCCGCACGGCCGAGATAG	MACIGREDWTVDRAPGVSVRLKLTLSYAGFLMLAGALLLAVVWLFLLRYVPEVIRPDPGPPGLNDGGLGPANPHIRFIPDRSDLQRAFIPKAVAMLAFLLMFGLLGGWILAGRMLAPLTRITNATRQAADGSLSHRIRLEGREDEFRELADAFDTMLARLEAQVAEQQRFAANASHELRTPLAIMQTLLDVARNDPNHDAGALVDRLHFVNTRAIDLTEALLLLSRADRRSYTGEHIDLSLIAEEATETLLPLAEKRGLTIETSGDLASTIGSYTLLLQMTTNLVQNAIVHNLPEVGTVWITTSVHPEGVVLAVENTGEKLTAQSVSTFVEPFQRGTGRIRDGHAGVGLGLPIVKSIAQAHDGALTLTPRPGGGLCVTVRLPAARPR	MLAGVLLLAAVWVFLLRGRSTNFQFPALADFARVFDPSNFGPVVFVPAAILALGFLLVFGLVGGWILAGRMLAPLARITRAAREAGSGSLSYRIELEGRNDEFRELADAFDAMLARLEARDAAQQRFAANASHELRTPLAITQTLLDVARNDPNRDGGELDERLRAVNARAIELTEALLLLSRTDQRSFSREDVDLSLIAEEAAETLLPFAEKHGVSIETSGDIAPVIGSHALLLQLTTNLLHNAIVHNVPEHGSVQISTAIGSESVMLTVENTGDKLSPQLVSTLTEPFQRGTARTRGDDARVGLGLAIVKSITQAHDGSLTLSPRAAGGLSVAVRLPAAQRRP	112.17	gnl|BL_ORD_ID|4732|hsp_num:0	465			0	1032	vancomycin
BGC0001178.1|UK-68,597_3 # 2416 # 2934 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.649	BGC0001178.1|UK-68,597_3	2416	2934	+	Strict	50	56.9954	vanY gene in vanB cluster	35.54	3002956	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanY; glycopeptide resistance gene cluster	ATGAGTCAGCCCGACCACCGTAGTACGACTACCGAATCTGACGGTGCCCTCCGCGGCCGCGTGACAGTGTTCGATGACAGGTATCCCGGCGTGGCCAACCTCGACCCAGATCTGCTCCAGGCCCTGCGCGAAGCGGCGATGGCCGCCGCTGACGACGGCGTCGAATTCTACGTCAACAGCGGCTGGCGCTCCCCGGCGTACCAGAATGAGCTTCTTCGCGAGGCGGTCTCGAAGTACGGCTCGGAAGAGGAAGCCGCCCGATGGGTCGCCACCGCCGACACTTCCGCTCACGTGTCCGGGAACGCGGTCGACATCGGGTCTTCCGACGCCACAGCGTGGCTGTCGGAGCATGGCGCCAAGTACGGACTGTGCCAGATCTACAGCAACGAGCCGTGGCACTACGAACTGCGTCCCCAGGCGATCGATCATGGTTGCCCACCCATGTATGCCGACCCCACACACGATCCGAGGATGCGGCAGCGGTCGGCGCTTTCGGTCGATCCCGTTCCGACCTCGTGA	MSQPDHRSTTTESDGALRGRVTVFDDRYPGVANLDPDLLQALREAAMAAADDGVEFYVNSGWRSPAYQNELLREAVSKYGSEEEAARWVATADTSAHVSGNAVDIGSSDATAWLSEHGAKYGLCQIYSNEPWHYELRPQAIDHGCPPMYADPTHDPRMRQRSALSVDPVPTS	MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK	64.18	gnl|BL_ORD_ID|602|hsp_num:0	556			372	726	vancomycin
BGC0001178.1|UK-68,597_6 # 6101 # 6784 # 1 # ID=1_6;partial=00;start_type=TTG;rbs_motif=GAG;rbs_spacer=12bp;gc_cont=0.658	BGC0001178.1|UK-68,597_6 	6101	6784	+	Loose	400	359.377	vanR gene in vanO cluster	90.23	3002930	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	TTGGTCGTCGAGGATGAGTCCTACATGGCGGAGGCCATCCGTGACGGGCTGCGCCTGGAAGCGATCGCGGCCGACATCGCCGGTGACGGTGACACCGCGCTGGAGCTGCTGAGCATCAACGCCTACGACATCGCCGTACTCGACCGGGATATCCCCGGCCCTTCCGGCGACGAGATCGCCAAACGCATCGTCGCCTCCGGCAGCGGCATGCCGATCCTGATGCTCACCGCCGCCGACCGGCTCGACGACAAAGCGTCCGGGTTCGAGCTCGGCGCCGACGACTACCTCACCAAGCCGTTCGAACTGCGAGAGCTCGTGCTCAGACTGAGAGCACTCAACCGCAGGCGCGCACACAACAGACCACCGGTACGGGATATCGCCGGCCTCCGACTGGACTCATTCCGCCGCGAGGTCTACCGCGACGGTCGCTACGTCGCACTGACCAGGAAACAATTCGCCGTGCTCGAGGTCCTCGTGGCCGCCGAGGGCGGGGTCATCAGCGCCGAAGAGCTCCTGGAACAGGCATGGGACGGAAACGCCGACCCCTTCACCAACGCCGTACGCATCACCGTCTCGGCTCTGCGCAAACGACTCGGCGAACCCTGGATCATCGCTACGGTGCCGGGCGTCGGATACTGTATCGACATAGGACGAGCTGCCGACGACCGAGGCGCGCAGCGCTGA	MVVEDESYMAEAIRDGLRLEAIAADIAGDGDTALELLSINAYDIAVLDRDIPGPSGDEIAKRIVASGSGMPILMLTAADRLDDKASGFELGADDYLTKPFELRELVLRLRALNRRRAHNRPPVRDIAGLRLDSFRREVYRDGRYVALTRKQFAVLEVLVAAEGGVISAEELLEQAWDGNADPFTNAVRITVSALRKRLGEPWIIATVPGVGYCIDIGRAADDRGAQR	MASMRVLVVEDERFMAEAIRDGLRLEAIAADIAGDGDTALDLLGVNAYDIAVLDRDIPGPSGDEIAQRIVASGGGIPILMLTAADRMDDKASGFELGADDYLTKPFELQELVLRLRALDRRRAHSRPPVREIAGLQLDPFRREVYRDGRYVALTRKQFAVLEVLVAAEGGVISAEELLERAWDENADPFTNAVRITVSTLRKRLGEPWLIATVPGVGYRIDTEPDARGGGDGG	97.42	gnl|BL_ORD_ID|4742|hsp_num:0	1689			18	663	vancomycin
BGC0001178.1|UK-68,597_7 # 6800 # 7852 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.618	BGC0001178.1|UK-68,597_7	6800	7852	-	Strict	200	514.612	vanH gene in vanO cluster	73.65	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGAGTCACAGCGAACCAGCACGAACAGCGGCTTTCCGCAGCCGATCGCTGGCGTCTTCGTCCTCCCCGGTCATTCCGACGACGGGAATCACGATCTACGGATGCGGCCACGACGAGGCCGTCCTGTTCCGTGAGCAGGCGCGTCGCTTCGGCGTCCTGCCGACCATCACCGGGGCAGCGGTGTCCGAGGCCAATGTCGATCTGGTATTCGGCAACCGATGCATCAGCGTCGGCCATAAGACTCAAGTCACAAACAGCACACTTCTCGCACTTGGCCGGGCCGGAGTGGAGTACGTCTCGACACGGAGCATCGGCTACGATCACATCGATCTGGGGTATGCGGAAAGCGTCGGCATCTCCGTCGGCAATGTCGCCTACTCGCCGGACAGTGTGGCTGACTACACGCTGATGCTGATGCTGATGGCCGTGCGCCACGCGAAGGCCATGATCCGCCGCACGGATGCCCATGACTACAGACTGAGCGACGCGCGCGGGAAGGAACTGCGCGATCTGACCGTCGGGGTAGCCGGAACGGGACGCATCGGCTCAGCGGTCCTGGACAGGCTGCGGGCTTTCGGTTGCCGCGTGCTGGCCTACGACAATCGCCGTGCGACCTCCGCCCACTATGTCCCGCTCGACGAACTGCTGCGGCAGAGCGACATTGTCACGCTCCACACTCCGCTTACCGCGGGCACGCACCATCTCCTCAACCGTCAACGTATCGCGCAGATGAAGCGCGGCGCGTTCATCATCAACACCGGGCGCGGTGCACTTCTCGACACCGAGGCCCTCATTCCGGCGCTGGAGTGCGGCAGACTGGGTGGTGCGGCACTGGATGTCCTCGAAGGAGAGGAGGGGATATTTTACACCGACCGTCGAAACAAGCCCATCGAGAACAAGGCGCTGTTGCGGCTACAAGAGCTTCCGAATGTGCTCATCAGTCCGCACCTGGCCTATTACACCCACCATGCGCTGAGCGACACCGTCGAAAACAGTCTCATCAACTGCATGAACTTCGAAAGCGGGAAGGGCATGGACAGAATGAAAGCATGA	MSHSEPARTAAFRSRSLASSSSPVIPTTGITIYGCGHDEAVLFREQARRFGVLPTITGAAVSEANVDLVFGNRCISVGHKTQVTNSTLLALGRAGVEYVSTRSIGYDHIDLGYAESVGISVGNVAYSPDSVADYTLMLMLMAVRHAKAMIRRTDAHDYRLSDARGKELRDLTVGVAGTGRIGSAVLDRLRAFGCRVLAYDNRRATSAHYVPLDELLRQSDIVTLHTPLTAGTHHLLNRQRIAQMKRGAFIINTGRGALLDTEALIPALECGRLGGAALDVLEGEEGIFYTDRRNKPIENKALLRLQELPNVLISPHLAYYTHHALSDTVENSLINCMNFESGKGMDRMKA	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	100.00	gnl|BL_ORD_ID|761|hsp_num:0	786			42	1044	vancomycin
BGC0001178.1|UK-68,597_8 # 8119 # 8316 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.727	BGC0001178.1|UK-68,597_8 	8119	8316	+	Loose	1320	33.8834	lmrD	60.87	3002882	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGATCCGCGGCGGAGGGATCCGGGAGCGCGACGGCACGCACGAGGAGCTGCCGGCCGAGGGTGGTCGCTACGCGGAGCTGTGTCACGCGCAGTTCGTCGAGTCAGACCGCGGCGGATTCAGGCCCGGCGGCAACCGGGAACGGGCTGGGACCGGCCAACGGGCCGGTGCGCCGGTGGTTCGTGAAGGGGGACGATGA	MIRGGGIRERDGTHEELPAEGGRYAELCHAQFVESDRGGFRPGGNRERAGTGQRAGAPVVREGGR	MENTKSTRKMSDTTRAIRFFYLYLKRYKLQFAVIMIFIILATWLQVVSPSLLGDAITNLTKYVTDFFTHQHAGQSQDALQQIAQQLSQQMHQTVDWHNVPEVVKSLPQAAQDQITANLPKGTTLETLKTVATSHAASTSTFMKGMWQLLAVYVATGVSMLIYTLLFSRIVAHSTNRMRKGLFGKLERLTISYFDRHQDGDILARFTSDLDNIQNTLNQALVSVISNAAVFVGVIIQIFNKDVTFAWLTVAASPVAILSAVIIIRQSKKATDKQQEEVSQLNAYMDEKISGQKAIIVEGLQEDSINGFLEHNENVKKRTFAAQAWSGMIFPLMNGFQLLSIAIVIFGGTAYVLNDDSMSIATGLGLLVAFVQYVQSYYNPIMQISSNFGQLQLAITGATRLNVMFDEPEEVRPENGKKFDTIKDGIQIENLDFEYLPGKPVLKKVNIDVKKGQMVALVGPTGSGKTTVMNLMNRFYDVNGGAIKFDGTDIREFDLDSLRSNVGIVLQESVLFDGTIADNIKFGKPNATQEEIETVAKTTHIHDFIDSLPDKYETHVSDDESVFSVGQKQQISIARTILTNPELLILDEATSNVDTVTEQQIQWAMEAAIAGRTSFVIAHRLKTILNADKIVVLKDGEVIEEGNHHELVAQGGFYSELYHNQFVFE	9.79	gnl|BL_ORD_ID|1488|hsp_num:0	1624			1917	1986	
BGC0001178.1|UK-68,597_9 # 8343 # 14567 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=12bp;gc_cont=0.715	BGC0001178.1|UK-68,597_9 	8343	14567	+	Loose	1000	108.612	almE	25.62	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGCCGGAGCTGCTCGCCCGGCAGGTGGACCGAACACCCGACGCGGTGGCCGTGGTCGACGGGGACCGGGTTCTGACCTACCAGGAGCTCGATGAGTGGGCGGGCCGGCTGGCCGGGCGTTTGATCGGCCGGGGCATCCGCCGTGGCGACTACGTCGCGGTCGTGATGGACCGCTCGGCGGAGCTGGTGGTGACGCTGTTCGCCGTCTGGAAGGCGGGGGCGGTCTATGTGCCGGTGGACGCCGGCTATCCCGCGCGGCGGGTGGCGTTCATGGTGGCGGATTCGGGGTCCTCCCTGATGGTGTGCTCGGCCGCGACGCGCGACCGAGTGCCGGAGGGGATCGAATCGATCGTCGTCACAGCCGAGGGGGCCGGCGACGCTTCGGCGGTCGCGGTGCGCCCGGGGGACCTGGCGTACGTGATGTACACCTCCGGCTCGACGGGGACCCCGAAGGGCGTGGCCGTCCCGCACCGGAGCGTCGCGGAGCTGGTGGGGAACACCGGTTGGGCGATGGGAACCGGCGATGCGGTCCTCATGCACGCGCCGTACGCCTTCGACGCGTCCCTGTTCGAGATCTGGGTGCCGCTGGTGTCGGGCGCCCGGGTGGTGATCGCCGAGCCGGGGCCGGTGGACGCCCGGCGCCTGCGGGAGGCGGTCGCGGCCGGGGTGACGAGGGCGCATCTGACCGCGGGAACCTTCCGCGCGGTGGCGGAGGAATCGCCGGAATCGTTCGCTGGGCTCCGTGAGGTGCTGACCGGCGGCGACGTGGTGCCCGCACACGCGGTGGAGAAGGTGCGGGCGGCCTGCCCCCGGACGCGGATCCGGCACCTGTACGGCCCGACGGAAACCACGCTGTGCGCGACCTGGCATCTGCTCGAGACGGGTGACGTCCTGGGCCCGGTCCTGCCGATCGGCCGTCCGCTGCCGGGCCGCCGCGCTCAGGTGCTCGACGCGTCGCTGCGGCCCGTGGCACCCGGCGTGGTCGGTGACCTGTACCTCTCCGGTGCGGGTCTGGCGGACGGCTACCTGGGCCGGCCGGGGCTGACAGCGGAGCGGTTCGTGGCGGATCCGTCCGCGCCTGGCAGCAGGATGTACCGGACCGGGGACCTGGCTCAGTGGACCTCCGACGGTGCGTTGCTGTTCGCGGGCCGGGCCGATGACCAGGTGAAGATTCGCGGGTTCCGGATCGAACCGGGCGAGATCGAGGCTGCGCTGACCGCTCAGCCGGAGGTGCACGAGGCCGTGGTGACGGCAGTCGATGGGCGCCTGACCGGCTATGTGGTGGCGGAAGGGGACGCGGATCCCGTTCGGATCCGCGAGCGTCTCGGGTCCGTGCTGCCGGAGTACATGGTCCCGGCCGCGGTGATCACGCTGGACGCGCTGCCGCTGACCGGCAACGGCAAGGTGGACAGGGCGGCGCTGCCCGCGCCCGTCTTCGCGGCGAATGCCGCGGGCCGCGAGCCCGGCACGGAGACGGAGCGCGTCCTGTGCGGCCTGCTCGCCGAGCTGCTCGGCGTGGACCGGGTCGGAGTCCACGAGAGCTTCTTCGAGCTGGGCGGGGACTCGATCGGCGCGATGCGGCTGGCGGCGCGGGCAGCCAAGGCCGGCCTGCTGGTGACGCTCGCCCAGATCTTCGAGGAGCCGACTCCCGCACGGCTGGCGGCCGTGGCGCGTCCCGTGCCGGCCGAAGGACCCGTCGCACGCCCGCTTGTGGCGCTCACCGCCGAGGACGAGACGGAGCTGGCGATCGCCGTACCGGGAGCTGAGGAGGTCTGGCCGCCGGCGCCGCTCCAGGAGGGGTTGCTCTTCCAGTCGACCATCGACGACGAGGGCCTCGACATCTACCAGGGGCAGTGGATCCTCGAAGTGAACGGGCCGGTGGACGTGGCCCGGCTGCGGGCCGCGTGGGAAGCGGTCTTCGCTCGGCACGCCGAGCTGCGGGTGAGCTTCAATCGATTCGCGTCGGGGAAGACGCTGCAGGTCGTCGCCAGGCACGTCGTACTGCCGTGGCGAGAGGTGGATCTGACCGATGCCGGCGATGTCGACGCGGCCGTCGAGGCCTTGGCCAGACGCGAACAGGAACAGCGATTCGATCTTGCCCGGGCGCCGCTGTTCCGGCTGGTGCTGGTCCGGTACGGCGAGGACCGGCACCGCCTGTTGGTCGTCCATCACCACATCCTGGCTGATGGCTGGTCGGTGTCGGTCGTCCTCAACGAGGTATCCGAGGCGTACACCTCCGGTGGGCGGTTGCCGGAGCGGACGGGTGCGGCCTCCTACCGGGACTACCTGGCTTGGCTGGACCGGCAGGACAAGGATGCGGCCCGTGCGGCCTGGGGAGCGGAGCTGTCCGGCCTCGACGAGCCCGCGACGATCGCGAGGGCGGCCGCCGGGGCGGGCTACGAGTACCGCGCCGCTTCTTTGACGCCGGATCTCTACACCGGGCTGATGGAGTTGGCCCGCGGCCACGGACTGACGCTGAACACGGTGGTGCAGGGCGCCTGGGCGATGGTGCTCGCGCGGCTCCTGCGGCGGACCGATGTGGTGTTCGGGACCACGGTCGCCTGCCGTCCCGCGGAGCTTCCGGGTGTGGAGTCGATGCCGGGTCTCATGATGAACACGGTGCCGGTCCGGGTGTCGCTGGAGGGCGGGAAGCCGGTCGTCGACCTGCTGGCCGGCCTGCAGCGGCGCCAGGCGGCCTTGATACCGCACCAGCATCTGGGACTGCCAGAGATCCAGAAGGCGGCCGGACCGGGCGCGGTGTTCGACACGCTGCTGGTGTTCGAGAACTATCCGCGGGACTTCGCCGGCCAGTTCACCTATCTGGGCACGGTCGAGGGGACTCACTATCCGCTGACCCTAGGCGTCCTCCCGGGAGATCACCTCAGGGTCCAGCTGGCCTACCGGCGGGGGCAGATCGAGGAGACCGTCGCCGAGTCGGTTCTGGGGTGGTTCGTCGGCGTTCTCGGCGCGCTGGCCGCTGACCCTTCCGGGCTGGTGGGGCGGACCGGTATCGGTGCGGCCCCGGTGGGCGGTTCGGCTGCGGCATTGGTGGTGGAGCAGTCATTGCCCGCGTTGATAGGGCGGGTGGTGCGGGAGCGGCCGAACGACGTCGCGGTGGTCGATGGCGATGGTGACTTGTCCTACGCGGGGTTGTGGGAGCGGGCGACGGCGCTGGCGGCGGTGTTGCGGGCTCGTGGGGTCGAGCGGGAGAGCCGGGTCGGCGTGCTGGTGGGGCGGTCGGCGTGGTCGGTGGTCGGAATGCTGGGAGCGTCGCTGGCCGGTGGCGCGTTTGTTCCGGTCGATCCGGCGTATCCGGCCGAACGCGTGGCGTGGATTCTCGGAGATGCGGATCCGGTGTCGGTGATCTGCGTGGGGAAGACGCGCGAGGCGGTGCCGGCGGAGTTCGCGGATCGGCTGATCGTGGTCGACGAGGTGGAGCCGGCCGCGGGCCCGGATGGGAAGCTGCCGCGGGTCGGCCCGGATGATGCGGCGTACGTGATCTATACGTCGGGGTCGACCGGGACTCCGAAGGGTGTCGTCGTCACGCACGCCGGGTTGGGGAATCTGGCGGCGGCGCAGATCGACCGGTTCGGGGTGTCGCCGTCGTCACGGGTCCTGCAGTTCGCGGCGCTGGGCTTCGACGCCGTGGTGTCGGAGACGCTGATGGCGCTGTTGTCGGGGGCGAGGCTGGTGCTGGCGCCCCCGCAGGACATGCCGCCGCGGGTGTCGCTGGCCGAGGCGCTGGAGCGGTGGGATGTCACGCACGTGACGGTTCCGCCGTCGGTGCTGGCCACGGCCGACGCGTTGCCGGCGAAGCTGGAGACGGTGGTGGTGGCGGGGGAAGCCTGCCCGCCGAGCCTGGTGGATCGCTGGTCGGCGGGACGGCGGCTGGTCAACGCCTATGGGCCGACCGAGGCCACGGTATGCGCGGCGATGAGCATGCCGCTGGCCGCGAGCCGGGACGTGGTCCCGATCGGGACGCCGATCGCCGGGGGCCGTTGCTATGTACTGGACGCGTTCCTGCGGCCGCTGCCGCCGGGGATCATCGGCGAGTTGTATGTGGCCGGGATCGGGCTGGCCCGCGGCTACCTGGGCCGGGCGGCGTTGACGGCCGAGCGGTTCGTGGCGGATCCGTTCGTCCCGGTCGAGCGGATGTACCGAACGGGCGACCTGGCGTACTGGACGGACCGGAGTGAACTGGTGTTCGCCGGGCGGGCCGATGACCAGATGAAGATTCGTGGGTTCCGGGTCGAGCCCGGCGAGATCGAGTCTGCCCTGTCCGGTCACCCAGGTGTCGCCCAAGCCGCGGTGACCGTCCGCGAGGACCGCCTGCTGGCCTATGTGTCGCCGGGCGATGTCGACCCGCAGGCGGTGCGGGACGATCTCGCGGCCCGGTTGCCTCCGCACATGGTGCCCGCAGTGGTGGTGGCGCTGGAGGCGTTGCCCACCACCCCGAACGGCAAGATCGATCGGGGCGCGCTGCCTGATCCCGACCGCATGGCCCGCCCGGCCGGCCGGGAGCCGCGCACCGAGGTCGAGCGGGTGCTGTGCGATCTCTTCGCCGAGGTGCTCGGCTTGGAGCGGGTCGGTATCGACGACAGCTTCTTCGAGATCGGCGGTGATTCCATCTCGTCGATGCAGCTGGTGGCGCGGGCTCGGCGGGCCGGTCTGACCTTCATCGCGGTAGACGTCTTCGAGCTGAGGACGCCGGAGCGGCTCGCGCAACTGGCGGCGCAATCGCGGCCGCAGCGATCCGATCGCTCCGCGATGGCCGACGGTGTCGGTGAGGTCGCGTGGACGCCGGTGATGCGGCTGCTGGGTGACGGCGTCGTCGGGGCGGGGTTCGCGCAGTGGGTGGTGGCGGGTGCGCCCGCGGATCTGGCCGAGGAGGTGTTGGTCGCGGGGCTGGCGGCGGTCGTGGATGCGCACGACATGTTGCGGGTGCGGGTGGACTCGGAACGGTTGGTGGTGGGTGAGCGTGGATCGGTGGACGTGGCGAGGCTGGTCGAGCGGGTCGAGGCCGGTGCCGGCGAGGTGGACGACATCGCGGATCGCTGTGCCCGGCCAGCGGTCGCAAGGCTGGATCCCGCCGCCGGTGCGGTGGTCCGGGTGGTGTGGGTGGATGCGGGCCCCGGCCGAATGGGACGGCTCGTGATGGTGGCGCATCACCTCGTGGTCGATGCGGTGTCGTGGCGCATCCTGCTGGCGGATCTGCGGGTGGCATGTGAAGCCGTGGCTACGGGCGGGAAACCGGCGCTCGATCCGGTGGACACTTCGTTCCGGCGGTGGGCGGGTCTGCTCGGTGAGTGGGCGGTCTCCGCGGAGCGGGTCGGGGAACTGGCGGCGTGGACGGAGATCCTCGGCGGAGCGGAGCCACGGCTGGGCGACCTGGAGCGCACGCGCGACGCCGTATCGACCGTGGGACGCCGATCGTGGACCTTGCCGCGTGACCGGGCGGGCGCGCTCGTGGAGAAGGTGACCTCGGCCTTCCACTGCGCGGTCCATGAGGTACTCCTGGCGGGGCTGGCCGCGGCGGTGGCGCGGTGGCGCGGTGGTGACGTCGTGCTGGTGAATGTGGAGGGTCATGGCCGGCATCCGGTCGCGGGGATGGACCTGTCCCGGACGGTGGGCTGGTTCACCAGCGTGCATCCGGTGCGGCTGAATGTGGCAGGAATCGATCTGACCGACGTGCCCGGCGGTGGTCCGGCGGCCGGCAAGCTGTTGAAGCTCGTGAAGGAGCAGGCCCGGGCCGCGCCGGGTGACGGGCTCGGTCACGGGTTGCTGCGTTTCCTCAACGGTGACACGGGCCCGGTGCTGGCGGCGCTTCCGTCGCCGGAGATCGCGTTCAACTACATGGGCCGGTTCACCGGCAGTGCGCGGAGCGGTGTGCGCGCGTGGCAGCCGGTCGGTGCTGTCGGCGGCGCGATGGATCCGGACATGAGCCCGCGGCATGTGCTGGAGGTCAATGCGATCGTCCAGGACACGCGCGTCGGCCCGGAGCTGACACTCATGCTGAGCTGGCCGGCGGACCTGTTCGACGAGGCCGAGATCGAACGGTTCGGCCGGACCTGGCTGGACATGTTGTCCGGGCTGGCCCGTCAGGCCGAGGACCCCTCGGCGGGGGGACACACCGCATCCGACTTCGACCTCCTCGACCTGGGCCAGGACGAGATCGAGAGCTTCGAGGCAATAGCAGCCGAACTCAATGGAGGCCTGCCATCGTGA	MPELLARQVDRTPDAVAVVDGDRVLTYQELDEWAGRLAGRLIGRGIRRGDYVAVVMDRSAELVVTLFAVWKAGAVYVPVDAGYPARRVAFMVADSGSSLMVCSAATRDRVPEGIESIVVTAEGAGDASAVAVRPGDLAYVMYTSGSTGTPKGVAVPHRSVAELVGNTGWAMGTGDAVLMHAPYAFDASLFEIWVPLVSGARVVIAEPGPVDARRLREAVAAGVTRAHLTAGTFRAVAEESPESFAGLREVLTGGDVVPAHAVEKVRAACPRTRIRHLYGPTETTLCATWHLLETGDVLGPVLPIGRPLPGRRAQVLDASLRPVAPGVVGDLYLSGAGLADGYLGRPGLTAERFVADPSAPGSRMYRTGDLAQWTSDGALLFAGRADDQVKIRGFRIEPGEIEAALTAQPEVHEAVVTAVDGRLTGYVVAEGDADPVRIRERLGSVLPEYMVPAAVITLDALPLTGNGKVDRAALPAPVFAANAAGREPGTETERVLCGLLAELLGVDRVGVHESFFELGGDSIGAMRLAARAAKAGLLVTLAQIFEEPTPARLAAVARPVPAEGPVARPLVALTAEDETELAIAVPGAEEVWPPAPLQEGLLFQSTIDDEGLDIYQGQWILEVNGPVDVARLRAAWEAVFARHAELRVSFNRFASGKTLQVVARHVVLPWREVDLTDAGDVDAAVEALARREQEQRFDLARAPLFRLVLVRYGEDRHRLLVVHHHILADGWSVSVVLNEVSEAYTSGGRLPERTGAASYRDYLAWLDRQDKDAARAAWGAELSGLDEPATIARAAAGAGYEYRAASLTPDLYTGLMELARGHGLTLNTVVQGAWAMVLARLLRRTDVVFGTTVACRPAELPGVESMPGLMMNTVPVRVSLEGGKPVVDLLAGLQRRQAALIPHQHLGLPEIQKAAGPGAVFDTLLVFENYPRDFAGQFTYLGTVEGTHYPLTLGVLPGDHLRVQLAYRRGQIEETVAESVLGWFVGVLGALAADPSGLVGRTGIGAAPVGGSAAALVVEQSLPALIGRVVRERPNDVAVVDGDGDLSYAGLWERATALAAVLRARGVERESRVGVLVGRSAWSVVGMLGASLAGGAFVPVDPAYPAERVAWILGDADPVSVICVGKTREAVPAEFADRLIVVDEVEPAAGPDGKLPRVGPDDAAYVIYTSGSTGTPKGVVVTHAGLGNLAAAQIDRFGVSPSSRVLQFAALGFDAVVSETLMALLSGARLVLAPPQDMPPRVSLAEALERWDVTHVTVPPSVLATADALPAKLETVVVAGEACPPSLVDRWSAGRRLVNAYGPTEATVCAAMSMPLAASRDVVPIGTPIAGGRCYVLDAFLRPLPPGIIGELYVAGIGLARGYLGRAALTAERFVADPFVPVERMYRTGDLAYWTDRSELVFAGRADDQMKIRGFRVEPGEIESALSGHPGVAQAAVTVREDRLLAYVSPGDVDPQAVRDDLAARLPPHMVPAVVVALEALPTTPNGKIDRGALPDPDRMARPAGREPRTEVERVLCDLFAEVLGLERVGIDDSFFEIGGDSISSMQLVARARRAGLTFIAVDVFELRTPERLAQLAAQSRPQRSDRSAMADGVGEVAWTPVMRLLGDGVVGAGFAQWVVAGAPADLAEEVLVAGLAAVVDAHDMLRVRVDSERLVVGERGSVDVARLVERVEAGAGEVDDIADRCARPAVARLDPAAGAVVRVVWVDAGPGRMGRLVMVAHHLVVDAVSWRILLADLRVACEAVATGGKPALDPVDTSFRRWAGLLGEWAVSAERVGELAAWTEILGGAEPRLGDLERTRDAVSTVGRRSWTLPRDRAGALVEKVTSAFHCAVHEVLLAGLAAAVARWRGGDVVLVNVEGHGRHPVAGMDLSRTVGWFTSVHPVRLNVAGIDLTDVPGGGPAAGKLLKLVKEQARAAPGDGLGHGLLRFLNGDTGPVLAALPSPEIAFNYMGRFTGSARSGVRAWQPVGAVGGAMDPDMSPRHVLEVNAIVQDTRVGPELTLMLSWPADLFDEAEIERFGRTWLDMLSGLARQAEDPSAGGHTASDFDLLDLGQDEIESFEAIAAELNGGLPS	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	373.02	gnl|BL_ORD_ID|4935|hsp_num:0	5928			108	1629	colistin A; colistin B
BGC0001178.1|UK-68,597_10 # 14564 # 18673 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.713	BGC0001178.1|UK-68,597_10 	14564	18673	+	Loose	1000	124.405	almE	25.19	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGAACATTCCGGCGACGTCCCCCGGCTCGGCGCTCGCGGAGCTCTGGCCGCTGTCACCGATGCAGGAGGGCATGCTGTATCACGCCTCGTTCGACGACGAGGCCCCCGACATCTACCTCATCCAGCAGTCGCAGATCATCGACGGACCCCTGGACGCGGAGCGGTTCCGGAGATCTTGGGAGGCCCTCCTCAACCGGCACGCGGCGCTCCGCGCGTCCTTCCATCGGCGGAAGTCCGGCGAGACCGTCCAGCTCATTCCCCGGCAGGTGGAACTCCCGTGGGCCGAGTGCGACCTGTCCGACCTGGCCGAGGAGGACGCGCTGGCCGAGGCGAGCATGATCGCGGAGAAGGAGCGCGCCAGGAGATTCGACCTGACGAAGCCTCCCCTGCTGCGGCTGATGCTGATCCGGCTCGGTCCGCAGCGACACTGTCTGGTGACCACGAACCATCACCTGCTCATGGACGGATGGTCGCGGGCCATCCTCGAGTCGGAGCTCCTCGAGATCTATGAGACGGGTGGCGTCGTCTCGGGGCTGCGGCCCGCATACTCCTACCGCGACTATCTGGCATGGCTGGGCCGGCGGGACAAGGAGGCCGCCCGGTCGGCATGGCGTGCCGAGCTGTCCGGCGCCGACGGATCCGCGCTCGGGATCCCCGAGATGCCCGGCAGGGCTCCGGAACTGCCGGCGGCGGAGGTGATCCGCCACTCACCGGAGTTCACGTCCGCTCTGATCGAGTTCGCCCGCCGCCATGGGCTGACACTGAACACGCTGGTGCAGGGGGCGTGGGCGCTGGTGCTGGCCCGGCTGGCGCGCCGGACGGACGTGGTGTTCGGCGCGGCCGTTTCGGGGCGTCCGGCGGAGCTGCCCGGCACGGAGCAGATTGTCGGGCTGTTCATCAACACCGTGCCGGTACGCGTACGGCTGGACGGCGGGCAGTCGGTCCTGGAGATGCTGACCGACCTGCAGCAGCGGCAGTCCACGCTGATCGCGCACCACCATCTCGGATTGCCGGAGATCCAGAAGCTCGGAGGGGCGAGCTTCGACACGATCGTCGTGTTCGAGAACTACGTCGATCCGGCCGCGGCGCCGGACTCCCTTCGCGATCTCCGCCTGAGCCTGCGGGAGGTCCATCAGGCGTCGCCGTACGCGATCACTCTGGGCGTGATGCCGGGCGAGAGCCTGGAGACCGAAGTGCAGTATCGCCCGGACGCGCTCGACGTCCACGTAGCCAGGGAGATTCTGCACGGGCTCGCCCGCGTCCTGGAGCGGATGGTCGCGGAGCCGGAGGCAGCGGTGGGCCGCCTGGACGTGGTGAGTGAGACCGGGCGTGAGCTGACGGTCAAGCGGTGGAACGAGACGGGTGACGCGGTGGACGCGCCATCGGCGCTCGATCTGTTCCGTCGGCAGGTGGAGACGGCACCTGACGCGACAGCGATGACGGCTGGGGACCGGTCCTGGTCGTTCAAGGAGCTTGACGAGTGGTCCGGCCGGCTGGCGTGGGCCCTGGCGGACCGGGGCGTGCGGCGCGGCGACCGCGTCGCGGTGATGCTGGAACGGTCGGCCGAGGTGCTGGCGGCATGGCTCGGCGTGTGGAAGGCAGGAGCCGCCTTCGTGCCGGTCGATCCGGGCTACCCGGCCGACCGGGTGGCGTACATGCTGGCCGACTCGGCGGTCGCGGCGGTGATGTGCCGGAAGGAGACCTCGGGTGCGGTGCCGGCGGGTCATGTGCGGATCACCGTGGAGGACGCCGTCGAGGGCGAGGTCCCGCCGGTCGCGATCGGGCCGGACGATCTGGCGTACGTGATGTACACGTCCGGATCGACCGGGACGCCGAAGGGCGTCGCGATCCCACACGGGGGCGTGGCGGCATTGGCGGGAGATCCGGGTTGGGACGTGGGGGCCGGCGACGCGGTGCTGATGCATGCCCCGCACACCTTCGACGCGTCGTTGTACGACGTGTGGGTGCCGCTCCTGTCGGGTGCGAGGGTGCTGCTCGCCGAGCCGGGCGTCGTCGACGCGGAGCAACTCGTCGCCCATGTGGCGGATGGTCTCACCGCGGTGAACTTCACCGCGGGGCAGTTCCGGGCGCTGGCGCAGGAATCGCCGGAGTCCTTTTCGGGGCTGCGCGTCGTGGCGGCGGGTGGAGACGTGGTGCCGCCCGGCGCGCTGGAGCGGGTACGGCGGGCGTGCCCGCGGTTGCGTGTCTTGCATTCGTACGGCCCGACGGAGACCACGTTGTGCGCGACGTGGAAGACGATCGAGCCCGACGACCGGATCGGGCCGGTGCTACCGATCGGTCGGCCGCTGCCGGGCCGGCGGCTGTACGTGCTGGATGTCTTCCTGCGTCCGTTGCCACCGGGCGTCGCGGGTGACCTCTACATCGCGGGCGTCGGGTTGGCACATGGCTACCTGGGCAGTCCGGCGTTGACGGGCGGGCGGTTCGTCGCCGATCCGTTCGCCTCTGGTGAGCGGATGTACCGGACGGGGGACGTGGCGTACTGGACCGGCGAGGGCGAGTTGGTGTTCGCCGGACGGGCCGACAACCAGGTCAAGATCCGCGGCTATCGGGTGGAGCCGGGCGAGATCGAGACGGTGCTGGCGGAGCAGCCGGGTGTCGACCAGGCGGTGGTGCTGGCGCGTGACGGACGCCTGATCGGCTACGTGGTGTCCGGCGGTGGGGTGGATCCGGTACGGCTGCTCGAGCAAGTCGCCAGGGTGCTGCCGGACTACCTGGTGCCGGCGGCGGTGCTGGTGCTGGACGCGCTGCCGGTGACGGTGAACGGGAAGGTGGACCGGGAAGCGTTGCCGGATCCCGATTTCAGCGGACGGGTCTCCGAGCGGGAGCCGGTCACGGCAGCCGAGCAGGTGTTGTGCGGCCTCTTCGCCGAGGTGCTCGGTCTGGAGCGGGTCGGCGTGGACGACAGCTTCTTCGAGGTGGGCGGGGACTCGATCACCTCGATGCAGCTCGCCGTGCGGGCCCGCCGCGCCGGGTTGATCTTCGGTGCGCGGGAGGTGTTCGAGCATCGGACGCCGGCCGGGATCGCGGCGATCGCCGAACCGAGAGACGAGTCGCCGGGCGGTACGGCCGATGGTGTGGGCGAAGTGGCGTGGACGCCGGTGATGCGACTGCTTGGCGACGGGGTGCTGGCTGCGGGGTTCGCGCAGTGGGTGGTGGTGGTTGTGCCCGCGGACCTCACGGAGGAGGTGCTGCTGGCGGGGTTGGCGGCCGTGGTGGACAGGCATGACATGTTGCGGCTGCGGGCCGAGCCGGCGGGGTTGGTGGCGGGCGCACCCGGGTCCGTGGAGGTGGCCGGTCTGGTGCGACGGGTGCACGTCGACGGGGATTCGGTGGACGAGACGACGGAGGCGGCGGTGCGGGCCGCGGTGGGGCGGTTGGAGCCGGCGGCGGGCGTGGTGATGCAGGCGGTGTGGGTGGATGCGGGGCCGGACCGGTTGGGGCGGCTGGTGCTGGTGGCGCATCACCTCGCGGTCGACGAGGAGTCGTGGCGGGTTCTGGTGCCGGATCTGCGGGCGGCCTGTGCGGCGGTGGCCTCGGGACGGGCTCCGGTGCTGGAGCCGGTGGCGGTGTCGTTCCGGCGGTGGGCCGGTCTGCTGGGGGAGTGGGCGGTCTCCGCGGCGCGGGTGGGCGAGCTGGCGGAATGGCACGCGGTCGTCGGTTCGGGGGATCAGCTCATCGGCGGGACGGGCCCGAAGGCCGGGGAAGTGTGTTCGCGGTCGTGGGTGGTGTCAGGGGGCGCGGGCGTCGGTGTTGGTGGAGCGTGCGCCGGCGGTGTTCTTCTGCGGGGTGCACGAGGTGGTGCTGGCCGCGCTGGTGGGCGCGGTGGCGCGGTGGCGGGGCGGCGAGGTGGTGCTGGTCGATGTGGCGGGTCATGGCCGTCAGCCGGTCCACGGGCTGGATGTGTCGCGGACGGTGGGCTGGTTCACCAGCGTGCATCCGGTGCGGCTGGATGTGGCGGGCCTCGACCTGACGGGCGTGCTGGCCGGTGGCCCGGCGGCGAGCGAATTGCTGAAGGTGGTCAAGGAGCAGTCGCGGGCGGTGCCGGGCGACGGGCTCGGCTACGGCTTGTTGCGGTTCCTCAATGGTGA	MNIPATSPGSALAELWPLSPMQEGMLYHASFDDEAPDIYLIQQSQIIDGPLDAERFRRSWEALLNRHAALRASFHRRKSGETVQLIPRQVELPWAECDLSDLAEEDALAEASMIAEKERARRFDLTKPPLLRLMLIRLGPQRHCLVTTNHHLLMDGWSRAILESELLEIYETGGVVSGLRPAYSYRDYLAWLGRRDKEAARSAWRAELSGADGSALGIPEMPGRAPELPAAEVIRHSPEFTSALIEFARRHGLTLNTLVQGAWALVLARLARRTDVVFGAAVSGRPAELPGTEQIVGLFINTVPVRVRLDGGQSVLEMLTDLQQRQSTLIAHHHLGLPEIQKLGGASFDTIVVFENYVDPAAAPDSLRDLRLSLREVHQASPYAITLGVMPGESLETEVQYRPDALDVHVAREILHGLARVLERMVAEPEAAVGRLDVVSETGRELTVKRWNETGDAVDAPSALDLFRRQVETAPDATAMTAGDRSWSFKELDEWSGRLAWALADRGVRRGDRVAVMLERSAEVLAAWLGVWKAGAAFVPVDPGYPADRVAYMLADSAVAAVMCRKETSGAVPAGHVRITVEDAVEGEVPPVAIGPDDLAYVMYTSGSTGTPKGVAIPHGGVAALAGDPGWDVGAGDAVLMHAPHTFDASLYDVWVPLLSGARVLLAEPGVVDAEQLVAHVADGLTAVNFTAGQFRALAQESPESFSGLRVVAAGGDVVPPGALERVRRACPRLRVLHSYGPTETTLCATWKTIEPDDRIGPVLPIGRPLPGRRLYVLDVFLRPLPPGVAGDLYIAGVGLAHGYLGSPALTGGRFVADPFASGERMYRTGDVAYWTGEGELVFAGRADNQVKIRGYRVEPGEIETVLAEQPGVDQAVVLARDGRLIGYVVSGGGVDPVRLLEQVARVLPDYLVPAAVLVLDALPVTVNGKVDREALPDPDFSGRVSEREPVTAAEQVLCGLFAEVLGLERVGVDDSFFEVGGDSITSMQLAVRARRAGLIFGAREVFEHRTPAGIAAIAEPRDESPGGTADGVGEVAWTPVMRLLGDGVLAAGFAQWVVVVVPADLTEEVLLAGLAAVVDRHDMLRLRAEPAGLVAGAPGSVEVAGLVRRVHVDGDSVDETTEAAVRAAVGRLEPAAGVVMQAVWVDAGPDRLGRLVLVAHHLAVDEESWRVLVPDLRAACAAVASGRAPVLEPVAVSFRRWAGLLGEWAVSAARVGELAEWHAVVGSGDQLIGGTGPKAGEVCSRSWVVSGGAGVGVGGACAGGVLLRGARGGAGRAGGRGGAVAGRRGGAGRCGGSWPSAGPRAGCVADGGLVHQRASGAAGCGGPRPDGRAGRWPGGERIAEGGQGAVAGGAGRRARLRLVAVPQW	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	246.22	gnl|BL_ORD_ID|4935|hsp_num:0	5928			117	1629	colistin A; colistin B
BGC0001178.1|UK-68,597_11 # 18624 # 19070 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=12bp;gc_cont=0.716	BGC0001178.1|UK-68,597_11 	18624	19070	+	Loose	2090	25.409	mdsB	44.83	3000790	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCCGGGCGACGGGCTCGGCTACGGCTTGTTGCGGTTCCTCAATGGTGAGACCGGGCCGGAGCTGGCGGCGTTGCCGTCGCCGCAGATCGGGTTCCACTACCGGGGCCGGCACGTCGCCGGTGTGCGGGAGTGGGAGCCGGTCGGGGGCGTGGGCGGTGCGTCGGGGCCGGGCCTGGATCTGCCGCATGTGCTGGACGCCGACGCGGTGGTCGAGGACGGGCCGGAGGGGCCGCGGCTGCGGCTGGTGCTGAACTGGCCGGCCGGCTCGCTGGCGGAGAACGAGATCGAGCGGCTGGGTCGCGGTTGGTTGGACATGTTGTCCGGGCTGGCCGGTCAGGCAGATGATCCCTCGGCGGGGGGACATACCGCGTCCGATTTCGACCTCCTCGACCTGGACCAGGACGAGATCGAGGAACTCGAGGCCGAGTTCGCCGACGACCTCTGA	MPGDGLGYGLLRFLNGETGPELAALPSPQIGFHYRGRHVAGVREWEPVGGVGGASGPGLDLPHVLDADAVVEDGPEGPRLRLVLNWPAGSLAENEIERLGRGWLDMLSGLAGQADDPSAGGHTASDFDLLDLDQDEIEELEAEFADDL	MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIADTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRLPEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVWGAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLGRLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGANAIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMFLQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTILSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAVRRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVVKQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKLMHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPELANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRAWRVMAQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPAPGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQYNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARAKEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGMLGVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA	14.03	gnl|BL_ORD_ID|1269|hsp_num:0	1385			2286	2358	chloramphenicol
BGC0001178.1|UK-68,597_12 # 19111 # 31326 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.729	BGC0001178.1|UK-68,597_12 	19111	31326	+	Loose	1000	117.087	almE	28.65	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACCCAGTCGCGGATCGAGGACGTCTGGCCGCTGTCCCCACTACAGGAAGGTCTGCTCTTCCACACCGTCTACGACGACGAAGGGCCCGACGTCTACGTAGGACATTGGATCCTGGATCTCGACGGGCCGGTGGACGTGGACAGGCTGCTCGCGGCATGGGAAGCGCTGCTGGCCCGGCACGCCTCGCTCCGGGCCTGCTTCCGGCAGCGCCGGACGGGTGAGACGGTGCAGATCATCGCCAGCCGGGTGGAGCTGCCGTGGCGCGTGGTCGACCTCTCCCACCTCGACGATGCCGAGGAGGCCGGGCGAGCGCTGGCCGAGGAGGATCGGCTGAGGAACTTCGACCTCGCGAAGGCGCCGTTGCTGCGGCTGACCCTGATCCGGCTGGCCGGCGACCGGCACCGCCTGGTGGTGACTTGTCATCACGCGGTCATGGACGGCTGGTCGTTGCCCATCGTCTTCGACGAGTTGTCGACGCTGTACGCCGCCGACGCCGGCGGCCGGCCGGACCTGCCGGCAGTGACGTCGTACCGCGAATATCTCGCGTGGCTGAGCCGGCAGGACAAGGAGCGGGCGCTCTCGGCGTGGGTGGCGGAGCTGCGTGGTGCCGAGGAGCCGACGCTGGTGGCGCCCGCCGATCCGGGACGAGCGCCCGGCATGCCGGAGAGCGTCACGGTCCAGCTGCCGGAGGACCTCACGCGCGCGCTCGACGGGCTGGCTCGCGGCCGAGGGCTGACGCTGAACACGCTGGTCCAGGGGGCGTGGGCGGTGGTGCTGGCCCGGCTGGCGGGCCGGACGGACGTGGTGTTCGGCGCGACGGTGTCGGGGCGCCCGGCGGATCTGCCCGGCGTGGAAGAGATGGTCGGGCTGTTCCTCAACACCGTGCCGGTACGCGTGCGGCTGGACGGCGGTCAGCCGGTCCTGGAGATGCTGGCGGACCTGCAGCAGCGGCAGTCGGCGCTCATACCCCACCAGTTCCTGGGGCTGGCCGACATCCAGAAGGCGGCCGGCCCGGTCGCGGTCTTCGACACCCTGCTCGTTGTCGAGAACTTTCCGCGTGAGCTCGGCGAACCGCCCTCCGCCGACACCTTCGGCATCCGGGTGCAGCAGGGCCGGGAAGCCGCCCACTATCCGCTGACGCTGGTCGCCGTCCCCGGCGAGTCGATGCTCATCAAGCTGGACTATCTGACGGATCTCTTCGACGAGGCCACGGCACTCTCCATTGTCGAGCGCTTCACGAGGGTGCTGCGCCAGCTGACGGGTGCGGGCGTGCGCACGGTGGCCGAGATCGATGTGACGAGTGCGGCCGAGCGCGATCTGGTGGTGCGGGACTGGGGTGCCGCCGCCGGCGTGGTGCCGAGCCGGCTGGCCCTGGATCTGTTCGGCCGCCAGGTGGAACGCCGCCGCGACGAGGTGGCGGTCGCCGACGGCGACCGGACGTGGTCGTTCGGGGAGCTCGCCGAGCACGCGGAGCGGATCGCCGGCTATCTGGGCGACCGGGGAGTCCGCCGCGGTGACCGGGTGGCCGTGGTGATGGAGCGGTCCTCCGAGCTGATCGCGACACTGCACGCGGTGTGGCAGGCGGGCGCGGCGTTCGTGCCGGTGGATCCCGCCTATCCGGTGGAACGCGTGAAGTTCATGCTGGCCGACGCCGAGCCGGCGGCGGCGGTGTGCGCCGAGGCGTTCCGCGCCGCCGTACTGGACGTCGGTCTCGACCCGATCGTCCTGGACGATCCGCGGACGCGGCAGTCGGTGGCGGAATCCGCGCCGCGGACCGTCGCCACCGGAGCCGACGACCTCGCCTACGTGATGTACACCTCGGGCTCGACGGGGACGCCGAAGGGCGTCGCGGTGTCGCACGGCAACGTCGCGGCGCTGGCCGGGGAGCCGGGGTGGGGGGTGGGCCCGGGCGACACCGTGCTGATGCACGCCTCGCACGCGTTCGACATCTCCCTGTTCGAGTTGTGGGTGCCGCTGCTGTCGGGCGCCCGGGTGATGATCGCCGGGCCGGGCGCGGTGGACGGCGAGGCCCTGGCCGGGCACGTGGCCGGCGGCGTCACGGCTGCCCACCTGACCGCGGGCGCCTTCCGGGTGCTGGCCGAGGAGTCGCCGGAGTCGGTCGCCGGCCTGCGCGAGGTGCTGACCGGTGGGGACGCGGTGCCGCCGGCGGCGGTGGAGCGGGTGCGGCGGGCGTGCCCGGACGTCCGGGTGCGGCATCTCTACGGCCCGACGGAGGCCACGCTGTGCGCGACGTGGTGGTTGCTCGAACCCGGCGACGAGACGGGATCGGCACTGCCGATCGGCCGTCCGCTCGCGGGACGGCGCGCCTACGTCCTCGACGCGTTCCTGCGCCCCCTGCCGCCGGGGGTCAAGGGCGAGCTGTATGTCGCCGGGGCCGGCGTGGCACGGGGCTACCTGGGGCGTCCGGCGTTGACGGCCGAGCGGTTCGTCGCCGATCCGTTCGCCCCCGGCGGGCGGATGTACCGGACCGGAGACCTGGCGTACTGGACCGACCAGGGTGCGCTGGTGTTCGCCGGGCGGGCCGATGACCAGGTCAAGATCCGTGGCTATCGGGTGGAGCCGGGCGAGGTGGAGGCGGTCCTCGGGCGCCTGCCGGGTGTCGGCCAGGCCGTGGTGTCCGTACGGGAAGAGCATTTGATCGGCTATGTGGTCGCCGAGGCGGGACAGGACGTCGACCCGGCCCGGCTGCGCGAACAGCTCGCCGAGACGATGCCCGAGTTCATGCTCCCGGCCGCGGTGATGGTGCTGGACGACCTGCCGTTGACGGTCAACGGCAAGGTGGACCGGCAGGCCCTGCCCGCACCGGACTTCGCCTCGAAGTCGGCGGGCCGGGCGCCGGCCACCGCGACCGAGCGGCTCCTCTGCGACGTGTTCGCCGAGGTTCTGGGCCTGGAACGGGTCGGAGTCGAGGACAGCTTCTTCGCGCTGGGCGGGGACTCGATCTCGTCGATGCAGGTGGCCGCCCGCGCGCGCCGGGAGGGGATCTCCCTGACCCCGCGCCAGGTGTTCGAGCAACGGACTCCGGAACGGCTGGCGGCGCTGGCCCGGGACGCCCGATCGACGCGACGGGACAACACCGCGGCGGATGCGGGCATCGGAGAGATTCCGTGGACGCCGGTGATGCGTGCCCTCGGGGACGACGCGGCGCGCCCCGGCTTCGCCCAGGCGAGGGTCGTCGTCACACCGGCCGGCCTCGACCCGGGCGCGCTGGCCGTCGCCCTGCAAGCGGTGCTGGACACCCACGATGTGCTGCGCGCGCGGGTGGCGCCCGGCGAACGGCTGCTGGTACCCGAACGGGGCGCCGTGGCCGCGGCGGAGCTGATGACGCGGGTGGCGGCCGGCACCGGGAACCTGGACGAGATCGCCGAGCGCGAGGCCGGGACGGCGGCGGGCACGCTGAACCCGGCGGCGGGGATCATGGTGCGGGCCGTGTGGCTCGACGCCGGAGACACCGAGCCGGGCCGGCTGGCACTGGTCGCGCATCACCTGGTGGTCGACGCGGTCTCGTGGGGCATCCTGCTGCCGGATCTGCGCGCGGCGTACGACGAGGTGATCTCCGGCGGGACCCCCGACCTCGAACCCGAGGCGACCCCGTACCGGCAATGGGTGCGGCGGCTGACCGAGCAGGCGTTCAGCGAGAGCACCGTGGCCGAGGCCGATTACTGGGTCACCGTGCTGGACGGAGCGGACCGGCCGTTGGAGCAGCGCACCGGGCAGTCGCACTCGTGGTCCTCGACCGTGTCCGGAGCCGCGGCGCGCAGCCTGGTGGGCCGGCTGCCAGGTGCCTTCCACTGCGGGATTCAAGAGATCCTGCTCGCCGGCCTGGCCGGAGCGGTGGCGCGCCGGCGCGGCGCTGACGCCGGGGTGCTGGTGGACGTGGAAGGCCATGGCCGGCATGCCGTCGACGGCGAGGACCTGTTGCGCACCGTGGGCTGGTTCACCAGCGTCCACCCGGTCCGTCTCGATGTCTCCGGCGTCGATCTGGCGGCCGCGGCGGCCGGGAACGAGGCCGCGGGCGAGCTGTTGAAGGCCGTGAAGGAGCAGGTCCGCGCGGTGCCCGGCGACGGGCTCGGCTACGGGCTGCTCCGCCATCTCAACCCCGGCACCGGGGCCAGGCTGGCCGCGTTGCCCTCCCCGCAGATCGGATTCAACTACCTCGGCCGGTCCGGCGTCGCCTCCGAGATCACCCCTTGGCAGGTGCGCGAGGGATCGCTCGGCGCCGGAGAGTCCGGTCCCGACCTGGTCCTGGCGCACGCGCTGGAGGCCGGCGCGGACATTCAGGACACCCCGGCCGGCCCCCGGCTGCGGCTCACCCTGGCCGGCAGGGATCTCGACCCCGCCGTGGTGGAGCTGCTCGGCGAGGCCTGGCTGGAGCTGCTGACCGGCCTCGCCACCCACGCCGGCACGCCCGACGCCGGTGGACACACCTCGTCCGACTTCGACCTGGTCGAGGTGGCGCAGCGGGACGTGGCGGAGCTGGAGGCGGCGGCGCCGGGGCTGACGGACATCTGGCCGCTGTCGGCACTTCAGGAGGGCATGCTCTTCGAACGCGCCCTCGATGAGGAGGGGGTCGACGTCTACCAGAGCCAGCGGATCCTCGACCTCGACGGGCCGCTCGACGCGGACCGGCTGCGCGCGGCATGGACATCGCTGGTCACCCGGCACGACTCGCTCCGGACAACCTTCCATGAGCTGGGATCCGGGGAAACGGTGCAGGTGGTCGTGGCCGAGGCCGACATCCCGTGGCGGGTGGCGGATGTGTCGCAGCTCGATGAGGTGGACGCGGCCGCGGAGGTCGAACGCCTCCTCACCGAGGATCAGGCGGAGCGGTTCGATGTCACCAGGGCGCCGCTGCTCCGGCTGTTGCTGATCCGTCTCGGCGAGAACCGCCACCGGCTCGTGGTGACGTCGCACCACATCGTCCTGGACGGCTGGTCGACACCGATCATCCTGGGTGAGATGTCGGCCACGTACGCGGGTGAGCAGGGCTCGTCGACGTCGCCCTCCTACCGGGACTACCTGGCATGGCTGAGCCGTCAGGACGAGGCGGCGACCCGGTCGGCGTGGCGCGCCGAGTTCGCCGGATCGGACGAACAGACGGTGGTGGACGCCGACGCGGGCAAGACCATGGTGATGCCGGACGAGCACTGCGAACCGCTCTCCGAGGAGGCGACCCGGAGCCTCACGGAGTTCGCACGAGGCCATGGACTGACGCTGAGCACGATCGTGCAGGGCGCCTGGGCGCTGGTGCTGGCGCGGCTGGCGGGCCGGACGGACGTGGTGTTCGGGACGGTGGTGGCGGGACGCCCCGCGGACGTGCCGGACGTCGAGCGGATGGTGGGGATGTTCATCAACACCATCCCGGTCCGCGTGCGCCTCGACGGCGGCCGGCCGGTGCTGGATCTGCTCCACGACCTGCAGGCGCGCCAGGCGGCGATGACCGAGCACCAGTACATGGGGCTGCGGGAGATCCAGAAAGTGGCGGGGCCCGGAGCGACCTTCGACACCATCATGATGGTCGAGAACTACCCGATGGACGCCACCGTCCTGGGCGACGACAGTGGTGTCACGATCGGCTCGGTCGTCACCCGGACCGGCACCAGCTATCCGCTGACCATGAGCGCCAGTCCCGGCAAGCGCCTGCAGATCCGCGTGTCCTACCGGCCCGATCGCATCGGCCAGGAGACGGCCGCCGAGGTCGCCAGGCAGGTCGTGCGGGTCATGGAACGGATGGTGGCGGAGCCCTCGCTTCCCGTCGGCCGGATGGCTGTGACGAGCGAGCCGGCGCGCGCCGCCGTGCTGGAGCGCGGGAACCCGACCGCCGAAGCAGCCGGTGGGCCGTCGGTGGTGGAGACCTTCCGGCGGCGATCGCACAGCTCACCGGACGCGGTGGCGGTCATGGACGGGGGACGCACCCTGTCCTACGCCGACCTCGACCGGGAGTCGGACCGGCTTGCCGCGCACCTGGCCGATACGGGTGTGCGGCGCGGTGACCACGTCGGCGTGGTGATGGCACGCGGCGTCGATCTGTTCGTCGCCTTCCTCGCGGTCTGGAAGGCGGGAGCTGGGTACGTACCGGTGAACCTGGACTACCCGCGGGAACGGATCGCGCGGATGCTGACCGATGCCGGCGCCTCGGTGGCGGTCTGTGTGGAGGCGACCAGGGACATGGTGCCGGCCGGGGTCGAGCCGGTGGTCCTCGACGCACCGGCGACCGGGGGAGCGCCGCACGAGGCGCCGCCGCTCACGGTCGGAGCGCACGACGTGGCGTACGTGATGTACACGTCGGGATCCACCGGGGTGCCGAAGGGCGTCGCGGTGCCGCACGGAAGCGTGTCGGCGCTGGCGAGCGACCCGGGCTGGTCGCTCGGCGCCGGGGACTGCGTCCTGATGCACGCCTCGCACGCGTTTGACGCGTCGTTGGTCGAGATCTGGGCGCCGCTGGTCAGCGGAGCCCGGGTGCTGGTCGCGGAACCGGGCGCGGTCGACGCGCAGCGGCTGCGGGAGGCGATCGCCCGCGGTGTGACCACCGTCCATCTGACGGCCGGGGCCTTCCGGGCGCTGGCGGAGGAGTCGGCGGACGCCTTCAGCGGCCTGCGCGAGGTCCTGACCGGCGGGGACGCCGTACCCCTCGGCTCCGTCGCCCGGCTGCGCGAGGCCTGCCCGGACGTCCGGGTCCGGCATCTCTACGGCCCCACCGAGACGACCCTCTGCGCCACGTGGCACCTGATCGAGCCGGGATCCGCGACGGGCGACACCTTGCCGATCGGTCGCGCCCTGGCCGGCCGGCGGGCGTACGTGCTCGACGCGTTCCTGCAGCCGGTGGGTCGGCACGTGACCGGCGAGCTCTACCTCGCCGGCGCCGGGCTGGCGCGCGGCTATCTGGGCGCCGCCGGGGCGACCGCGGAGCGGTTCGTCGCCGACCCCTTCGTCCCCGGTGAGCGGATGTACCGCACCGGCGACCTGGCCCGCTGGACGGATCGGGACGAGCTGCTGTTCGCCGGCCGCGCCGACTCCCAGGTGAAGATCCGCGGCTACCGGGTCGAGCCGGCGGAGATCGAGGCGGCGCTGGCCGAGGTGCCCCGGATCGCGCAGGCGGTTGTCGTGGCGCGGGAGGACCGTCCGGGCGAGAAGCGGCTGATCGCCTACGTCACCGCGGCGGAAGATCCAGGACCGGACCCCGGCGCGGTACGCGAGCACCTGGCGACGCGGCTGCCGGAGTTCATGGTGCCGGCGGCGGTGGTGGTGCTGGACGGCTTCCCGCTGACGGTCAACGGGAAGATCGACCGCGCGGCGCTGCCTGCCCCCGAGCTCACCGGGAAGCCGGCCGGCCGCGAGCCCCGTACCGAGACCGAGCGGGTGCTGTGTGACATGTTCGCCGAGATCCTCGGGCTGGAGCGGGTCGGTGCCGACGACAGCTTTTTCGAGCTGGGCGGAGACTCGATCCTGTCGATGCAGCTGGCCTCCCGCGCGCGCCGCGAGAACGTCGTCTTCGGCGCGACGGACGTCTTCGACCGGAAGACGCCGGCGGGCATCGCGGCGATCGCCGAGCGCGGCGGTGAGACGCGGGCCGACCTCACCGACGGCGTCGGCGAGGTCGCGTGGACGCCGGTGCTGCGGGCGTTGCTCGAAGGCGATCCCGGCGCGATGACCCGGGGAGCGCTGGCGCAGTGGACGACGGTGGGCGCGCCCGACGACCTGTCGGTGGACACACTGGCGGCCGGGTTGGGCGCGCTGATCGACACGCACGACATGCTGCGGAGCCGGGTCGTCGGGACCGGGGGACAGGAGCCCCGGCTGGTCGTGGCCGAGCGCGGCACGGTGGACGCGACGAGGCTGGTCGACCGGGTCGAGGCCGGTGCCGGTGAGCTGGATGACGTCGCGGATCGCTGCGCCACGGAGGTGGCCGCCCGGCTGGATCCCGCCGCCGGCGTGATGGTCCGGGCGGTGTGGGTGGACGCGGGAGCCGGGCGTGCCGGACGGCTCGTGGTGGCGGCGCACCACCTCGTGGTCGACGCGGTGTCGTGGCGGATCCTGCTGCCGGACCTGCGGGCGGCGTGCGAGGACGTGGCCGCGGGCCGGGAGCCGGCGCTCGATCCGGTGGACGTCTCGTTCCGGCGCTGGGCGCGGACGCTCGCCGATCAGGCGGCGGCCCGGACCGCGGAGCTGGAGACGTGGACGGAGATCCTCGGCGCGGAGGAGCCGCGGCTGGGCGAGCTCGACCCCGCGCGCGACACCATATCGAGCGCGGGACGCAGATCGTGGACACTGCCGCGGGAGCAGGCGGGCGCGCTCGTGGAGAGGGTCACCGCGGCCTTCCACTGCGGTGTGCACGAGGTGTTGCTGGCCACGCTGGCGGGCGCGGTGGCTCGATGGCGCGGCGGCACCGCCGTCGTGGTGGACGTCGAGGGTCATGGCCGCCAGCCCATCGGCGCGATGGACCTGTCGCGGACGGTCGGCTGGTTCACCGACGTGCACCCGCTCCGGCTGGACGTGACGGGGATCGACATGGCCGCGGCGCTCGCGGGTGGCGATGCGGCCGGCCGGCTGCTGAAGAGCATCAAGGAGAGCGTGCGAGCCGTGCCCGACGGCGGGCTCGGCTACGGGATGCTGCGTCACCTCAACGCCGAGACCCGGCCGGTCCTGGCGGCGCGGCCGGCAGTGGAGTTCGGTTTCAACTACCTGGGCCGCTTCTCCTCCCGGTCCGGCGGTGACGTGGAGCCCTGGCAGCCGGCCGGGACCATCGGCGGTGCGGCGGAGCCGGACGTTCCGCTGCGGCACGTCGTGGAGATCGACGCGGCCGTGCTCGACTCCGTGGACGGACCCCGGCTCGACCTGACCCTGACGTGGGCCGGGCGGATCGTCAGTGAGGCCGAGGCGGAGTCACTCGGGAAGGCATGGCTGGACATGCTGACCGGCCTGGCCGCACACGCCCACGACGTCCGCGCCGGGGGGCACACCCCGTCCGACTTCCCGCTCACCGCGCTGGCGCAGCGAGACGTGGCGGAGATCGAGGCCGTCGTACCGGGTCTGCTCGACATCTGGCCGCTCTCTCCGCTGCAGGAGGGCCTGCTGTTCCATGCCGCCGACGAGCGCGGCCCGGACGTCTACGCGGGTATGCGCACCCTCGCCATCGAGGGCCCGCTCGACGTCGCCCGCTTGCGCGCGTCCTGGCAGGCCGTTCTCGACCGGCACGCCGCCCTGCGGGCGAGTTTCCATCAGCTCGAGTCCGGCACGGCCGTGCAGGTGATCGCCCGCGAGCTGACGCTGCCCTGGCGGGAGACCGACCTGTCGCACCTGCCCGAGGATGAGGCGCTGGCCGAGTTCGAGCGTCTCGTGGCGGAGTTGCGCGACGACCGATTCGACCTGACCCGGGCGCCACTGCTGCGCCTGCACCTGGTGCGCCTCGGGGAAGGCCGGCACCGGCTGGCCCTCGCGTCGCATCACATCTCGTGTGATGGCTGGTCCCTTCCGGTCCTCTCCGTCGACGTCATGGCGGCGTACGAGGCCGGCGGTGACGGCCGGGCCCTGCCGGCTCCGACGTCGTACCGCGAGTACCTCGCCTGGCTCGCGCGCCAGGACAAGGAGGCCGCCCGGGAGGCGTGGCGGACCGAACTCGCGGGGCTCGACGAGGCGACCCATGTCGTGCCGCCCGACACGATCAGCGCGCCCATCGAGCCGGAGCGGGTACGGTTCGCGCTCGACGACGAGCTGAGCCGGCGCCTGGTGGAGTTCACCCGCCGCCACGGCGTGACGATGAATACCCTCTTCCAGGGGGTCTGGGCGCTGTTCCTGGCCCGGCTGACGGGACGCGACGACGTGGTCTTCGGTTCCGCCGTGGCCGGGCGCCCGCCGGAGATCCCCGGCGTCGGATCCGTGGTCGGCCTGTTCATGAACACGCTGCCGGTCCGGGCTCGCCTGGACGGCGCCGAGCCGTTCCTCGACATGCTGACGGATCTGCAGGGTCGGCAGGTCGCGATGATGGCGCACCAGCACGTCGGGCTCAGCGAGATCAACCAGTTCGCCGGTCCCGGCGCGGCGTTCGACACGCTCGTGGTGTTCGAGAACTACCCTCGCCCGCCGCGTCGGTCCGAAGGCCCCGATGCGCTTGTCATGCGCCCCGCGGGAATTCCGAACGACAGCGGGCACTACCCGGTGTCGATGCGCGCGTCGGAGGACGGCGGCGTCCACGGTGAGTTCATCTTCCGCCCGGACGCGTTCGACCGGCCCCAGGCCGACGAGATGCTCGCGAGCATCATCCGGGCCTTGGAACAGGTGGTGACCGATCCACGGATGCCGGTGGGGCGGGTCGGCCTGATCGGTGCGGCGGAGCACGGACTGGTGGTGCGCGAGTGGAACAGGACCGCTGTGCCGCTCGTGGCGGAGCCGCTGCCGGTGTTGTTCCGCCGGCAGGTGGAACGGTCGCGGGATGCGGTGGCGGTGCGGGACGCGGCCCGGAGCCTGTCGTTCGGTGGGTTGCTGGGTGCGGCGGAGGGCCTGGCGCGGCTGCTGGTGACGGCGGGCGTGCGGCGTGAGACCCGGGTGGCTGTGCTCGTGGAGCGGTCGGTGGAGCTGGTGGTGGCCCTGCTCGGGGTGTCGCTGGCGGGCGGGGTGTTCGTTCCGGTCGATCCGGACTACCCCGGTGAGCGGATCGCCTTGATGCTGGCGGATTCGGCGCCGAAGGTGCTGGTTTGCACGTCGGAGACCCGAGCGGTCGTGCCGGCGGGCTTCGCCGGCGCGGTGCTGGTGCTGGACGAGCCGCCCGCCGCCGAACCGGAAGCGGTGCTGCCGGGCGTGGTGGCGGGTGACGGCGCGTACGTGATCTACACGTCGGGGTCGACGGGCGTGCCCAAGGGCGTCCTGGTCACCCACGCCGGGCTCGGCAACCTGGCGAGCGCGCAGATCGAGCGGTTCGGCGTGACGTCCGCGTCGCGGATCCTGCAGTTCGCCGCGCTCGGATTCGACGCCGCCATCTCCGAGGTGTGCATGGCTCTGCTGTCGGGCGGGACCATCGTGCTGGCCGACGCCGAGAGCATGCCGCCTCGAGTGTCGCTGGGCGACGCGGTACGCCGGTGGAGCATCACCCACGTCACCGTGCCGCCGAGCGTGCTGGCCGTCGAGGACGACCTCCCGGAAAGTCTGGAGACCCTCATCGTGGCGGGCGAGGCGTGCCCGCCCGCGCTGGTGGATCGCTGGTCGCGGGGCCATCGGATGATCAACGGCTACGGGCCGACCGAGACGACCGTGTGCGCGACCATGAGTTCCCCGCTGTCTCCGGGCCGCGACGCGGTCCCCATCGGTGGCCCGATCACGAACATGCGGGCCTATGTGCTCGACGCCTTCCTGCAGCCGGTGCCGGTGGGCCTGGCCGGCGAGCTCTACGTCGCGGGGGCCGGGCTCGCCCGCGGCTACCTCGGGCGCCCGGGCCTGACGGCGGAACGGTTCGTCGCCGACCCGTTCTCTCCGGGTGGCCGGATCTACCGCACCGGCGATCGGGTCCGCTGGACCTCCGGCGGTGAGCTGGTCTTCGTCGGCAGGGCCGACGCGCAGGTCAAGGTGCACGGATACCGGATCGAGCCGGGTGAGATCGAGGCCGTGCTGGCCGAGCACCCAGAAGTCGCCCAGGTGGTGGTCGTCGCCCGACAGGACGGGCCGGGCGAGAAGCAACTGGTGGCTTACGCCGTCCCGGCGAACGGACCGTCGGCCGACTCCGCCGCGCTGATCTCCGCTCTCCGGGAGACGGCGGCCGCACGCCTACCGGAGCACCTGGTGCCGGCGGCGTTCGTGCCGCTGGACACGATGCCGCTGACCCCCAACGGCAAGGTCGATCACCGGGCGCTCCGGGCCCCCGACTTCGCCGGGATGTCGTCCGGGCGGGACCCGCGCACGGCCATGGAGACGAGGCTGTGCGAGCTGTTCGCGGAGGTGCTCGGCCTGGACCGGGTGGGCGCCAACGACAGCTTCTTCGAACTCGGCGGCGACTCGATCACTTCGATGCAGCTGTCCACCCGGGCCCGCCGGGAAGGTCTGGAACTGACCCCGTGGCAGGTGTTCGACGAGAAGACGCCGGAACGGCTGGCGGCACTCGTCAAGGAACTCCCGGCCGAGGACGAGGACACCGGGGTGCCGGAGTCCCCGGCGGGCCCGCTCGTGGCTCTTTCGCCTGAACAGATGGACCAACTAGAGGCCTGA	MTQSRIEDVWPLSPLQEGLLFHTVYDDEGPDVYVGHWILDLDGPVDVDRLLAAWEALLARHASLRACFRQRRTGETVQIIASRVELPWRVVDLSHLDDAEEAGRALAEEDRLRNFDLAKAPLLRLTLIRLAGDRHRLVVTCHHAVMDGWSLPIVFDELSTLYAADAGGRPDLPAVTSYREYLAWLSRQDKERALSAWVAELRGAEEPTLVAPADPGRAPGMPESVTVQLPEDLTRALDGLARGRGLTLNTLVQGAWAVVLARLAGRTDVVFGATVSGRPADLPGVEEMVGLFLNTVPVRVRLDGGQPVLEMLADLQQRQSALIPHQFLGLADIQKAAGPVAVFDTLLVVENFPRELGEPPSADTFGIRVQQGREAAHYPLTLVAVPGESMLIKLDYLTDLFDEATALSIVERFTRVLRQLTGAGVRTVAEIDVTSAAERDLVVRDWGAAAGVVPSRLALDLFGRQVERRRDEVAVADGDRTWSFGELAEHAERIAGYLGDRGVRRGDRVAVVMERSSELIATLHAVWQAGAAFVPVDPAYPVERVKFMLADAEPAAAVCAEAFRAAVLDVGLDPIVLDDPRTRQSVAESAPRTVATGADDLAYVMYTSGSTGTPKGVAVSHGNVAALAGEPGWGVGPGDTVLMHASHAFDISLFELWVPLLSGARVMIAGPGAVDGEALAGHVAGGVTAAHLTAGAFRVLAEESPESVAGLREVLTGGDAVPPAAVERVRRACPDVRVRHLYGPTEATLCATWWLLEPGDETGSALPIGRPLAGRRAYVLDAFLRPLPPGVKGELYVAGAGVARGYLGRPALTAERFVADPFAPGGRMYRTGDLAYWTDQGALVFAGRADDQVKIRGYRVEPGEVEAVLGRLPGVGQAVVSVREEHLIGYVVAEAGQDVDPARLREQLAETMPEFMLPAAVMVLDDLPLTVNGKVDRQALPAPDFASKSAGRAPATATERLLCDVFAEVLGLERVGVEDSFFALGGDSISSMQVAARARREGISLTPRQVFEQRTPERLAALARDARSTRRDNTAADAGIGEIPWTPVMRALGDDAARPGFAQARVVVTPAGLDPGALAVALQAVLDTHDVLRARVAPGERLLVPERGAVAAAELMTRVAAGTGNLDEIAEREAGTAAGTLNPAAGIMVRAVWLDAGDTEPGRLALVAHHLVVDAVSWGILLPDLRAAYDEVISGGTPDLEPEATPYRQWVRRLTEQAFSESTVAEADYWVTVLDGADRPLEQRTGQSHSWSSTVSGAAARSLVGRLPGAFHCGIQEILLAGLAGAVARRRGADAGVLVDVEGHGRHAVDGEDLLRTVGWFTSVHPVRLDVSGVDLAAAAAGNEAAGELLKAVKEQVRAVPGDGLGYGLLRHLNPGTGARLAALPSPQIGFNYLGRSGVASEITPWQVREGSLGAGESGPDLVLAHALEAGADIQDTPAGPRLRLTLAGRDLDPAVVELLGEAWLELLTGLATHAGTPDAGGHTSSDFDLVEVAQRDVAELEAAAPGLTDIWPLSALQEGMLFERALDEEGVDVYQSQRILDLDGPLDADRLRAAWTSLVTRHDSLRTTFHELGSGETVQVVVAEADIPWRVADVSQLDEVDAAAEVERLLTEDQAERFDVTRAPLLRLLLIRLGENRHRLVVTSHHIVLDGWSTPIILGEMSATYAGEQGSSTSPSYRDYLAWLSRQDEAATRSAWRAEFAGSDEQTVVDADAGKTMVMPDEHCEPLSEEATRSLTEFARGHGLTLSTIVQGAWALVLARLAGRTDVVFGTVVAGRPADVPDVERMVGMFINTIPVRVRLDGGRPVLDLLHDLQARQAAMTEHQYMGLREIQKVAGPGATFDTIMMVENYPMDATVLGDDSGVTIGSVVTRTGTSYPLTMSASPGKRLQIRVSYRPDRIGQETAAEVARQVVRVMERMVAEPSLPVGRMAVTSEPARAAVLERGNPTAEAAGGPSVVETFRRRSHSSPDAVAVMDGGRTLSYADLDRESDRLAAHLADTGVRRGDHVGVVMARGVDLFVAFLAVWKAGAGYVPVNLDYPRERIARMLTDAGASVAVCVEATRDMVPAGVEPVVLDAPATGGAPHEAPPLTVGAHDVAYVMYTSGSTGVPKGVAVPHGSVSALASDPGWSLGAGDCVLMHASHAFDASLVEIWAPLVSGARVLVAEPGAVDAQRLREAIARGVTTVHLTAGAFRALAEESADAFSGLREVLTGGDAVPLGSVARLREACPDVRVRHLYGPTETTLCATWHLIEPGSATGDTLPIGRALAGRRAYVLDAFLQPVGRHVTGELYLAGAGLARGYLGAAGATAERFVADPFVPGERMYRTGDLARWTDRDELLFAGRADSQVKIRGYRVEPAEIEAALAEVPRIAQAVVVAREDRPGEKRLIAYVTAAEDPGPDPGAVREHLATRLPEFMVPAAVVVLDGFPLTVNGKIDRAALPAPELTGKPAGREPRTETERVLCDMFAEILGLERVGADDSFFELGGDSILSMQLASRARRENVVFGATDVFDRKTPAGIAAIAERGGETRADLTDGVGEVAWTPVLRALLEGDPGAMTRGALAQWTTVGAPDDLSVDTLAAGLGALIDTHDMLRSRVVGTGGQEPRLVVAERGTVDATRLVDRVEAGAGELDDVADRCATEVAARLDPAAGVMVRAVWVDAGAGRAGRLVVAAHHLVVDAVSWRILLPDLRAACEDVAAGREPALDPVDVSFRRWARTLADQAAARTAELETWTEILGAEEPRLGELDPARDTISSAGRRSWTLPREQAGALVERVTAAFHCGVHEVLLATLAGAVARWRGGTAVVVDVEGHGRQPIGAMDLSRTVGWFTDVHPLRLDVTGIDMAAALAGGDAAGRLLKSIKESVRAVPDGGLGYGMLRHLNAETRPVLAARPAVEFGFNYLGRFSSRSGGDVEPWQPAGTIGGAAEPDVPLRHVVEIDAAVLDSVDGPRLDLTLTWAGRIVSEAEAESLGKAWLDMLTGLAAHAHDVRAGGHTPSDFPLTALAQRDVAEIEAVVPGLLDIWPLSPLQEGLLFHAADERGPDVYAGMRTLAIEGPLDVARLRASWQAVLDRHAALRASFHQLESGTAVQVIARELTLPWRETDLSHLPEDEALAEFERLVAELRDDRFDLTRAPLLRLHLVRLGEGRHRLALASHHISCDGWSLPVLSVDVMAAYEAGGDGRALPAPTSYREYLAWLARQDKEAAREAWRTELAGLDEATHVVPPDTISAPIEPERVRFALDDELSRRLVEFTRRHGVTMNTLFQGVWALFLARLTGRDDVVFGSAVAGRPPEIPGVGSVVGLFMNTLPVRARLDGAEPFLDMLTDLQGRQVAMMAHQHVGLSEINQFAGPGAAFDTLVVFENYPRPPRRSEGPDALVMRPAGIPNDSGHYPVSMRASEDGGVHGEFIFRPDAFDRPQADEMLASIIRALEQVVTDPRMPVGRVGLIGAAEHGLVVREWNRTAVPLVAEPLPVLFRRQVERSRDAVAVRDAARSLSFGGLLGAAEGLARLLVTAGVRRETRVAVLVERSVELVVALLGVSLAGGVFVPVDPDYPGERIALMLADSAPKVLVCTSETRAVVPAGFAGAVLVLDEPPAAEPEAVLPGVVAGDGAYVIYTSGSTGVPKGVLVTHAGLGNLASAQIERFGVTSASRILQFAALGFDAAISEVCMALLSGGTIVLADAESMPPRVSLGDAVRRWSITHVTVPPSVLAVEDDLPESLETLIVAGEACPPALVDRWSRGHRMINGYGPTETTVCATMSSPLSPGRDAVPIGGPITNMRAYVLDAFLQPVPVGLAGELYVAGAGLARGYLGRPGLTAERFVADPFSPGGRIYRTGDRVRWTSGGELVFVGRADAQVKVHGYRIEPGEIEAVLAEHPEVAQVVVVARQDGPGEKQLVAYAVPANGPSADSAALISALRETAAARLPEHLVPAAFVPLDTMPLTPNGKVDHRALRAPDFAGMSSGRDPRTAMETRLCELFAEVLGLDRVGANDSFFELGGDSITSMQLSTRARREGLELTPWQVFDEKTPERLAALVKELPAEDEDTGVPESPAGPLVALSPEQMDQLEA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	732.19	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1632	colistin A; colistin B
BGC0001178.1|UK-68,597_13 # 31360 # 36972 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.725	BGC0001178.1|UK-68,597_13 	31360	36972	+	Loose	1000	89.3521	almE	28.3	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACCATTGACGACACTCGTGCGAAGCCGCGCTCCAGCGTGGAAGACGTCTGGCCCCTGTCGCCGCTGCAGGAGGGAATGCTCTACCACACCGCCCTCGACACGGACGGGCCGGACACCTACACCGTGCAGTCCGTCTACGGCATCGACGGCCCGCTGGACGCCGGGCGGCTGAAGGCGTCGTGGCAGGCTCTCCTGGACCGGCATGCCGCGCTGCGGGCCTGCTTCCGCTACGTCAGCGGCGCGCAGATGGTGCAGGTCATCCAGCGCGACGTCGAGATCCCGTGGCGAGAGACGGACCTTTCCGGGCTGCCGGACGACATAGCCGCCGGCGAGGTGAGCCGGCTGGCGGCCGACGAGATGGCCGAGCGGCTCCGCCTGGAGGTGGCGCCGCTGATGAAACTGCACCTGATCCGGCTCGGCCCGGAGCGCCACCGGCTCGTGCACACCCTGCATCACGTGCTGGCGGACGGCTGGTCGATGCCGATCCTGCACCGCGAGCTCGCCGCGATCTACGCGGCGGACGGGGACGCGTCCGGCCTGCCCGCCGCGGTGTCGTACCGGGACTACCTCGCCTGGCTGGGCCGGCAGGACAAGGAGGCGGCCCGGGCGGCCTGGCGGGAAGCGCTCGCCGGGCTGGACACCCCCACCACGGTCGCCGCGGCCGATCCGGCCCGCGTGCCGGACATCGACACGGTGCTGATCGAGCTGTCCCCGGAGCTGACGGACGACCTGCTACGGCTGGCACGCGGCCACGACCTCACGATGAACACCGTCGTGCAGGGCGCGTGGGCCGTCGTGCTGTCGCAACTCGCCGGCCGGACCGACGTGGTGTTCGGCGCGACCGCCTCGGGCCGGCCGGCCGAACTGGCCCGGGTGGAGTCGATGGTCGGCCTGCTGCTCAACACGCTGCCGGTGCGGGTCCGGCTCGACGGTGGCCAGCGGGTCGTCGAGATGCTCGCCGACCTGCAGCGGAACCAGTCGGCGCTGGGGGCTCACCAGCATCTCGGTCTGCAGGAGGTGCAGGCCGCCGTCGGACCCGGCGCCGTCTTCGACACGCTCGTCATCTACGAGAACTTCCCTCGTACGGGACTCGGCGGGTCGGCGGACGACGGCCTGAGGTTGCGCCCGGTGCAGAAGGGGCGTGACTCCTCGCACTACCCGTTCACTCTGGTCACCGGGCCGGGCGAGCGGATGCCGGTCATCCTCAACTACGAGCGGGGCCTCTTCGACCACGCGGCCGCCGAATCGGTGGTGGGCGCGATCGTTCGCGTGCTGGAGCGGTTGGTCGCCGAGCCCGACGTCCTCGTCGGCCGGCTGACGCTGCTGAGCGAGACCGAGCGCGCCGCGGTGGTGGACAACTGGAACGCGACCACGGGTCCGGTGCCCGGGGAATCAGTGGTCGAGATGGTCGGGCGGCGGGTGGCCGCGGCACCGGGCACGGTGGCGATCACCGCGGCCGGCGGTACGGACCTGACCTATGCCGAGGTCGACCAGGCGTCGAACCGGCTGGCGGCCTACCTCATCGGCCGTGGCGTGCGCCGCGGCGACCGCGTCGGGGTGGCCATGGACAGGTCCGCGGACCTGCTGATCGTGTTTCTGGCCATCTGGAAGGCAGGCGCCGGCTACGTCCCGGTGGACATCGGGTATCCGGTCGAGCGGATGGCGCTCATCTTCGCCGACTCCGAGGTCTCGGCCGTCATCTGCACGCAGGCCACCGGCGAAGGGCTACCCGGGGACGTCGCGGGCCGGGCCACGATCGTCCTGGACGCGCCGGAGACGCGGGCAGCCGTCGAGGGCTGCGCCGCCACGGCGCCGGAGATTCGGCTCAGCGCCGGCGACCTGGCGTACGTGATGTACACCTCGGGATCCACCGGCGTTCCGAAGGGCGTGGCGATCCCCCACGGGGCAGTGGCCGGCCTCGCGGGCGACGCGGGCTGGCAACTCGGCACCGACGACGGCGTGCTGATGCACGCGACGCACGTCTTCGACCCCTCGCTCTACGAGATGTGGGTGCCGCTCGTCACGGGTGGCCGGGTCCTGGTCGCCGAGCCCGGAGTGGTGGACGCGGGCGGCATCCGTCAGGCCGTGGAACGGGGCGCGACCGCCGTTCACCTCACCGCCGGCACCTTCCGCGCGCTGGCGGAGGCGTCTCCGGACTGTTTCGCGGGCCTGCGGGAGATCGGGACCGGCGGCGACGTGGTGCCCGCGCACACCGTGGCGAACCTGCGACGGGCCCAGCCCGGCGTGCGGGTGCGCAACACCTACGGACCGACCGAGACCACCCTGTGCGCCACGTGGAAACCGATCGAGCCCGGTGACCCGCTCGGGCCGGAGCTGCCGATCGGCCGTCCCATGACCAACCGCAGGATCTACCTCCTCGACGCCTTCCTGCGCCCGGTCGCGCCCGGGGTGGCCGGCGAGGTCTACATCGCCGGCACGGGGCTGGCCCGCGGATATCTCTCCCGGCCGGACCTGACCGCCGAGCGGTTCGTGGCGTGCCCGTTCCTGGCGGGCGAACGCATGTACCGGACCGGAGACCTGGCGCGCTGGAACCGCGACGGCGAGGTGGTGTTCCTCGGGCGCGCCGACGATCAGGTGAAGATCCGCGGCTTCCGGGTGGAGCTGGCCGAGGTGGAGGCCGTACTGGCGGCCCAGCCGGGAGTCCGCGAGGCGGTCGTCGTGGCGCGGGAGTACCAGCCGGGCGAGCGGCGTCTGGTGGGCTACGTCGTCTCCGACGCCGGTGAGGTGGACACCGAGGAGATCCGGCGGCAGATGAGCCGGGTCCTGCCCGCGTACATGGTTCCGGTAGCGGTCGTCGGCCTGATCAGCCTGCCCGTCACCGCCAACAGCAAAGTGGATCGCCGGGCCCTGCCCGACCCGGAGCTCGCGGGTCACGCGTCGGCGAAGGCCCCGGAGAGCGAGACCGAGAAGGTGCTGTGCGCGCTCTACGCCGAGATCCTCGGCGTCGAGCGGGTGGGTGTCGACGACGCCTTCCACGACCTGGGAGGCAGCTCGGCGCTGGCCATGCGGCTCATCGCGCGCATCCGTGAGGAACTCGGCGCGGATCTGCCCATCCGGCAGCTGTTCTCCTCGCCCACCCCCGCGGGCGTCGCCCGGGCGCTGGCCGCGAAGTCGCGGCCCGCGCTGGAAGCCGTCACCCGGCCGGAGCAGGTGCCCCTCACAGCCCGGCAGCTCCGCGCCTGGCTGCTGGCCCGTCCCGCGGAAGAGACCCGGGGCCTGCACGCCTCGGTCGCGCTGCGCTTGCGCGGCCGGCTGGACGTGGCCGCCCTGGAGGCGGCGATCGGCGACGTCGCGGCCCGGCACGAGATCCTCCGGACCACCTTTCCGGGCGACGCACAGAGCGTTCACCAGCACATCCACGACGCCGCGACGGTGCGGCTGACCCCGGTCCCGGCCGCCGAGGAGGACCTTCCCGGACTGCTCGCCGAGCGGCGCGAGCAGCTCTTCGACCTCACCCGGGACATGCCGTGGCGATGCGAGCTCTTCGCCCTCGCGGAGAAGGAGCACGTCTTGTCGGTGACGGTGCACCGCATCGCCGTCGATGACGACTCGATGGACGTGTTCTTCCGCGACCTCGCGGCCGCGTACGGTGCGCGGCGCGCCGGCCGGGCTCCGGAGCGCGCGCCCCTGGTCCTGCAGTTCGCCGACTACGCGATCTGGGAGCGGCGGCTGCTCGAAGGTGAGCGCGACCAGGACAGCCTCATCAACGACCAGCTGACCTTCTGGCGGAACCACCTGGCCGGCATCGACGGGGAGACGGTGCTGCCGTTCGACCGCCCGCGACCGGCCATCCCGTCGCGGCGAGCCGGCACGGTCGCGGTGCGGCTGGGCGCCGGCGCGCACGTCCGGTTGACGCAGGCGGTGGAGTCGGCCGGCGCGGACGCGCTCCAGACGGTGCACGCCGCGCTCGCCATGCTGCTGGCCAGGTACGGAGCCGGCCACGACCTGGTGATCGGCACGACGCTGCCCCGAGACGAGGACCTGATCGACCTGGAGCCGATGATCGGGCCGTTCGCCCGGCCGTTCCCGGTGCGCACGGACCTGTCGGCCGATCCGACGTTCCTGGAGGTCGTCGCCCGGGTGCAGGAGTCGGTCCGGGAGGCGCGCCAGCATCTGGACGTGCCCTTCGAGAAGGTTCCCGAGCTGCTGGACCTGCCCGCATCGCTCTCCCGTCACCCCGTGTTCCAGGTCGGCCTGCGGGTGAGCGAGGAGGACCTGGGCTCGTGGGACGCCGCGGATCTGCCCGCCCTGCGCACCAGCGTCGAACCCGGCGGGGTGGAGGCCATCGAGCTGGATCTCGCGTTCGAGCTCGCCGAGCGCCGCAACGACGATGACGACGAGGACGGCATCGAGGGCGCGCTGCACTATGCCGCCGACCTGTTCGATCGGGCCACGGCCGAGTCCGTGGCCCGGCGGCTGGTCAGCGTCCTGGAGCAGGTGGCGGAGGATCCCCAGCGGCGGATCAGTGACCTGGACATCTTCCTGGACGACGCCGAGCGCGGCCGCCCGGCCATCACACCGGCGCGCTGGGCCGGGCCCGTGCCGCAGGTGGTCGCCGACCTGGCCGAGGACGGCCCGCTCGGTGCGCTCCTGCTCGACGACCTGCAGCGCCCGGTCGCTCCCGGGGCCGTCGGCGAGCTCTATGTCACCGGTCCGGCAGTGGACGCCTGCGTGACCGGGCAACCGACCGTGCCCTGCCCGTTCGGGACCGCGGGGCACCGCATGCTGCGCACGGGCCTGCTCGTCCGCAGGTCCCTCGACAAGGCGCTGGTCGTCGTGGGTGAGCGGCGGGGATCGAGCGCCTCGGTGAAGACGGGTGACTACGAGGTGCTGCTGCCGTTGCGCGCCGGCGGTGATCGCCCGCCACTGTTCTGCGTCCACGCGAGCGGCGGCCTGAGCTGGAACTACGGGCCGTTGCTGCGGCACCTTCCGGCGAATCAGCCGGTCTACGGGGTGCAGGCGCGCGGTCTGGCCCGTACCGAATCCTTGCCGGGCAGTGTCGAGGAGATGGCGGCCGACTACGTCGAGCAGATCCGCACCGTGCGGCCGGCCGGGCCGTACCACCTGCTCGGTTGGTCCCTCGGCGGCCGGATCGCGCAGGCGATGGCCGTGTTGCTCGAGGCGGAAGGGGAGGAGGTCGGGCTGCTCGCCCTGCTCGACGCCTACCCCGTCTACATGGGAAGGAACGCGACCGGCACGGTGAGCGAACAAGCCTCGCGTGATGAAGCGGCCCTGGACAAGCGGAAGCAGCAGGAGCTGGAGCTCGCCGGTCAAATGGTCCAGGGGACCGGTGCCCAGTCGCGCTTGGAGGCGGTCATGCGCAACCTCTGGAAGGTCGGTCCGGCTCATACCGCCCTGCCCTTCGCCAGCGATGTCCTCCTCTTCGTGGCCTCGGTGGACCGCCCCGCACATCTGCCCGTGCCGGAGGCGATAGACAGCTGGAAGGACGTCACCAGCGGGGCCGTCGAGCCCCACGAGATCCCGACCAACCATTACGAGATGGTGCAGCCCGCGGCGCTGGCCCAGATCGGGGCCATCCTCGCCGAGAAGCTCCGGCACCGGCCGGAGCGGGACGGCCGGGAGAGATGA	MTIDDTRAKPRSSVEDVWPLSPLQEGMLYHTALDTDGPDTYTVQSVYGIDGPLDAGRLKASWQALLDRHAALRACFRYVSGAQMVQVIQRDVEIPWRETDLSGLPDDIAAGEVSRLAADEMAERLRLEVAPLMKLHLIRLGPERHRLVHTLHHVLADGWSMPILHRELAAIYAADGDASGLPAAVSYRDYLAWLGRQDKEAARAAWREALAGLDTPTTVAAADPARVPDIDTVLIELSPELTDDLLRLARGHDLTMNTVVQGAWAVVLSQLAGRTDVVFGATASGRPAELARVESMVGLLLNTLPVRVRLDGGQRVVEMLADLQRNQSALGAHQHLGLQEVQAAVGPGAVFDTLVIYENFPRTGLGGSADDGLRLRPVQKGRDSSHYPFTLVTGPGERMPVILNYERGLFDHAAAESVVGAIVRVLERLVAEPDVLVGRLTLLSETERAAVVDNWNATTGPVPGESVVEMVGRRVAAAPGTVAITAAGGTDLTYAEVDQASNRLAAYLIGRGVRRGDRVGVAMDRSADLLIVFLAIWKAGAGYVPVDIGYPVERMALIFADSEVSAVICTQATGEGLPGDVAGRATIVLDAPETRAAVEGCAATAPEIRLSAGDLAYVMYTSGSTGVPKGVAIPHGAVAGLAGDAGWQLGTDDGVLMHATHVFDPSLYEMWVPLVTGGRVLVAEPGVVDAGGIRQAVERGATAVHLTAGTFRALAEASPDCFAGLREIGTGGDVVPAHTVANLRRAQPGVRVRNTYGPTETTLCATWKPIEPGDPLGPELPIGRPMTNRRIYLLDAFLRPVAPGVAGEVYIAGTGLARGYLSRPDLTAERFVACPFLAGERMYRTGDLARWNRDGEVVFLGRADDQVKIRGFRVELAEVEAVLAAQPGVREAVVVAREYQPGERRLVGYVVSDAGEVDTEEIRRQMSRVLPAYMVPVAVVGLISLPVTANSKVDRRALPDPELAGHASAKAPESETEKVLCALYAEILGVERVGVDDAFHDLGGSSALAMRLIARIREELGADLPIRQLFSSPTPAGVARALAAKSRPALEAVTRPEQVPLTARQLRAWLLARPAEETRGLHASVALRLRGRLDVAALEAAIGDVAARHEILRTTFPGDAQSVHQHIHDAATVRLTPVPAAEEDLPGLLAERREQLFDLTRDMPWRCELFALAEKEHVLSVTVHRIAVDDDSMDVFFRDLAAAYGARRAGRAPERAPLVLQFADYAIWERRLLEGERDQDSLINDQLTFWRNHLAGIDGETVLPFDRPRPAIPSRRAGTVAVRLGAGAHVRLTQAVESAGADALQTVHAALAMLLARYGAGHDLVIGTTLPRDEDLIDLEPMIGPFARPFPVRTDLSADPTFLEVVARVQESVREARQHLDVPFEKVPELLDLPASLSRHPVFQVGLRVSEEDLGSWDAADLPALRTSVEPGGVEAIELDLAFELAERRNDDDDEDGIEGALHYAADLFDRATAESVARRLVSVLEQVAEDPQRRISDLDIFLDDAERGRPAITPARWAGPVPQVVADLAEDGPLGALLLDDLQRPVAPGAVGELYVTGPAVDACVTGQPTVPCPFGTAGHRMLRTGLLVRRSLDKALVVVGERRGSSASVKTGDYEVLLPLRAGGDRPPLFCVHASGGLSWNYGPLLRHLPANQPVYGVQARGLARTESLPGSVEEMAADYVEQIRTVRPAGPYHLLGWSLGGRIAQAMAVLLEAEGEEVGLLALLDAYPVYMGRNATGTVSEQASRDEAALDKRKQQELELAGQMVQGTGAQSRLEAVMRNLWKVGPAHTALPFASDVLLFVASVDRPAHLPVPEAIDSWKDVTSGAVEPHEIPTNHYEMVQPAALAQIGAILAEKLRHRPERDGRER	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	336.33	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1629	colistin A; colistin B
BGC0001178.1|UK-68,597_14 # 36974 # 38044 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.678	BGC0001178.1|UK-68,597_14 	36974	38044	+	Loose	200	25.7942	vanX gene in vanO cluster	39.29	3002954	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	ATGAAAGCCTTGATACCTGCCGGAGGTGCGGGGACCAGGCTGCGGCCGATCACGCACACCTCCGCCAAGCAGCTGATACCGATAGCGAACAAACCCGTGATCTTCTACGTGCTGGAGTCGATCGCCGAGGTCGGGATCATCGAGGTCGGCATCGTCGTGGGCGATACCGCCGCGGAGGTCCAGCGCGCCATCGGCGACGGGTCGGCCTGGGGCCTGAAAGTCACCTACCTGCCACAGGCGGCCCCGCTCGGCCTGGCGCACACGGTGCTCATCGCTCGCGAGTTCCTGGGCGACGACGACTTCGTCATGTACCTCGGGGACAACTTTCTGATCGGGGGCATCACGAAACTGGTGGAGCAGTTCCGCGGCGACCGCCCCGCTGCCCAGATCATGCTGACGAAGGTCGCCGATCCGCGGGCGTTCGGGGTGGCGGAGCTGGACGTCGATGGGCGGCTGATCGGGCTCGAGGAGAAGCCCGAGAACCCCAAGAGCGATCTGGCGCTGGTCGGGGTCTTTCTCTTCACAGCGGCGGTGCACGCGATCGTGGCGGGCCTGACCCCCTCGGCCCGGGGCGAGCTGGAGATCAGCGACGCCATCTCCATGCTGATGCGCGCCGGCCATCCGGTGGTGACGACGATAACCGAGGGCTACTGGAAGGACACCGGCAACGTCGCCGACATTCTGGAGGTGAACCGGCTCGTCCTGGAAGAGTTGGCACCCGAGGTCGCCGGCGTGGTGGACAACTCGGAGCTGATCGGCCGGGTGACGGTGGCGCCGGGCGCGGTGGTGCGGGGTTCACGCATCGTGGGGCCGGTCATCATCGGGTCCGGCTCCGTCGTGGAGGACTCCTATGTGGGGCCGTTCACCTCGATCGCGGAGGACTGCCGGATCATCGAGAGCGAGCTGGAGTACTCCGTGGTCCTCGGCGGGTCCGTGATCCGCGGAGTGGGGCGGATCGAGGCATCCCTCATCGGCCGCGAGGTGGAGGTCATCCCGGCGCCGCGGACGCCCCGGGCGCATCGCCTGCTCCTCGGCGACCACAGCAAGGTGCAGGTCTGCGCGTACACGTGA	MKALIPAGGAGTRLRPITHTSAKQLIPIANKPVIFYVLESIAEVGIIEVGIVVGDTAAEVQRAIGDGSAWGLKVTYLPQAAPLGLAHTVLIAREFLGDDDFVMYLGDNFLIGGITKLVEQFRGDRPAAQIMLTKVADPRAFGVAELDVDGRLIGLEEKPENPKSDLALVGVFLFTAAVHAIVAGLTPSARGELEISDAISMLMRAGHPVVTTITEGYWKDTGNVADILEVNRLVLEELAPEVAGVVDNSELIGRVTVAPGAVVRGSRIVGPVIIGSGSVVEDSYVGPFTSIAEDCRIIESELEYSVVLGGSVIRGVGRIEASLIGREVEVIPAPRTPRAHRLLLGDHSKVQVCAYT	MNDDFVYVDDWVPGVRWDAKYATWDNFTGKPVDGYLANRIVGTRALCAALEQAREKAASLGFGLLLWDGYRPRRAVDSFLRWSEQPEDGQTKQRHYPNIDRPEMLEKGYVATQSGHSRGGAVDLTLYHLATGELAPMGGDHDLMDPISHHRARGIKPIESKNRELLRSIMEDCGFDRYDCEWWHYTLKREPYPDVYFDFPIT	176.24	gnl|BL_ORD_ID|1672|hsp_num:0	1699			399	483	vancomycin
BGC0001178.1|UK-68,597_15 # 38089 # 38724 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.706	BGC0001178.1|UK-68,597_15 	38089	38724	-	Loose	300	26.5646	dfrA12	42.42	3002858	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGTCGGAACGAGCACGGCAACTGACGGTCGGCGGGGCCTACGCGTTCACTACCCCCGCCTTCCCGGACGAACGCGGCGTCTTCCTGTCGCCGTACCAACAGGCGGTGTTCGTCGAGGCCCTCGGCCATCCGCTGTTCGCGGTGGCCCAGTGCAGCTACAGCGTGTCCCGCCGGGGGGTGGTTCGCGGCGTGCACTACACGGCCACCCCGCCGGGCTGCGCCAAATACGTCTACTGCCCGAGCGGCCGGGTGCTCGACATCGTCGTCGATCTGCGGGTGGGCAGCCCCACCTTCGGCGTTCACGACGCGGTGGAGCTGGGGGGCCCGGACTTCCCCGCCGTCTACTTGCCGGTCGGGGTCGGCCACATGTTCGTCGCCCTCGAGGAGGGGACGACGATGACCTACCTGCTGTCCACCGAGTACCGGCCGGAGAACGAGCTCGCCGTCACCGCCCTCGACCCCACGCTGGAGCTGCCGATCCCCCGCGACATCACCCCGCTGCTGTCCGAGCGGGACCGGCAGGCGATCAAGCTGCGCGAGGCCCTTTCTCGCGGTCTGCTGCCCAGCTACGACGCGAGCGGGCAAGCCGAGGCCGCGCTCTACGTCCGTCCAGAACGGGCTGCGCCGGACCGGTGA	MSERARQLTVGGAYAFTTPAFPDERGVFLSPYQQAVFVEALGHPLFAVAQCSYSVSRRGVVRGVHYTATPPGCAKYVYCPSGRVLDIVVDLRVGSPTFGVHDAVELGGPDFPAVYLPVGVGHMFVALEEGTTMTYLLSTEYRPENELAVTALDPTLELPIPRDITPLLSERDRQAIKLREALSRGLLPSYDASGQAEAALYVRPERAAPDR	MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPLPNRHTLVISRQANYRATGCVVVSTLSHAIALASELGNELYVAGGAEIYTLALPHAHGVFLSEVHQTFEGDAFFPMLNETEFELVSTETIQAVIPYTHSVYARRNG	127.88	gnl|BL_ORD_ID|1047|hsp_num:0	1139			276	375	trimethoprim
BGC0001178.1|UK-68,597_16 # 38739 # 39953 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.700	BGC0001178.1|UK-68,597_16 	38739	39953	-	Loose	700	28.8758	cmlv	33.33	3002700	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol phosphotransferase	ATGCCCCACGCCTGTCAGATCTGCGGCGGCGCGCTCGAGGAGTTCCTGGACCTCGGCCGGCAGCCGCTCTCCGACGCGTTCCTGAGCGAGCATGACCCGCAGGACGAATTCTTCTACCGGCTGGCGGTCGGCGCTTGCTCCTCGTGCACGATGGTGCAGCTCGTGGAGCAGGTGCCGAGGGAGAAGATGTTCCACACGGACTACCCGTACTACTCGTCCGGCTCCTCGGTGATGCGCGAGCACTTCCAGCAGACCGCGCGCGCCCTGCTCGACACCGCCGGGCCGGACCCGTTCGTGGTGGAGATCGGCAGCAACGACGGCGTGTTGCTGCGGACGGTACACGAGGCCGGCGCCCGGCACCTGGGCTTCGAGCCGTCGGGCAAGGTCGCGGCGGCCGCGATGGAACATGGGGTACGCGTGCGTAACGAGTTCTTCGACGCCGGCACCGCGGCCGACACGCGACGCGAGGAGGGCGCCGCGGACGTCATCTTCGCGGCCAACACCATCTGCCACATCCCGTACATGCGCTCAGTGCTGGACGGCATCCGCACGCTGCTCGCGCCGGAGGGCGTCTTCGTCTTCGAGGACCCCTATTTCGGCGACATCGTGGCGAAGACGTCGTTCGATCAGATCTACGACGAACACTTCTACTTCTTCACCGCCCGCTCGGTGCAGGCGATGGTCGCGCCCTTCGGCCTGGAACTGGTCGATGTGGAGCGGCTGCCGGTGCACGGCGGCGAGGTGCGCTATACCGTCGCCCGGGCCGGGGCTCGTACGCCGTCGGCCGGGGTCGCCGCCCTCATCGCCGACGAGAAGGCGCGGGGCCTCGCCGAGCCGCCGACCCTGCGCCGCTTCGCGGCCGACACCGCCCGCATCCGCGACGACCTGCGCACGCTGCTCCGGCGGCTGCGCGACGAGGGCCACCGGGTCGTCGGCTACGGCGCGACCGCCAAGAGCGCGACCGTCACCAATTTCGCCGGCATCGGGCCGGACCTGATCGAGTTCGTGTGTGACACGACGCCGGCCAAGCAGGGCCGGCTCACCCCCGGCGCGCACATTCCGGTGCGGCCGGCGGAGGCGTTCGCCGATCCGTACCCCGACTACGCGCTGCTCTTCGCGTGGAACCACGCCGACGAGATCACGGCCAAGGAGCAGGGATTCCGCGCGGCGGGCGGCAAGTGGATCCGGTACGTGCCGGACGTACACGTGAGCTGA	MPHACQICGGALEEFLDLGRQPLSDAFLSEHDPQDEFFYRLAVGACSSCTMVQLVEQVPREKMFHTDYPYYSSGSSVMREHFQQTARALLDTAGPDPFVVEIGSNDGVLLRTVHEAGARHLGFEPSGKVAAAAMEHGVRVRNEFFDAGTAADTRREEGAADVIFAANTICHIPYMRSVLDGIRTLLAPEGVFVFEDPYFGDIVAKTSFDQIYDEHFYFFTARSVQAMVAPFGLELVDVERLPVHGGEVRYTVARAGARTPSAGVAALIADEKARGLAEPPTLRRFAADTARIRDDLRTLLRRLRDEGHRVVGYGATAKSATVTNFAGIGPDLIEFVCDTTPAKQGRLTPGAHIPVRPAEAFADPYPDYALLFAWNHADEITAKEQGFRAAGGKWIRYVPDVHVS	MPSPSAEPTTSTPTPDAGPAASPRMPLAVYILGLSAFALGTSEFMLSGLVPPIAEDMNVSIPRAGLLISAFAIGMVVGAPLLAVATLRLPRKTTLIALITVFGLRQMAGALAPNYAVLFASRVISALPCAGFWAVGAAVAIAMVPVGSRARALAVMIGGLSIANVLRVPAGAFLGEHLGWASAFWAVGLASAIALVGVVTRIPRIPLPETRPRPLKNEVAIYRDRQVLLSIAVTALAAGGVFCAFSYLAPLLTDVSGLDEAWVSGVLGLFGIGAVVGTTIGGRVADAHLFGVLLTGISASTVFLVALALFASNPAATIVLTFLLGVSAFYTAPALNARMFNVAGAAPTLAGATTTAAFNLGNTGGPWLGGTVIDANLGFASTAWAGAAMTVLGLGTAALALRLTKRPAPGHVVARSRGAGGTTPSEPARGKATSSC	92.66	gnl|BL_ORD_ID|649|hsp_num:0	703			459	630	chloramphenicol
BGC0001178.1|UK-68,597_17 # 40226 # 41449 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.716	BGC0001178.1|UK-68,597_17 	40226	41449	+	Loose	600	388.652	rgt1438	57.64	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGCGTGTGTTGTTGTCGACGTCTGGGAGCCGGGGAGATGTCGAACCGCTGGTGGCGCTGGCGGTGCGGTTGCGGGCACTCGGTGCGGACGTGCGGATGTGCGCATCTCCGGACTCCGCGGGACGGCTGGCCGAGGTCGGCGTGCCGCTGGTGCCGGTCGGCGGGTCGGCCCGTACCGAAATGAAAGGGCCGAGGCCGAGGCCGGAGGACGGGCCACGGCTCGCGGCCGAGGCGATGGCCGTGCAGTTCGACCAGGTCCCGGCGGCTGCCGAGGGCTGCGACGCGGTGGTGGTGACCGGAATGCTGGCCGCCGCGGTCGCCGTCCGGTCGGTGGCCGAGAAGCTGCGCATCCCCTATTTCTACGGCTTCTACTGTCCGATCTTTGTGCCATCGCCGTACTACTCGCCGCCGCTGCCCCTCGGCGAGCCACCCGCGCAGGACGTGACCGACAACCGGGCGCTGTGGGACCGGAACAACCAGGGCGCCTACCGGCGATTCGGTGACCCGCTCAACAGACACCGGGCGTCGATGGGCCTGCCGCCGGTGGATGACATCTTCCGGTACGGCTTCACTGATCACCCCTTGCTGGCGGCGGACCCGGTCCTGGCACCGCTGCAGCAGACGGACCTCGACGCCGTGCAGACCGGCGCGTGGATCATGCCCGATGAACGGCCTCTCGCCGCGGAGTTGGAGGCATTTCTGGACTCGGGGTCACCCCCGGTGTACGTGGGTTTCGGCAGCATGCCCGTACCGGCTGACGCTGCGAGGGTGGCTATCGACGCGGTCCGCGCCCAGGGCCGCCGGGTGATCCTCTCCCGCGGCTGGGCCGACCTGGCGCTGCCCGACGACCGGGACGACTGCCTCGCCGTCGGCGAGGTGAACCATCAGGCGCTGTTCGGCCGGGTGGCCGCCGTCGTCCACCACGGCGGCGTGGGCACGACCACCACGGCCGCCCGGGCCGGCGTTTCTCAGGTCGTGGTACCCCAGATGGTGGACCAGCCGTACCTCGCCGGCCGGGTGGCGGAGCTGGGTATTGGTGTGGCGCACGACGGTCCTGCTCCGACACTCGATTCCCTGTCGGCCGCGCTCGCGGTGGCCTTGGCTCCGGAGACCCGGGCGCGGGCCGCTGCCGTGGCCGGCACGATCCGCGCCGACGGGGCAACGGTGGCCGCGAAAATGCTGCTCGACGTGGCCAGCCGGGAAGAGCCTGCCGTCGCTGTGTGA	MRVLLSTSGSRGDVEPLVALAVRLRALGADVRMCASPDSAGRLAEVGVPLVPVGGSARTEMKGPRPRPEDGPRLAAEAMAVQFDQVPAAAEGCDAVVVTGMLAAAVAVRSVAEKLRIPYFYGFYCPIFVPSPYYSPPLPLGEPPAQDVTDNRALWDRNNQGAYRRFGDPLNRHRASMGLPPVDDIFRYGFTDHPLLAADPVLAPLQQTDLDAVQTGAWIMPDERPLAAELEAFLDSGSPPVYVGFGSMPVPADAARVAIDAVRAQGRRVILSRGWADLALPDDRDDCLAVGEVNHQALFGRVAAVVHHGGVGTTTTAARAGVSQVVVPQMVDQPYLAGRVAELGIGVAHDGPAPTLDSLSAALAVALAPETRARAAAVAGTIRADGATVAAKMLLDVASREEPAVAV	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	99.03	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1212	rifampin; rifaximin; rifabutin; rifapentine
BGC0001178.1|UK-68,597_18 # 41515 # 42732 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.724	BGC0001178.1|UK-68,597_18 	41515	42732	+	Loose	600	366.696	rgt1438	55.8	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGCGTGTGTTGTTGACAACGTGCGGAAGCCGCGGAGACGTCGAACCGCTGGTGGCGCTGGCGGTGCGGTTGCGGGCACTCGGTGTGGAGGTGCGGATGTGCGCCCCGCCGTTGGCCGCCGAGCGGCTGGCCGAGGTCGATGTGCCGCTGGTGCCGATCGGCCGGGCGATGCGCATGATGAAGCGCAAGGGGGCACCGCCGTCGGCCGAGGACGAGCGCCGGATGACAACCGAGGCGATCGCCATGCAGTTCGACCAGGTCCCGCCGGCTGCCGAAGGGTGTGACGCGGTGGTGACGACCGGAGAGCTGTCCGCGGCGGTGGCTGTGCGGTCGGTGGCCGAGAAGCTGGGCATCCCCTACTTCTACTGCACCCACGCTCCGGTCTATCTGCCGTCGCCGCACCACCCGCCGCCCGCTGACGAGCGGCTCACACCGGGTGTGACCGACAACCAGGTGCTGTGGGAACAGCGCAGCCGGCGCTTCTGCGAGCGGTTCGGCGAACCGGTCAACAGCCGACGGGCCTCGATCGGACTACCGCCGGTGGAGAACATCTTCCGGTACGGCAACACCGATCAGCCCTGGATGGCGGCCGACCCGATCCTGGCGCCCCTTCAGCCGGGCCAGAACGCCGTGCAGACCGGTGCGTGGATCCTGCCCGACGATCGCCCCCTCGCCGCGGAGCTGGAGGCGTTTCTGGCGGCTGGTCCGCCGCCGGTGTACGTGGGGTTCGGCAGCCAGTCCGGCACCGGGGACGCCGCGACGGTGGCCATCGCGGCGATCCGTGCCCAGGGCCGCCGGGTGATCCTCTCCCGCGGCTGGGCCGACCTCGCGCTGCCCGACGACGGGGCCGACTGCCTCGCCGTCGACGAAACCAACCTTCAGGCGCTGTTCGGCCGGGTGGCCGCCGCCGTCCACCACGGCAGCGCGGGCACGACGACCGTGGCCACGCGGGCCGGCAGCCCTCAGATCGTGATAGCCAGGGACACCGACCAGCCGTACTTCGCCGAGCGGGTGGCCGAGCTGGGCGTCGGCGTGGCGCACGACGGTCCGGAGCCGACCTTCGACTCCCTGTCGGCCGCGCTCGCGACGGCCTTGGCCCCGGAGGTCCGAGCTCGGGCGGCGGAGGTGGCCGGCATGATCCGCGACGACGGGGCAGCGGTGGCCGCGCGACAGCTGCTCGACGCGGTCAGCCGGGAGAAGCCTGCCGTTTCCGTGTGA	MRVLLTTCGSRGDVEPLVALAVRLRALGVEVRMCAPPLAAERLAEVDVPLVPIGRAMRMMKRKGAPPSAEDERRMTTEAIAMQFDQVPPAAEGCDAVVTTGELSAAVAVRSVAEKLGIPYFYCTHAPVYLPSPHHPPPADERLTPGVTDNQVLWEQRSRRFCERFGEPVNSRRASIGLPPVENIFRYGNTDQPWMAADPILAPLQPGQNAVQTGAWILPDDRPLAAELEAFLAAGPPPVYVGFGSQSGTGDAATVAIAAIRAQGRRVILSRGWADLALPDDGADCLAVDETNLQALFGRVAAAVHHGSAGTTTVATRAGSPQIVIARDTDQPYFAERVAELGVGVAHDGPEPTFDSLSAALATALAPEVRARAAEVAGMIRDDGAAVAARQLLDAVSREKPAVSV	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	98.54	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1230	rifampin; rifaximin; rifabutin; rifapentine
BGC0001178.1|UK-68,597_19 # 42860 # 43981 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.687	BGC0001178.1|UK-68,597_19 	42860	43981	+	Loose	450	26.9498	CfiA21	21.13	3006913	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CfiA beta-lactamase	ATGACGACTCGTGTATGGGACTACCTACCGGAGTACGCGAAAGAGAAGGACGACATCCTCGACGCCGTGCAGAAGGTCTTCGGCTCCGGGCAGCTGGTGCTCGGCGAGAGCGTCCGCGGGTTCGAGGCCGAGTTCGCCGCGTACCACGGGCTCACCTATGGCACCGGCGTCGACAACGGGACCAACGCGCTCAAGCTCGGCCTCGAGGCCCTGGGCATCGGGCCAGGTGACGAGGTCATCACCGTGGCCAACACGGCGGCGCCGACCGTGGTCGCCATCGTCGGCGCCGGGGCGACGCCGGTCTTCGTCGACGTCCGCGCCGACGACTTCCTGATGGACGTCGACCAGGTCGCCGCAGCGATCACCGCGCGGACCAGGGCGATCGTCCCGGTGCACCTGTACGGCCAGTGCGTCGACATGGCGCCGTTGACCGCCCTGGCCGAGAAGTACGGGCTGAAGATCCTCGAGGACTGCGCCCAGGCGCACGGCGCACGCCAGCACGGGCGGCTCGCCGGGACCATGGGCGACGCCGCCGCGTTCTCCTTCTATCCCACCAAGGTGCTCGGCGCCTACGGCGACGGTGGCGCGGTGCTGACCTCCGACGAAGAGGTCGACCGCAGCCTCAAGCAACTGCGCTACTACGGGATGGAGAAGGTCTACTACGTCGTGCGCTCACCGGGCCACAACTCCCGGCTCGACGAGGTCCAGGCCGAGATCCTGCGGCGCAAGCTGGGCCGCCTCGACGACTACATCGCCGGGCGAAACGCCGTCGCCCGACGATACGAGGAACGCCTCGGCGACCTCGCCCGGCCGGGCGGGCTCCAGCTGCCGGCCACCAATTCCGGCAACACCCACGTCTTCTACGTGTACGTGGTCCGCCATCCTCGCCGCGATCACATCATCGAGGCACTCAAGGACCACGACATCGCCCTGAACATCAGCTACCCGTGGCCGGTGCACACGATGAGCGGCTTCGCCGACCTCGGCTACGCGCCGGGCTCCCTGCCGGTCACCGAGGANCTCGCCGGCGAGATCTTCTCCCTGCCGATGTACCCGTCCCTGCCCGAGGCCGAGCAGGACCGCGTCATCGACGCTCTGCGCGCTGTCCTGGGAACGTTGTGA	MTTRVWDYLPEYAKEKDDILDAVQKVFGSGQLVLGESVRGFEAEFAAYHGLTYGTGVDNGTNALKLGLEALGIGPGDEVITVANTAAPTVVAIVGAGATPVFVDVRADDFLMDVDQVAAAITARTRAIVPVHLYGQCVDMAPLTALAEKYGLKILEDCAQAHGARQHGRLAGTMGDAAAFSFYPTKVLGAYGDGGAVLTSDEEVDRSLKQLRYYGMEKVYYVVRSPGHNSRLDEVQAEILRRKLGRLDDYIAGRNAVARRYEERLGDLARPGGLQLPATNSGNTHVFYVYVVRHPRRDHIIEALKDHDIALNISYPWPVHTMSGFADLGYAPGSLPVTEXLAGEIFSLPMYPSLPEAEQDRVIDALRAVLGTL	MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGIIVINNHRAALLDTPINDAQTETLVNWVADSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYANQMTIDLAKEKGLPVPEHGFTDSLTVSLDGTPLQCYYLGGGHATDNIVVWLPTENILFGGCMLKDNQTTSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVNQYIESTSKP	149.80	gnl|BL_ORD_ID|3383|hsp_num:0	4452			135	315	
BGC0001178.1|UK-68,597_20 # 43978 # 45372 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.695	BGC0001178.1|UK-68,597_20 	43978	45372	+	Loose	710	28.1054	efrB	23.39	3003949	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; rifamycin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGACCGCCGCGATCGCCCTGCGCCAGCGCGCCGACGATGCCCTGCCGTACCGGCTGCGGCGCTCGGCAGCGCAGACTGTCGAGGGTCACATGATCCGGACCGCTGACTTCCTGCCGTGGCTCGCCGACCGGGCCCGCGCGCACCGATTCAAGGTCGACCGGGTCGCGTTCGACGAGCTCGACGGCTGGTCGTTCGCGTCGGGAACGGGCAACCTGGTGCACCGCACGGGCCGGTTCTTCAGCGTCGAAGGGTTGTCCGTCGCCCTCAGCGAGGGCCCGATCCGCAGCTGGGAGCAGCCGATCATCCGTCAGCCGGAGGTCGGCATTCTGGGTATCCTCGCAAAGGAGTTCGACGGCGTCCTGCACTTCCTGCTCCAGGCCAAGATGGAGCCGGGCAACCCCAATCAGCTGCAACTCTCGCCCACCGTGCAGGCCACCCGCAGCAACTACACGGGGGCACACGGCGGCGCCGGAGTGCGGTATCTGGAGCATTTCACCGGACCGGGGCGCGGCCGGGTGCTCATCGACGTGCTCCAGTCGGAGCACGGCTCCTGGTTCTACCGCAAGTCCAACCGCAACATGCTGGTCGAGGCGACCGGCGACGTCGTGCCGCACGAGGACTTCCGCTGGCTCACGCTGGGCCAGATCGGCGAGTTGCTGCGTCTGAACAACGTGGTGAACATGGACTCCCGGACGGTCATCGCCTGTCTGCCTATGGTCACCTCGGAGTCGGGGGCGCTGCACAGCGATGCGGAGCTGCAGTCCTGGTTCACCGTCGAGCGGTCCCGGTGGAGCAATACGATCGAGCGCAGACCGCTGGCCGGGATCGCGGGCTGGGAGCGCGACGCGCTGTCCATACACCGGTCCGACAGCCGCTTCTTCCGGGTGGTCGCCGTCTCCGTCGAGGCGGGCAACCGGGAGGTGCCGAGCTGGTCGCAGCCGCTGATCGAACCGACGGGGAGGGGCGTCATCGCGTTTCTGGTCCGTGACATCGGCGGCGTACCGCATCTGCTGGTCCAGGCGAAGCCGGAGGCCGGCTTCCTGGACACCGTCGAGCTGGCCCCGACGGTGCAGTGCGACCCCGCCAACTGGCTGCACCTGCCCGCGGAGGATCGTCCACCCTTTCTGGACCTCGTGCTGGCGGCCCCACCCGAGCGGATCCGCTACGAGGCCCTGCACTCCGAGGAGGGCGGCCGCTTCCTCAATGCGGAGAACCGCACTCTGCTCGTCGACGTCACCGGGGACGAGGTCGCGCTGCAGCCGCCGGCCGGCTTCCAATGGGCGACCACGGGCCAGCTCGGCGCCCTGGCCGGTCACGGTCACTACCTCAACGTCCAGGCCCGCACGCTGCTGTCCTGTGTGAACGCCGGCGCTGTCGGGCTGTCGCCGCGCTGA	MTAAIALRQRADDALPYRLRRSAAQTVEGHMIRTADFLPWLADRARAHRFKVDRVAFDELDGWSFASGTGNLVHRTGRFFSVEGLSVALSEGPIRSWEQPIIRQPEVGILGILAKEFDGVLHFLLQAKMEPGNPNQLQLSPTVQATRSNYTGAHGGAGVRYLEHFTGPGRGRVLIDVLQSEHGSWFYRKSNRNMLVEATGDVVPHEDFRWLTLGQIGELLRLNNVVNMDSRTVIACLPMVTSESGALHSDAELQSWFTVERSRWSNTIERRPLAGIAGWERDALSIHRSDSRFFRVVAVSVEAGNREVPSWSQPLIEPTGRGVIAFLVRDIGGVPHLLVQAKPEAGFLDTVELAPTVQCDPANWLHLPAEDRPPFLDLVLAAPPERIRYEALHSEEGGRFLNAENRTLLVDVTGDEVALQPPAGFQWATTGQLGALAGHGHYLNVQARTLLSCVNAGAVGLSPR	LDTCRIFRRNAKSPVNIAKHAKFIRRLKWLCSENMTGFSVLKLYVRKKKPLKGFKQVNHRFKWFGFKASFISGLMLPLVQMTAYGTYIGVAVLGSYYVVAGVIVVGQLQAFIQYIWQISQPMGNITQLSAALQSASASTMRIFEILDEPEEELNEQDVPLPEPILGSVEFENVSFSYDPEKPLIRNLNFKVDAGQMVAIVGPTGAGKTTLINLLMRFYDVTEGAIKIDGIDTKKMNRSDVRSVFGMVLQDAWLYKGTIADNIRFGKLDATDYEVVDAAKTANVDHFIRTMPDGYEMEINSEGDNVSLGQKQLLTIARAVISDPKILILDEATSSVDTRLEALIQKAMDRVMEGRTSFVIAHR	128.18	gnl|BL_ORD_ID|2183|hsp_num:0	2422			699	1044	erythromycin; ciprofloxacin; rifampin
BGC0001178.1|UK-68,597_21 # 45466 # 46620 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.709	BGC0001178.1|UK-68,597_21 	45466	46620	+	Loose	600	328.561	rgt1438	53.03	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGCGTGTGTTGTTCTGGTCGTGTGGACCACGCGGAGATCTCGAACCGCTGGTGGCATTGGCGGTGCGGTTGCGGGCTCTCGGTGTGGAGGTGCGAATGTGCGCGCCATCGAACTTCGTGGAGCGGCTGACGGAGGTCGGTGTGCCGCTCGTACTGGCCGACCGGTCGATGCTCGAAGGGGCACGCGAGCCGGGACGGGCGCCTGAGCCTGAACTCGCGGCCGCGCGGCTCGCCGAGCGGTTCGACAAGGTCCCGGCGGTGGCGCGGGGATGCGATGCGGTAGTGGCGAGCGGTTTGCCGTCCGGCGCGACCGCCGTCCGGTCGGTGGCCGAGAAGTTGGGCATCCGGTACTTCTACACCGTTTCGTCTCCGTTCCTGCTGCCCTCGCCGACGCAGCGGGCCTTGTACAACCAGGGCGCGGACAGGATGTTCGGCGGCGCGCTCAACGAGCAGCGAGCCTTGATCGGCCTGCCGCCGGTGGAGAACGTCTACGACTATTGCTGCACCGATCGGCCCTGGTTGGCTGCGGACCAGATCCTGGCTCCGCGGCGGCCGGGCATCGACGGCGTGCGGACCGGTGCGTGGATCCTGCCCGACGAACGGCCTCTCCCGGCCGAGTTGGAGGCGTTCCTGCGCGCCGGTCCACCGCCGGTGTACGTGGGTTTCGGCAGCGGACCCGCTCCCGCTGATGTGACAAGGGTGGCCGTCGAGGCGATCCGGGCCCAGGGGCGCCGGGTTGTCCTTTCCCGAGGGTGGGCCGGCCTGGCCTTGCCCGATGACCGGGACGACTGCCTCGCCGTCGGTGAGGTGAACCTTCAGGAGCTGTTCGGCCGGGTGGCCGCCGCCGTCCACCACGGCGGTACGGGGACGACACACGTGGCCGCCCTGGCCGGCGTCCCCCAGATCGTGGTGCCTCAGATAGCGGATCAGCCGCGCTACGCCGACCGGGTGGCCGAGCTGGGCATCGGTGCGGCAATCGACGGTCCGGCCCTCACCTTCGGCTCCCTGTCCGCCGCGCTCGCCACGGTCTTGGCCCCGGACACCCACACGCGAGCGGCCGCCCTGGCCGGCACGATCCGTACCGACGGGACAACCGTGGCCGCGCGACTGCTGTTCGACGCGGTCAGCCGGGAGAAGCCGGCTGTCTCCGTGTGA	MRVLFWSCGPRGDLEPLVALAVRLRALGVEVRMCAPSNFVERLTEVGVPLVLADRSMLEGAREPGRAPEPELAAARLAERFDKVPAVARGCDAVVASGLPSGATAVRSVAEKLGIRYFYTVSSPFLLPSPTQRALYNQGADRMFGGALNEQRALIGLPPVENVYDYCCTDRPWLAADQILAPRRPGIDGVRTGAWILPDERPLPAELEAFLRAGPPPVYVGFGSGPAPADVTRVAVEAIRAQGRRVVLSRGWAGLALPDDRDDCLAVGEVNLQELFGRVAAAVHHGGTGTTHVAALAGVPQIVVPQIADQPRYADRVAELGIGAAIDGPALTFGSLSAALATVLAPDTHTRAAALAGTIRTDGTTVAARLLFDAVSREKPAVSV	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	93.43	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1230	rifampin; rifaximin; rifabutin; rifapentine
BGC0001178.1|UK-68,597_22 # 46826 # 48715 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.662	BGC0001178.1|UK-68,597_22 	46826	48715	+	Loose	1190	378.637	novA	38.44	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGCTCAGATACTTTCGCCCGCACATCGGTAAAGTGGTGCTCTTCGCCGTCGTCGCCTCGTTGGATTCGCTCATCGTGGTCGCCATTCCGTTGTTGCTGATGAAACTCGTCGACGACGGCATTCTCAAGAACGATCTCGAGCTTGTGACCGAGATGGCCGTCCTGGCCGCCGGGCTCGCTGTGGCGGGCGCGTTGTTGCAGCTGCTGTCGGCCTACATCTCCGGGCGGATCGGGGAGGGGGTCACCTACGACCTCCGGATCCAGTCACTCGACCACGTCCGGCGGATGCCGGTCGCATTCTTCACCCGTACCCAGACCGGGGTGCTGGTGGGCCGGCTGCACACGGAACTGATCATGGCTCAGCAGGAGTTCGGCTTCCTGCTGATGGCGACCACGAGTGCGCTCACGGTGCTGCTGGTGCTGGCCGAGATGTTCTACCTCTCGTGGTTCGTCGCCATCGTCACGCTGGTGGTGATTCCGGTGTTCATCGTGCCTTGGATCTACGTGGGGCGCGCGATACAGCGGCGCACCGGACGGCAGATGGAGGCGAATACCGGCCTCAGTGGACTCCTCCAGGAGCGGTTCAACGTGCAGGGGGCGATGCTCTCCAAACTCTTCGGCCGTCCGGACGAGGAGATGGCCGAGTACGTCGGCCGTGCCGACCGGATCCGCCAGATCGGGGTGAGCCTTGCCGTGTGGGGCCGGCTTGCCTTCGTCATGATGGGGTTGATGGCCTCACTCGCGACGGCGCTCGTCTACGGGGTCGGCGGCGGGCTCGTGCTCGACGGGGCGATCGCGCTCGGGGCGCTCGTCGCCATCGCCACCCTGCTCGGGCGGCTGTTCGGACCGATCGTCCAGTTGTCCGGGCTGCAGGAAACCGCGCAGACCGTCGTGGTGAGCTTCTCCCGGGCCTTCGAGCTGCTCGATCTCAAGCCGCTGATCCAGGAACGCCCCGACGCGATCGCGCTCGCGAAGAACGTGGCGCCGGACATCGAGTTCGATAACGTGTCGTTCCGCTATCCCACCGCGGACGAGGTCTCGCTGCCGTCGTTGGAGTACCTACGGGCCGCACGGGATCGCGCGGAGGTGATGCGGGATGTCCTGCGCGGCGTGAGCCTGCGTGTGCCTTCCGGAAGCCTCACCGCGCTCGTTGGCCCGTCCGGCGCGGGGAAGAGCACGATCACCCACCTGGTGTCTCGGCTGTACGACCCGACCTCCGGGACCGTTCGCGTCGGCGGACACGATCTGCGGGACCTCACCTTCGACTCGCTCCGCGAAACGGTAGGGGTGGTCAGCCAGGACACCTACCTCTTCCACGACACGATCCGGCAAAACCTCCTCTACGCTCGCCCCACCGCCACCGAGGAGGAGCTGATCGAGGCCTGTAAAGCGGCCCAGATCTGGGATCTGATCGAATCTCTTCCGGGCGGGTTCGACACCGTCACGGGCGATCGCGGCTACCGCATGTCGGGCGGGGAGAAGCAACGACTGGCCATCGCCCGGCTGCTGCTGAAGGCACCCACGGTCGTCGTGCTCGACGAGGCCACCGCTCATCTGGACTCCGAGTCGGAGGCTGCCATCCAGCGGGCACTCAAGACCGCCCTGCACAACCGCACCTCGCTGGTGATCGCCCACCGGTTGTCCACGATCCGCGAGGCCGACCAGATTCTCGTGATCGACGACGGAGGGGTTCGGGAGCGAGGGACGCACGAGGAGTTGCTCGCCAAGGGCGGTCTCTACGCGGTGCTCTACCACACGCAGTTCGCCGGGCCGGAAGGCAACGGAGCCACGCCCGAAAGCAACGGCGCAGGGCCGGCGAGCAATGAGACCGGGATCTACGACGATGAGCCTGAGCCGGTGCACTACGTGGTTCGTGGCGGAGGCGGATGA	MLRYFRPHIGKVVLFAVVASLDSLIVVAIPLLLMKLVDDGILKNDLELVTEMAVLAAGLAVAGALLQLLSAYISGRIGEGVTYDLRIQSLDHVRRMPVAFFTRTQTGVLVGRLHTELIMAQQEFGFLLMATTSALTVLLVLAEMFYLSWFVAIVTLVVIPVFIVPWIYVGRAIQRRTGRQMEANTGLSGLLQERFNVQGAMLSKLFGRPDEEMAEYVGRADRIRQIGVSLAVWGRLAFVMMGLMASLATALVYGVGGGLVLDGAIALGALVAIATLLGRLFGPIVQLSGLQETAQTVVVSFSRAFELLDLKPLIQERPDAIALAKNVAPDIEFDNVSFRYPTADEVSLPSLEYLRAARDRAEVMRDVLRGVSLRVPSGSLTALVGPSGAGKSTITHLVSRLYDPTSGTVRVGGHDLRDLTFDSLRETVGVVSQDTYLFHDTIRQNLLYARPTATEEELIEACKAAQIWDLIESLPGGFDTVTGDRGYRMSGGEKQRLAIARLLLKAPTVVVLDEATAHLDSESEAAIQRALKTALHNRTSLVIAHRLSTIREADQILVIDDGGVRERGTHEELLAKGGLYAVLYHTQFAGPEGNGATPESNGAGPASNETGIYDDEPEPVHYVVRGGGG	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	102.28	gnl|BL_ORD_ID|1112|hsp_num:0	1210			84	1779	novobiocin
BGC0001178.1|UK-68,597_24 # 49074 # 50330 # 1 # ID=1_24;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=3bp;gc_cont=0.679	BGC0001178.1|UK-68,597_24 	49074	50330	+	Loose	800	26.5646	PDC-285	28.57	3005287	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	TTGGACGGGCTCGACGGTCGTGCGGCCGGCCGGACCATCCAAGTCGCGTATGCCGGTGGGATGAGCGAAAGGATCTGTGGCGTGTTCGAGGAGCTCAACGTCGGCCTGGCCTCGGAGCTGCACCAGCGAGACCGGTTCGACCCGGTGCCACAGCTCCGCTCCCTGATGGCCGAAGACCCTTTGACGATTCTGGGCGCCGAGGACGCCCCCGATGGCCGAACCGCTTGGCTCGCCACCGGGTACGACGAGGTCCGGCGGGTGCTCGGCGGGAGTGAGTTCAGTTCCCGGCTGCTCTACGGCGGGACCGCGGCCGGCTTGGCCTGGCCCGGCTTCCTGACCCATTACGATCCGCCAGAGCACACGCGACTGCGCAGGATGGTCGCGCCCGCTTTCGCCGTCCGGCGGATGCAGAAGTTCCAGCCGCAGGTCGAGCTGATCGTCGAGGACAGCCTCGACGAAATCGAGGCCCTCGGCGGACCGGTGGACTTCGTCCCGCGCTTCGGATGGTCGGTGGCGACGACGGCGACCTGCGACTTCCTCGGCATCCCCCGTGACGATCAGGCGGATCTGGCACGCTGCCTCCACGCCAGCCGAACGGAACGGTCGGATAAGCGGCGTGTCGCGGCGGGAAACAAGTTCATGACCTACATGAGCAAGACCACGGCTCGCACCCGCCGCGATCCCGGTGACGACATGTTCGGTGTCGTGGTGCGCGAGTACGGCGACGAGATCAGCGACGCGGAACTGACCGGGGTGGCCGCGTTTGTCATGGGCGCGGGGGCCGACCAGGTAGCCCGCTTCCTCGCGGCGGGCGCCTGGCTGATGGCCGAGAACCCCGGGCAGTTCGCCCTGCTCCGGGATGAGCCGGAGACCGTACCGAACTGGCTGGACGAGATGGTTCGATACCTCACCACGGACGAGAAGACCCATCCGCGTGTCGCACTGGAGGATGTGCGCATCGGTGATCACCTCATCAGGGCCGGCGATGCCGTCACGTGCTCCTTGCTGGCGGCGAACCGCCGGGACTTCCCAGCTCCGGCGGATCGATTCGACATGACGCGGGAACGACCGGAGCACGTCGCGTTCGGGCACGGCATTCATCACTGCCTCGGCAGGTCCATGGCCGAGCTGGTGTTCCGGACGGCGATTCCGGCGCTGGCGCGCCGCTTTCCCACGCTGAGGCTGGCCGAGCCGGACCGCAAGATCAAATTGGGGCCGCCGCCGTTCGACGTGGAAGCCCTGCTGCTCGACTGGTAG	MDGLDGRAAGRTIQVAYAGGMSERICGVFEELNVGLASELHQRDRFDPVPQLRSLMAEDPLTILGAEDAPDGRTAWLATGYDEVRRVLGGSEFSSRLLYGGTAAGLAWPGFLTHYDPPEHTRLRRMVAPAFAVRRMQKFQPQVELIVEDSLDEIEALGGPVDFVPRFGWSVATTATCDFLGIPRDDQADLARCLHASRTERSDKRRVAAGNKFMTYMSKTTARTRRDPGDDMFGVVVREYGDEISDAELTGVAAFVMGAGADQVARFLAAGAWLMAENPGQFALLRDEPETVPNWLDEMVRYLTTDEKTHPRVALEDVRIGDHLIRAGDAVTCSLLAANRRDFPAPADRFDMTRERPEHVAFGHGIHHCLGRSMAELVFRTAIPALARRFPTLRLAEPDRKIKLGPPPFDVEALLLDW	MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAAHSLGQPFKRLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR	105.29	gnl|BL_ORD_ID|2991|hsp_num:0	4019			552	741	
BGC0001178.1|UK-68,597_25 # 50353 # 51507 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.680	BGC0001178.1|UK-68,597_25 	50353	51507	+	Loose	900	27.335	msrF	33.33	3005087	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGACACTTCCTCTGCCGCATCAGCGGGTCTGGCTCGATCCGGTGCCGGAGCTCGATGAGCTGCGAAAAGACGGCCCCTTGCACGAGTATGACTCCGAGCCGGGTATGGACGGCCGCAAACAGTGGCTGGTCACCGGCTACGACGAGGTCCGGCAGATTCTCGCCGACCACCATCGGTTCAGCTCGGCGCGGCCGGTCGACGACGAGGCGGATCGAGCCCGGTTGCCGGGCATTCTGCAGGCGTACGATCCGCCCGAGCACACTCGGCTGCGCCGGACGGTTTCCCCGGCGTACTCCGCCCGGCGGATGGAGCGGCTGCGGCCCCGTATCGAAGAAATCGTTGAAGACGGCTTGGACGATTTCGAGAGTGTGGGATCGCCCGCCGACTTCGTCCGGCACGCCGCCTGGCCGATTCCCGCGTTCATCGCCTGTGAGTTCCTCGGCGTCCCTCGTGACGATCAGGCGGAGTTGTCGCGGATGATCCGGGAAACCCGAGAGAGCAAGATCCCTAGGCAGCGGGTCGCGTCAGGTCTGGGCGTCGTGAACTACACCGAGAGGCTGGCAGCCAGCAAACGCCGCGACCCCGACGAAGGCATGATCGGCGCCCTCGTCCGCGAGCACGGAGATCAGGTCACCGACGAGGAACTGGCGGGACTCGCCGAGGCGAGTCTGACCATGGCCACCGAGCAGGTGGCCGCCCAACTGGCCGTCGCGGTGCTCCTCCTGGTCTCCCATCCCGCGCAGCTGGCGCTGCTCCGCGAGCGTCCTGAACTTGTGGACGGCGCGATCGAGGAGGTGCTTCGCTACGGGTCGGTCGTCGAGGCCCCCTCTCCCCGGGTCGCGCTTGCCGATGTGCGTGTGGCAGGACGGGACATCCGCGCTGGCGAGGTCCTGACGTGCTCGATGCTGGCGATCAACCGTGCGCCGGGGGACCGGTTCGACATCACCCGACGGGACCGCACGCACCTGTCGTTCGGGCACGGCATCCACCACTGCATCGGGGCGCCGCTGGTCAGACTCGAGCTACGGGTGATGCTGCCGGCGGTGGTCCGCCGGTTCCCGTCCTTGCGGCTTGCGGTCCCGGAGGAGGAGCTGCGATTCAAACCGGGCAGGCCGGCCCCTTTCGCCGTGGAGGAGCTTCCCCTTGAGTGGTGA	MTLPLPHQRVWLDPVPELDELRKDGPLHEYDSEPGMDGRKQWLVTGYDEVRQILADHHRFSSARPVDDEADRARLPGILQAYDPPEHTRLRRTVSPAYSARRMERLRPRIEEIVEDGLDDFESVGSPADFVRHAAWPIPAFIACEFLGVPRDDQAELSRMIRETRESKIPRQRVASGLGVVNYTERLAASKRRDPDEGMIGALVREHGDQVTDEELAGLAEASLTMATEQVAAQLAVAVLLLVSHPAQLALLRERPELVDGAIEEVLRYGSVVEAPSPRVALADVRVAGRDIRAGEVLTCSMLAINRAPGDRFDITRRDRTHLSFGHGIHHCIGAPLVRLELRVMLPAVVRRFPSLRLAVPEEELRFKPGRPAPFAVEELPLEW	MEQICFELENVEVTFLDKKILEIDRLAVHQFDRIGIVGKNGAGKSTLLKILGGIIKPTRGKVNRYIDYGYFEQVESPKVSMADPRLLGKLNVKVDSNNLSGGELTRLKIAQLFTDYYESLLIDEPTTHLDQDGISFLIDKLKYYYGALVLISHDRNLLDELVTTIWEIDDGMIKVYSGNYSEYLRQKKVEREQQAHDFDLYLKEKNRLEKAAKEKMNKAEKIANSSSMSKKESKAKANRMFESKSKGTSQKSLQRAAKAVEKRIEQLEVVDAPKEIHTIQFHQTHSTPPLHNKFPILGDRLTLQAGDKTLLEETSFQFPLGKTIAITGNNGSGKTTLIHHIIQKGEGITISPKAVIGFYEQMGYQFNEDKTVLSYMKARSDYDESKIRSVLHAMNFNGNDLKKNVRYLSGGEATRLVLCQLFLGRYNILILDEPTNFLDIFCIEALERFIEEYEGTIILISHDKKFVDHVSDTIYKIENKKLNLVN	79.01	gnl|BL_ORD_ID|2804|hsp_num:0	3821			177	267	erythromycin
BGC0001178.1|UK-68,597_26 # 51497 # 52693 # 1 # ID=1_26;partial=00;start_type=TTG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.677	BGC0001178.1|UK-68,597_26 	51497	52693	+	Loose	850	27.335	tet(K)	36.0	3000178	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGAGTGGTGACGACTCGCCTCCGGTCCACACTCTCCGGCAGGGTTTCGACCCGGCGGACGAGCTACGCGCTGCTGGAAAGCTGACGAGGATCTCCATCGGGTCCGGTGCGGCGGCCGAGTCCACCTGGCTGGCCGCGGGGCATGCCGTCGTACGGCAGGTGCTCGGCGATCACAAGCGGTTCAGCACCCGGCGTCGCTTCGACCGGCGGGACGAGATCGGCGGGACGGGCATCTTCCGGCCGCGCGAGCTGGTCGGCAACCTGATGGATTACGACCCGCCCGAGCACACCCGGCTCCGGGCGCTGCTGACCCCGGGATTCACCCAGCGCCGGATGCGGCGCATGGCGCCGCGCATCGAAGAGATCGTGACGGAACGTCTCGACGCCATGGAGCATGCGGGACCCCCCGCCGACCTGGTCGAGCTGGTCGCCGACGAGGTGCCCGGGGCGGTGCTGTGCGAGCTGATCGGAGTGCCCCGAGACGACCGCTCCATGTTCCTGCAGCTGTGTCACCGACATCTCGATGCCGCGCTGAGCGCGAGGAAGCGGGCGTCCGCCGGCGAAGCGTTCTCCCGCTACCTCGTGGCCATGATGGCCAGGGAACGGAAGGACCCGGGCGAAGGGTTCATCGGAGCGATCGTCGCCGAACACGGCGACACGATCACGGATGAGGAGCTGAGAGGCGTCTGCGTGCAGCTGATGCTGGCCGGAGACGACAACGTGTCCGGCATGATCGGGCTGGGCGTGCTGGCGCTGCTGCGCCATCCCGAGCAGATCGCCGCGTTGCGGGGTGACGTTCAGTCGGTGGATCGGGCGGTCGACGAGCTGATTCGGTACCTGACAGTCCCGTATGCGCCGACCCCCCGGACCGCGACTGAGGACGTCGCCATCGCCGGCCAGGTGATCAAGGAGGGGGAGACCGTCCTCTGCTCTCTCCCGATGGCCAACCGTGACCCTGCGCTGCTGCCCGATGTGGACCGCCTCGATCTCACCCGCGGGTCCGTTCCACATGTCGCCTTCGGGCACGGCATCCATCATTGCCTGGGAGCTGCTCTGACCCGCCTCCAACTGCGCATCGTCTATACCGCGCTGTGGCAACGTTTTCCCGGGCTGGAGCTGGCGGATCCCGACCAGGAAACCATGTTTCGGACGAGCACCCCGGCGTATGGATTGACCACTCTGATGGTCACTTGGTGA	MSGDDSPPVHTLRQGFDPADELRAAGKLTRISIGSGAAAESTWLAAGHAVVRQVLGDHKRFSTRRRFDRRDEIGGTGIFRPRELVGNLMDYDPPEHTRLRALLTPGFTQRRMRRMAPRIEEIVTERLDAMEHAGPPADLVELVADEVPGAVLCELIGVPRDDRSMFLQLCHRHLDAALSARKRASAGEAFSRYLVAMMARERKDPGEGFIGAIVAEHGDTITDEELRGVCVQLMLAGDDNVSGMIGLGVLALLRHPEQIAALRGDVQSVDRAVDELIRYLTVPYAPTPRTATEDVAIAGQVIKEGETVLCSLPMANRDPALLPDVDRLDLTRGSVPHVAFGHGIHHCLGAALTRLQLRIVYTALWQRFPGLELADPDQETMFRTSTPAYGLTTLMVTW	MFSLYKKFKGLFYSVLFWLCILSFFSVLNEMVLNVSLPDIANHFNTTPGITNWVNTAYMLTFSIGTAVYGKLSDYINIKKLLIIGISLSCLGSLIAFIGHNHFFILIFGRLVQGVGSAAFPSLIMVVVARNITRKKQGKAFGFIGSIVALGEGLGPSIGGIIAHYIHWSYLLILPMITIVTIPFLIKVMVPGKSTKNTLDIVGIVLMSISIICFMLFTTNYNWTFLILFTIFFVIFIKHISRVSNPFINPKLGKNIPFMLGLFSGGLIFSIVAGFISMVPYMMKTIYHVNVATIGNSVIFPGTMSVIVFGYFGGFLVDRKGSLFVFILGSLSISISFLTIAFFVEFSMWLTTFMFIFVMGGLSFTKTVISKIVSSSLSEEEVASGMSLLNFTSFLSEGTGIAIVGGLLSLQLINRKLVLEFINYSSGVYSNILVAMAILIILCCLLTIIVFKRSEKQFE	86.71	gnl|BL_ORD_ID|1337|hsp_num:0	1345			297	447	tetracycline
BGC0001178.1|UK-68,597_27 # 52735 # 53574 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.611	BGC0001178.1|UK-68,597_27 	52735	53574	+	Loose	450	27.7202	aadA21	36.73	3002618	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGACACGGATCTCATGGATCGTCAGCTACCCGAAGTCCGGCAACACGTGGTTGCGCAGCATGCTGACGACCTACATCGGCGGTGCTCCGGCCGAATCTCTCCGGCGTCTCCAGGACCTGATCCCTGACATCCATCCCATGCTTGCGGAGGGCGATGTGCCGGCGTGGGACGACGGCGGATCCGCCCTCGTCAAGACCCACTTTCTGCCCGACGTTCGTGTGCTGCGCCTCTACCGTGAAGTGTCCCGCAAGGCTGTCTATATCGTACGGAATCCGCGGGATGTTCTGCTCAGCAGTCTGCGGGCGATGCACATCTCCCATGACGACACGGCAGAGTGCCGGCGGATAGCCGAAGGCTTCATCGCGCACGAGAGCTTTTTCGCCGACCGTGGCCGCATCGGTATTGGATCATGGACAGAGAGCCTGCGGATGTGGACCTCGACCGATATTGTCCGGGACAGCTTTCCGGACATCGACGTGCTGACGGTACGGTACGAGGACATGCGCAGCGATCCGGCCGGAAAGCTTACCGAGATCGTGGAGTTCCTCGACCTTGGCCGCCCCATTGTCGAGCACGACATCCAGGGCGCGGTGGAAGGCAGCACCCTGGATCGTATGCGTGAGATGGAAAAGAAGGACAAGGTCAATAGAAAGCCGCCGCCGCTGTCGAGGTGGGCCGCCGCGAAAAATCCGGCGCAGCAATTTCCATTCATCGGGGAAGGGCGGCAGGGGCAATCGCTCGCCTTCATGGGCGAGGATATCGAGGATGCATTCCGGGAGCGACTGCGGGATGGGTCCGAATTCGCCTTGCTGGCGAAGCAATTCGGTTATGACGAGTGA	MTRISWIVSYPKSGNTWLRSMLTTYIGGAPAESLRRLQDLIPDIHPMLAEGDVPAWDDGGSALVKTHFLPDVRVLRLYREVSRKAVYIVRNPRDVLLSSLRAMHISHDDTAECRRIAEGFIAHESFFADRGRIGIGSWTESLRMWTSTDIVRDSFPDIDVLTVRYEDMRSDPAGKLTEIVEFLDLGRPIVEHDIQGAVEGSTLDRMREMEKKDKVNRKPPPLSRWAAAKNPAQQFPFIGEGRQGQSLAFMGEDIEDAFRERLRDGSEFALLAKQFGYDE	MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVARDWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK	106.08	gnl|BL_ORD_ID|532|hsp_num:0	584			630	762	spectinomycin; streptomycin
BGC0001178.1|UK-68,597_28 # 53672 # 55147 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=12bp;gc_cont=0.661	BGC0001178.1|UK-68,597_28 	53672	55147	+	Loose	600	61.6178	Streptomyces venezuelae rox	29.89	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCCAGTGGAAGAGTTCGATGTGGTGGTGGCCGGTGGCGGGCCGGCCGGTTCGACGGTGGCTTCCCTGGTGGCCATGCAGGGTCATCGGGTGTTGCTGCTGGAGAAGGAGGTCTTTCCCCGGTACCAGATCGGCGAGTCGTTGCTGCCCTCCACCGTCCACGGGGTGTGCCGGATGCTCGGCGTCACCGAAGAACTGGCGGAGGCCGGTTTCCCGACGAAGCGGGGTGGCACCTTCCGCTGGGGTGCGCGCCCGGAGCCGTGGACGTTCTCCTTCGCTGTTTCGTCCCGGATGACCGGCCCGACGTCGTTCGCGTACCAGGTCGAGCGGGCGCGTTTCGATGAGATCCTGCTGCGTAACGCGCAGCGCAAGGGTGTCGAGGTGCGTGAGGGCTGCTCGGTCGCCGGTGTGATCGAAGGGGACGAGCGGGTCGCCGGCCTGCGCTACACCGACTCCGACGGCGGTGAGCACGAGGTGCGTGCGCGCTTCGTGGTCGATGCGTCGGGCAACAAGAGCCGGCTGTATTCCAGTGTCGGCGGGACCCGGAACTACTCGGAGTTCTTCCGCAGCCTGGCGCTTTTCGGCTACTTCGAGAACGGCAAGCGGCTGCCGGCGCCGAACTCGGGCAACATCCTCAGCGTGGCCTTCGACAGTGGCTGGTTCTGGTACATCCCGCTGAGCGACACGATGACCAGCGTCGGCGCGGTGGTGCGCCGGGAGATGGCGGAGAAGATCCAGGGCGACCGGGAGAAGGCGCTCCAGGCTCTGATCGCCGAATGCCCGCTGATCTCCGAGTATCTGCAGGATGCCCGCCGGATCACCACCGGCAGGTACGGGGAGCTGCGGGTCCGCAAGGACTACTCCTATCTCCAGACGAGCTTCTGGCGGCCCGGGATGATTCTGGTCGGCGATGCCGCGTGCTTCGTGGATCCGGTCTTCTCCTCGGGCGTGCATCTGGCGACCTACAGTGCGTTGCTCGCCGCGCGTTCGATCAACAGCGTCCTCGCGGACGACCTGGATGAGAAGACCGCGCTGACCGAGTTCGAGGCGCGGTACCGCCGCGAGTACGGGGTGTTCTACGAGTTCCTCGTCTCGTTCTACGAGATGAACGTGAACGAGGAGTCGTACTTCTGGCAGGCGAAGAAGGTCACCAAGAACAAGCGCACGGAGCTGGAGTCGTTCGTGGAACTGATCGGCGGAGTGTCGTCCGGCGAGGCGGCGCTGACCACGTCCGGCAGGATCACCGAGCGCAGCGCCGAGTTCGCCGCGGCCGTGGATCAGATGGCTTCCAGCGACGACGGCAACATGGTGCCGATGTTCAAGTCGCAGGTGGTCAAGCAGGTCATGCAGGAGGGCGGTCAGGTGCAGATGAAGGCCGTGCTCGGCGAGGACGCCGAGCCCGAACTGCCGCTCTTCCCCGGCGGCCTGGTGGCCTCACCCGACGGGATGAAATGGCTGCCCTACCATCCCGCGTGA	MPVEEFDVVVAGGGPAGSTVASLVAMQGHRVLLLEKEVFPRYQIGESLLPSTVHGVCRMLGVTEELAEAGFPTKRGGTFRWGARPEPWTFSFAVSSRMTGPTSFAYQVERARFDEILLRNAQRKGVEVREGCSVAGVIEGDERVAGLRYTDSDGGEHEVRARFVVDASGNKSRLYSSVGGTRNYSEFFRSLALFGYFENGKRLPAPNSGNILSVAFDSGWFWYIPLSDTMTSVGAVVRREMAEKIQGDREKALQALIAECPLISEYLQDARRITTGRYGELRVRKDYSYLQTSFWRPGMILVGDAACFVDPVFSSGVHLATYSALLAARSINSVLADDLDEKTALTEFEARYRREYGVFYEFLVSFYEMNVNEESYFWQAKKVTKNKRTELESFVELIGGVSSGEAALTTSGRITERSAEFAAAVDQMASSDDGNMVPMFKSQVVKQVMQEGGQVQMKAVLGEDAEPELPLFPGGLVASPDGMKWLPYHPA	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	103.15	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	486	rifampin; rifaximin; rifapentine
BGC0001178.1|UK-68,597_29 # 55241 # 56473 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.658	BGC0001178.1|UK-68,597_29 	55241	56473	+	Loose	500	26.1794	OXY-3-1	24.83	3002409	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	OXY beta-lactamase	ATGGATCACGGTATCGATGAGGTCGCGCCGGTCGTGCGGCCGACGGCGAACTACATGTTGAGAACGCACTGCGATCCGCACGAGGACATGTTCGCTCTCCGGGCGCACGGCCCGCTGATCCGGATCGCCGGGAACGCGGCCACTCAGACGGGCAAGGATTATGTCTGGCAGGCCCTTGGCCACGACGTCGTGCGAAGGATCATCGGCGACCACGAGAATTTCTCGACGCGGCTGCGGTTGACCGAGGCGCAACCGATCAGCGGAGAAGGGGTTCCGATCCCGCCGGAGATCGTCGGACAGATATCAACCTATGATCCGCCCGAGCACACCCGCCTGCGACGGATGCTGACGCCGGAGTTCACGGTGCGGCGGATCCGTCGACTGGAGCCCGCGATCCAGGCCATCATCGATGAGCGCCTCGATGCGATGGAGGCTGCGGGCCCGCCCGCGGACGCGCAGGTGCTGTTCGCGGATCCGGTCGGCGGGGGCGCCCTGTGTGAGCTGCTCGGCATCCCGCGTGATGATCGGAACGAGTTCATGCGACGCGTCCGGCAGAACGTCGATCTGAGCCGCGGGTACAAGGCCCGGGCGGCCGACAGCGCGGCGTTCAACCGGTACCTGAACAGCCTCATCACCAGGCAGCGGAAGGACCCCGACGAGGGATTCATCGGCATGCTTGTACGAGAACACGGCGCGGACGTCACGGATGAGGAGTTGAAGGGCGTCTGCACGGCGCTCATCCTCGGTGGTGTCGAGAGCGTCGCGGGGATGATCGGTTTCGGGATTCTCGCGCTGCTGGACCATCCCGACCAGAGACAGCTGCTCTTCGCCGGGCGCGAGGAGGCCGACCGCGTGGTCAATGAACTGTTGCGGTTCCTGTCTGCCATCCAGCAGCCGACTCCGCGAATGGCCATCAAGGACGTGGTCATCGACGGACAGCTGATCAAGGCGGGGGAGATGGTTCTGTGCTCGATTCTCATGGCCAACCGGGATGAGGCGCTGACGCCGAATCCCAACACGCTCGACGCGAGCCGTGACCAGGCCCCGCACCTGGCGTTCGGGCACGGCATCCACCACTGCATAGGTGCGGCGGTGGCGAGAGCGGTGCTGCGCATGGCCTATCAAACCCTGTGGCGGCGATTCCCCGAGCTGCGCCTGGCCGTACCCGCCGATTCGGTGAAGCTCAGAAGGGCGTTCATCGACAGCCCGGATCGGTTGCCGGTCGCCTGGTAG	MDHGIDEVAPVVRPTANYMLRTHCDPHEDMFALRAHGPLIRIAGNAATQTGKDYVWQALGHDVVRRIIGDHENFSTRLRLTEAQPISGEGVPIPPEIVGQISTYDPPEHTRLRRMLTPEFTVRRIRRLEPAIQAIIDERLDAMEAAGPPADAQVLFADPVGGGALCELLGIPRDDRNEFMRRVRQNVDLSRGYKARAADSAAFNRYLNSLITRQRKDPDEGFIGMLVREHGADVTDEELKGVCTALILGGVESVAGMIGFGILALLDHPDQRQLLFAGREEADRVVNELLRFLSAIQQPTPRMAIKDVVIDGQLIKAGEMVLCSILMANRDEALTPNPNTLDASRDQAPHLAFGHGIHHCIGAAVARAVLRMAYQTLWRRFPELRLAVPADSVKLRRAFIDSPDRLPVAW	MIKTSWRKSALIAAALPLLLCSSSLWANAIQQKLADLEKSTGGRLGVALIDTTDNSQILYRGDERFAMCSTGKVMAAAAVLKQSESNKDVVNKRLEIKASDLVVWSPVTEKHLQSGMTLAELSAAALQYSDNTAMNKMIGYLGGPEKVTAFARSIGDVTFRLDRTEPALNTAIPGDERDTTTPLAMAESLHKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQPLQDAKSRKDVLAAAAKIVTEGL	142.36	gnl|BL_ORD_ID|317|hsp_num:0	348			114	528	
BGC0001178.1|UK-68,597_30 # 56541 # 57875 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.660	BGC0001178.1|UK-68,597_30 	56541	57875	+	Loose	600	59.6918	Streptomyces venezuelae rox	30.68	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCCGGTTGAGGAGTTCGATGTGGTGGTGGCCGGTGGCGGGCCGGCCGGTTCGACGGTGGCTTCGCTGGTGGCCATGCAGGGTCATCGGGTGTTGCTGCTGGAGAAGGAGGTCTTTCCCCGGTACCAGATCGGCGAGTCGTTGCTGCCCTCCACCGTTCAGGGGGTCTGCCGGATGCTCGGCGTCATGAACGAGCTGGCAGGAACGAATTTCCGGGTCAAGCATGGTGGCACCTTCCGCTGGGGTGCGCGCTCGGAGCCGTGGACGTTCTCCTTCGCCGACTCTCCTCAGCTGACCGGGCCGACGTCGTTCGCGTACCAGGTCGAGCGGGCGCGTTTCGATGAGATCCTGCTGCGTAACGCGCAGCGCAAGGGTGTCGAGGTGCGTGAGGGCTGCTCGGTCGCCGGTGTGATCGAAGGGGACGAGCGGGTCGCCGGCCTGCGCTACACCGACTCCGACGGCGGTGAGCACGAGGTGCGTGCGCGCTTCGTGGTCGATGCGTCGGGCAACAAGAGCCGGCTGTATTCCAGTGTCGGCGGCGCCCGGAACCACTCGGACCTCCCCGGCGGCCTGGCGCTCTCCGGCTACTTCGGTCGCTGCAGGGAGCCGGCGCCATACTCGGGCAACACTCTGATCGTGGCCTTCGAAAGTGGCTGGTTCTGGTACACCAATATCACCGGCGGGCTGAGCAGCGTCGGCGCGGTGGTGCGCCCGGAGATGGCGGAGAAGATCCAGGGCGACCGGGAGAAGGCCTTCGCGGCCCTGATCGCCGAATGCCCGCTGATCTCCGAGTTGCTCTCGGAGGCGTCGCGGGTGAAGGCCGGTAAGTACGGGAAGTTGCGGGTCAGTGAGAACTACTCCTATCACCAGACTGCTTTGTGGCGGCCCGGGATGATTCTGGTCGGGGACGCCGCGTGTGTCATGGATCCGGTGCTCTCGTCCGGCGTGCATCTGGCGACCTACGGCGCGTTGCTCGCGGCGCGCTCGATCAACAGCGTCCTGGCGGACGACCTGGATGAGAAGACCGCGCTGACCGAGTTCGAGGCGCGGTACCGCCGCGAGTACGGGGTGTTCCACGACTTCCTCATGTCGTTCTACGACATGGACGTGAGCGAGGAGTCGTATTTTCGGCAGGCCAAGAAGGTCACGAACAGCGAGCGCACCGAGCTGGAGTCGTTCGTGGACCTGGCCGTCGGGCTGTCATCCGGTGAGCCGGCGCCGACAGCGCCGGGCGGCGAAGACGACGCGCCTGAGGTGCCGCTGTTCCCAGGCGGAATGGTCGCCTCGCCCGACGGAATGAAATGGCTGCCTTATCCGGAAGCTATTCGATCATGA	MPVEEFDVVVAGGGPAGSTVASLVAMQGHRVLLLEKEVFPRYQIGESLLPSTVQGVCRMLGVMNELAGTNFRVKHGGTFRWGARSEPWTFSFADSPQLTGPTSFAYQVERARFDEILLRNAQRKGVEVREGCSVAGVIEGDERVAGLRYTDSDGGEHEVRARFVVDASGNKSRLYSSVGGARNHSDLPGGLALSGYFGRCREPAPYSGNTLIVAFESGWFWYTNITGGLSSVGAVVRPEMAEKIQGDREKAFAALIAECPLISELLSEASRVKAGKYGKLRVSENYSYHQTALWRPGMILVGDAACVMDPVLSSGVHLATYGALLAARSINSVLADDLDEKTALTEFEARYRREYGVFHDFLMSFYDMDVSEESYFRQAKKVTNSERTELESFVDLAVGLSSGEPAPTAPGGEDDAPEVPLFPGGMVASPDGMKWLPYPEAIRS	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	93.28	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	492	rifampin; rifaximin; rifapentine
BGC0001178.1|UK-68,597_31 # 57885 # 59477 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.648	BGC0001178.1|UK-68,597_31 	57885	59477	+	Loose	400	26.5646	IMP-31	28.57	3002222	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGAGTGACGAGCGCCTTTTTTTGCGGCCAAATACCATTATTGAGCCTTTGGTTGATCGATTTTACGCGTCGATGTACGCGGTGGCCCCCGTCACGGGGACCATGACCCTCGCCAACCGGCTGATACCGATGCTGGAGTCCTACCTGCAGGCCCCGGAATGGCATTACAAGGGCAGCCGGGACCCGAAGTTCCGCGGCGGATTCTTCGTCGGCATCGAGGACAAGCGGAAGGATGAGGTCCAGGCGCTGCTCACCGCCATCCGGCACGACCGCGCGGACATGATCCGCTTCGCCGAGGCGATCGCCGCGGCCGAGAAGATCGTCCGCGAGGAGGCGACCGGTTACGACCTGAAGCCGCTCTACCCGAAGCTGCCCCCCGAGCTGGCGGGTCTGGTGGAAATCTCCTATGACACCAGCAACGCTGCCTCGCTGCACTTCCAGGAGCCGCTCGTCTACAAGAGCAAGGCCTACACGGAGGACCGCCAGTCGGTTCAGCTCTCCGTGGAGACGGGCATCGAACGGCCGTTCGTGATGAGCACCCCGCGGCTGCCCTCGCCCGACGTGCTCGAGTTGCGGATCCCGTTCCGGCACCCGGGTCTGGAGCAGCTCTTCCGGTCCAGGGTCCGGCCCACCACCCTGGCCGCCCTCCGTGAGGCGCTGGAGCTCGGCGACGCGGAAGCGGCCCAGCTCTCCGGGCTGCTGGTCCCGGAGTCCGCGCTCGCCGCCGACCGCCACATCACGGCCGGCGCCCGGATCCGCTACTGGGGGCACGCCTGCCTGCTCCTGCAGACACCCGACGTGGCCATCATGACGGACCCGTTCATCAGCGCGGATACCGACGCGACCGGCCGGTACACCTACAACGACCTGCCCGACCACATCGACTATGTGGTCATCACCCACGGGCATTCCGACCATCTCGTGCCGGAGACGCTGCTTCAGCTGCGCGGCCGGGTGGGCACCTTTGTGGTGCCGAGGACCTCGCGCGGTAATCTGCTCGATCCTTCGCTGGCGCTCTACCTCAGGAGCTTCGGGTTCTCCGCCGTCGAGGTGGATGACTTCGACGAGATCGAGTTCCCGGGCGGCAAGATCGCCGCCACTCCGTTCTTCGGGGAGCACGCCGATCTCGACATTCGTGCCAAGGCGACGTACTGGATCAGTCTCGGTGGAAAGTCGATCTATGTGGGTGCGGACTCCTCCGGCCTCGACCCGGTTCTCTACCGCTATGTCCGCGGGCATCTCGGACCGGTCGACATCGCCTTCCTCGGCATGGAGTGCGACGGGGCCCCGCTGAACTGGCAGTATCAGGCGTTCATGACCAAGCCGATCTCCAACAAGATGAGTGACAGCCGCAAGATGTCCGGCTCCAACGCGCAGCAGGCGAGTGCGATCGTCACCGAGCTCGGCGTCGACGAGGTGTACGTCTATGCCATGGGCGAGGAGAGCTGGCTCGGCCACGTCATGGCCACCAGCTACAACGAGGACTCCTACCAGCTCCAGCAGATCGCCGAGTTCGAGACATGGTGCTCGAACAACGGCGTGAAATCCGGCCATCTGCTTGATCGGCATGAATGGAACTGGTCGCAACCCTGA	MSDERLFLRPNTIIEPLVDRFYASMYAVAPVTGTMTLANRLIPMLESYLQAPEWHYKGSRDPKFRGGFFVGIEDKRKDEVQALLTAIRHDRADMIRFAEAIAAAEKIVREEATGYDLKPLYPKLPPELAGLVEISYDTSNAASLHFQEPLVYKSKAYTEDRQSVQLSVETGIERPFVMSTPRLPSPDVLELRIPFRHPGLEQLFRSRVRPTTLAALREALELGDAEAAQLSGLLVPESALAADRHITAGARIRYWGHACLLLQTPDVAIMTDPFISADTDATGRYTYNDLPDHIDYVVITHGHSDHLVPETLLQLRGRVGTFVVPRTSRGNLLDPSLALYLRSFGFSAVEVDDFDEIEFPGGKIAATPFFGEHADLDIRAKATYWISLGGKSIYVGADSSGLDPVLYRYVRGHLGPVDIAFLGMECDGAPLNWQYQAFMTKPISNKMSDSRKMSGSNAQQASAIVTELGVDEVYVYAMGEESWLGHVMATSYNEDSYQLQQIAEFETWCSNNGVKSGHLLDRHEWNWSQP	MKKIFVLFVFLFCSITAAGESLPDIKIEKLDEDVYVHTSFEKITGWGVITKHGLVVLVNTDAYIIDTPFTAKDTEKLVRWFVGRGYKIKGSISSHFHSDSAGGIEWLNSQSIPTYASKLTNELLKKNGNAQAENSFSGVSYWLVKHKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFIKPDGLGYLGDANLEAWPKSAETLMSKYGNAKLVVSSHSEIGGASLLKRTWEQAVKGLKESKNHHSPK	216.33	gnl|BL_ORD_ID|1248|hsp_num:0	1362			111	297	
BGC0001178.1|UK-68,597_35 # 62552 # 64135 # -1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.693	BGC0001178.1|UK-68,597_35 	62552	64135	-	Loose	1800	26.9498	mdtC	39.22	3000794	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGTGTCAGTGCTGAACCGGTGTTTCTGAGGTCCAACGCGATCATCGAACCGCTGGTCGACCGGTTCTATGCCTGGATGCACACCGTGTCGCCCGCCGCGGCCTCGTTGAATCTGGCGAGGATCCAGATTCCCCTGCTCGAATCGCGCCTGCGAGATCCGCAGCCGCACGTGGCCGCCGGCACCGACTCCCCCGCGCCCGGCCACTTCGCCGACGTCGGGGAGCCGCGCGGCATGGAGGTCGCGGCACTGCTCGACTCGATCAAGAAGGACCGCGCGGACATGCTGGCGTTCGCCGACGCCGTCGCCGAGGCCGGCGCCCTGCTCCGGCAGCACGTCACGGGCTCCGATCTCACGCGTCTCCACCCGAAGCTTCCGGCCGCGCTGAACGGGCTGGTGGAGCTGGCCTGCGACCCCGGCAACCAGGCGTCCCTGCGCCTGCTCGAGCCACTCCTGTACGCGAGCCCGTACTACGACGTCAGCCGTCAGTCGATCCAGCTGTCGCTGGACACCGGCGCCGAACGGCCGTCCATCCTCGACACCCCCCGGCTGCCCCATCCGGACGTGCTGGATCTGAAGATCCCGTTCACCCATCCCGGCATCGACGAACTGTTCGCCGCGCGGATCGCGCCCACCACGCTGGGCCGCCTGCGCGAGGCACTGGAACTCGACGACGCGCGGACGGAGCAGCTGCGTCGGCTGCTCACCGACAAGCCGAACCTATCGCCCGACCGGCACATCGAGAAGGGCGGCCGGATCCGCTACTTCGGCCACGCCTGCCTGGTGATCCAGTCGGCCGGGACGACCATCGTCACCGATCCGTTCATCAGCGCCGACAACCGCCACGGTGACCGATACACCCTCGACGACCTGCCGGACCGCATCGATCTGGCGCTCATCACGCACGCCCGTCCGGATCACCTCGTGCTGGAGACGCTGCTCCAGCTCCGCACGCGGATCGGCGCGATCGTGGTGCCGCGCTCCTCGCGCGGCAACCTGTGCGACCCGTCGATCGGGCTGTGCCTCAAGGAGCTCGGCTTCACCGTCATCGAGGTCGACGACTTCGACGCGGTCCCGATCCCCGGTGGCCGGGTGGTGGCCACCCCGTTCCTGGGTGGGCACAGCGCACTGGACATCCGCGCCAAGTCGACGTTCTTCGTGCGCATCGCGGGCGCCACCATCTACATAGGCGCCGATACCTCGGGCATCGACCCGGTGGTGTATCGCTACGTCCGCAACCGCCTCGGCCACGTCGACATGGCGTTCCTCGGCATGGAGCGCGCCAGCGCGCCGCTGGCCCGGCGCTATCAGGGCCTGTCGACCCGCCCGGCGACCACCGTCAGCGACTCGCGCGAGCCGTCGCGCTCCGACGCCGCGCGGGCCGCGGCGATCATGACCGAGCTCGGCGCGGATGAGGGCTACCTCTACGCCATGGGCGAGGAGAGCTGGCTCGGCCACGTCGTGGCGACGGTTCACGCCGAGGACACTGACCAGATCAAGCAGATCGAGGAATTCCTCGGCTGGTGCTCCGGCAACGGCATCACCGCCGGGCGCCTCTTCAACAAGCGCGAGTGGCGTTGGTAG	MSVSAEPVFLRSNAIIEPLVDRFYAWMHTVSPAAASLNLARIQIPLLESRLRDPQPHVAAGTDSPAPGHFADVGEPRGMEVAALLDSIKKDRADMLAFADAVAEAGALLRQHVTGSDLTRLHPKLPAALNGLVELACDPGNQASLRLLEPLLYASPYYDVSRQSIQLSLDTGAERPSILDTPRLPHPDVLDLKIPFTHPGIDELFAARIAPTTLGRLREALELDDARTEQLRRLLTDKPNLSPDRHIEKGGRIRYFGHACLVIQSAGTTIVTDPFISADNRHGDRYTLDDLPDRIDLALITHARPDHLVLETLLQLRTRIGAIVVPRSSRGNLCDPSIGLCLKELGFTVIEVDDFDAVPIPGGRVVATPFLGGHSALDIRAKSTFFVRIAGATIYIGADTSGIDPVVYRYVRNRLGHVDMAFLGMERASAPLARRYQGLSTRPATTVSDSREPSRSDAARAAAIMTELGADEGYLYAMGEESWLGHVVATVHAEDTDQIKQIEEFLGWCSGNGITAGRLFNKREWRW	MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE	51.41	gnl|BL_ORD_ID|1212|hsp_num:0	1315			2340	2487	novobiocin
BGC0001178.1|UK-68,597_36 # 64317 # 65120 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.713	BGC0001178.1|UK-68,597_36 	64317	65120	+	Loose	1200	25.409	tet(T)	21.78	3000193	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGATCGGTATATCCGCGCCCGAGCGTCCCCTCCTCCGGCTCGCTCTCCGGCGGTTGGAGCGAATTGCTCCGCGAATGACAAGAATGGTGGTCACCGGGCCGGCTCTAGCGCAAACCGGCACCGGCCCGTTCACGGACACATACGTACGGCTGGTCTTCCCGCGGCCCGGAGTGACCTATCCGGACGACCTCGACCTGCGTCGTATCCATGCCGAGCTGCCTCGCGCGGCGTGGCCGCGCACCCGGACCTACACGGTGCGCTCCCTCGACCCGGTCGCCGCCGAGCTGGCCATCGACATCTACGACCACGGCTGTCCCGGGCTGACCCGCTCCTGGCTGACCGGGCTCCGCGTCGGCGATCCGGTGCTGATGTGCGATCTGCGTGGCCGGTACCACCCCGGCACCGAGGCCGACTGGCACCTGCTCGTGGGCGATGCCGTCGCGCTGCCGGCGATAGCCGTGACGCTCGCGGCGATGGCGCCGGGAGCCCGGGCGAAGGTGATCGTCGAGGTCGCCGACGCCTCGGACGAGCAGCCGCTGCCGACCGCCGCCGACTGCGAGGTCCGGTGGGTGCACCGGGCCCGCGGCGAGACCCTGGTCGAGGCCGTCCGGTCGCTCGCCTTCGATCCCGGCGTGGTGCAGGCCTTCGTGCACGGTGAGGGCGGCGCCATCCAGGAGTTGCGCCGCTTCCTGCTGCGCGAGCGTGGGCTGGCGAAGGAACTGCTGTCGATTTCCGGATACTGGCGCCGGGGTCTCACCGACGAGCAGTGGCGTCAGGTCAAGGCCGCGGCAGCGGGACGGTGA	MIGISAPERPLLRLALRRLERIAPRMTRMVVTGPALAQTGTGPFTDTYVRLVFPRPGVTYPDDLDLRRIHAELPRAAWPRTRTYTVRSLDPVAAELAIDIYDHGCPGLTRSWLTGLRVGDPVLMCDLRGRYHPGTEADWHLLVGDAVALPAIAVTLAAMAPGARAKVIVEVADASDEQPLPTAADCEVRWVHRARGETLVEAVRSLAFDPGVVQAFVHGEGGAIQELRRFLLRERGLAKELLSISGYWRRGLTDEQWRQVKAAAAGR	MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRASTVSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLNIPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQIIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFAITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIKSLESIMNGEIVKVGQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPCDLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILRLFGNIQMEVIESLLKSRYKIDARFGELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSFQNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGTEILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSELLSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN	41.01	gnl|BL_ORD_ID|1954|hsp_num:0	2037			972	1227	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0001178.1|UK-68,597_37 # 65141 # 66286 # -1 # ID=1_37;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.731	BGC0001178.1|UK-68,597_37 	65141	66286	-	Loose	600	26.9498	MAL-2	36.84	3006950	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MAL beta-lactamase	GTGGACCACAACGCTGAACCGCTCACCGCGAGCGACTTCGAGCGCGCCGCCGCCGGGATTCTGCCCGCCGAGATCTGGGACTTCGTCGCCGGCGGAAGCGGCGCCGAAACCACCGTCACGGCGAACCGCACCGCCCTGGACAACGTCTTCCTGCTCCCCCGGGTATTGCGTGACGTCTCCGCCTGCACCACCCGCTCGACGTTGCTGGGCCGCCCGGTCGAGCTGCCCGTCGCCACCGCGCCCGTGGCCTACCAGCGGCTGGTCCACCCCGACGGGGAGGCGGCCACCGCGCGGGCGGCGGCCGCGGCGGGAGTCCCGTTCATCGCCAGCACGCTCAGCAGCGTGCCCCTCGAACAGGTCATCGAGGCCGGCGGCCGGGTCTGGTTCCAGCTCTACTGGCTGCGCGACGACGCCGCCACGCTCGGCCTGGTCCGGCGGGCCGAGCAGACCGGCTGCGACGCCATCGTGCTCACCGTCGACGTGCCCTGGATGGGCCGGCGGCTGCGGGACATCCGTAACCGATTCGCGCTGCCCGCCCACGTCCGCGCCGCCAACATCACCACCACCGGCGTCGCACACGAACGCCACTGCGACGGTTCCGCCGTCGCCGCCCACACCAGCCAGGAGTTCTCACACAGCCTGACCTGGTCGGCGGTCGAGCGGATCCGCCAGGCGACCCGGCTGCCGCTGGTGCTGAAGGGCCTGCTGGCTCCGGAGGACGCCGTGCAGGCGGTCGAGTGCGGCGTGGACGCGATCGTGGTCTCCAACCACGGCGGCCGTCAACTCGACGGCGCTGTCACCAGCATCGACGCGCTTCCCGAGATCGTCGACGTGGTGCGCGGCAGCTGCGAGATCCTGCTCGACAGCGGCATCCGCACCGGTACGGACGTCCTGCGGGCGCTGGCTCTCGGCGCCTCCGGTGTCCTGATCGGCCGGCCGCTGATCTGGGGGCTGGCCGTCGGCGGCGAGCGCGGGGCGGCACGCGTCCTGGAGCTGCTGGCGACCGAGCTGCGGGACGCCATGGGCCTCGCGGGGTGTGCGGACGTCGACGGCGCACGACGGCTGCGGACGACGCGTGGACCGCGCGTCGCCGGCACACCACCCGCCGTCCAAACGTCGGATACGGCCAGTTGGACAGATGCCTGA	MDHNAEPLTASDFERAAAGILPAEIWDFVAGGSGAETTVTANRTALDNVFLLPRVLRDVSACTTRSTLLGRPVELPVATAPVAYQRLVHPDGEAATARAAAAAGVPFIASTLSSVPLEQVIEAGGRVWFQLYWLRDDAATLGLVRRAEQTGCDAIVLTVDVPWMGRRLRDIRNRFALPAHVRAANITTTGVAHERHCDGSAVAAHTSQEFSHSLTWSAVERIRQATRLPLVLKGLLAPEDAVQAVECGVDAIVVSNHGGRQLDGAVTSIDALPEIVDVVRGSCEILLDSGIRTGTDVLRALALGASGVLIGRPLIWGLAVGGERGAARVLELLATELRDAMGLAGCADVDGARRLRTTRGPRVAGTPPAVQTSDTASWTDA	MRNEEVISMWQRMKWGLCVLALSGSAMAAPLTAQYVSAIATQEEQRLHARIGIAVLDTATNSITHYRGEERFPLNSTHKPLLCAALLREVDRKALALSASTQFEPSQLVEYSPITEKHVAPDAMNWAQLCSAAVSYSDNTAANLIARKLNGPQAVTQFLRDSGDTITRLDRYEPELNSAIPGDERDSTTPVAIAKTLNTLLLGNVLQPSSREQLMQWMRDDKVADGLLRSVLPDGWKIADKTGAGDNGSRSIVSVVWPTSQKPLLVVIYITQTPATMAQRDAAIVRIGESLFSTLAVYD	127.42	gnl|BL_ORD_ID|3691|hsp_num:0	4761			576	687	
BGC0001178.1|UK-68,597_38 # 66978 # 69401 # 1 # ID=1_38;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=3bp;gc_cont=0.708	BGC0001178.1|UK-68,597_38 	66978	69401	+	Loose	450	28.1054	ANT(4')-IIb	25.0	3002625	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(4')	GTGACGCTACGTAAGCAGAATTCAAGATTGCTCCTGTTCGAGCAGGTTTACGCGGCGACGACCCAGGGCAGAGGTGCGGTTCTGCTGATCAGTGGGCCGGTGGGCACCGGGAAGACAGCTCTCGCGCAGGAGTTGGCCGCGCATGCCGGGCGCCAGGGCGCCCTTCGCTTCCTGGTCACCGCCTCGGCGGGGGAGCGGGAGCACCCGTTCGGGGTGCTGGACAGGCTTATCGACTCGATGCACGTGGCCGGCTTGCCGCGGCTCCTCCCGGACGGCACGCCGCATCGCAGCCGCGACCCGCACGTCCTGATGGATCAGACCGGCGCCGCGATTCAGCAGTTCGCCGGAGGGCGGCCGGTTCTCATCGGCATCGACGACGTCCACTTCGCCGACGAGCAGTCCCTGCGCTGCCTGAGCTATCTGATCCGGCGGATGGAACAGTCCAAGCTGATCATCATCCTGAACGAGAGCACCTCCTACGAGCGGGACACGGCGGACCTGCGTGCCGAGATGCTGCATCTGCCCTACTGCCATCGGATCCAGCTGGCGCCGCTCACCCCGGCGGATGTCGCCGGGCAGTTGACCGAGCGGCTCGGTGGCGCGGTCGACGATGAGTTCGCCCGGCTCTGCACCGAGGTCAGCGGCGGAAACCCGCTGCTGATGCACGCTCTCATCGATGATCGGATCGCGGCGCCGGCGCAGACGTCCGGCGAACCAGGCGTCAGTTTCCGGCAGGCCGTGCTGCGCATCCTGCACCGGTCCGCGCCCGCGACCGCCGCGGTCGCCCGGGTCATGGCGGTCCTCGGCGACTACGCCACCCCGGAGCTGGTCGCCGATCTCGGCGGCGCGGACACCGTCCTGGTTCGCGAGTGCATGCGGGACCTGCACGAAGTCGGGTTGCTGGACGCCGAGGGCGCCGAGGGTTTCCGGCACGGCCACATCCGCTCGGCGGTGCTCGCGAGCATCCCGCTGGGAAGCCTGCCCGCGCTGCACAGCCGTGCGGCGGAGTTGCTGCACGCCAGCGGGGCGCCGGCGATCGCCGTGGCCGAACATCTGGTCACCGCGCAGGACGGCGGCAAGGGCACGTGGCGGGTCGCCATCCTCTGCGAGGCGGCCCGGGAGGCGATGACGGAGGGTGACGTCGACAGCGCGGTGAACAGCCTCCGGTACGCGGTCGGCGCCAGCCCGGACGAGACCCAGCGAGCCCAGGCCGCCGTGCTGGCCGCCGCGGCGCAGTGGCATGCCGATCCCAGCCGCGCCGCGCGCCAGCTGTACGGACTCATGCGCGATGCGCGTGCCGGGCTGCTGACCCAGCCGGATGCGCTGATCGTGATGAACCAGTTGCTCTGGTGGGGCGAGTTCACCGACGCCGACGAGCTGATGCGGCTCACAGGTGTGCAGGACGAGGTGCCGAGTCTCGCCCAGCTGTGGAGGCTGTACTGCCAGACCGGAGTGGGTTCGGAGCGGTACGCGGAATCCGGCCGGCCCGCCGAGCCGTCGATGGCCGGGTCGGGCCCGATGGCCTCGGTCACCTACCTCAGTTCGGCGGCCACGTCGGCGTACGACGACACGGCGACCGAGCAGGTCGACCAGATGCTGATGGGAATCCGCGCGGGAAACCTGCTCACGCCCGCGCTCTACGCCCTGGTCGTCCTGGTGCAGACCGGCCGGCTGGACGAGGTGGCCGCCTGGTGCGACTCGCTGCTGAAGGAGGACTGGATCGCGCGGGTGCCCATGCGGCGGGTGCTGATCGGCACGATCAAGGCGGTCACGGCGCTGCGCGGCGGAGACAGCGGGACGGCGCTGTACGAGATCCGGGAGGTGTTCGACGCGGTCCCGCCGCCGGCCTGGGGTGTGGTGGCCGGCCTGCCCTTGTCGGTCGCGGTCCGGGCCGCCACCGATCTCGGCGACACCCAGTCCGCCCGGATGTATCTCGCCGTGCCGGTGCGGGCGGCCATGTTCGACACCCCGTTCGTGCTGCCCTATCTGCAGGCGCTGGGGCGGTATCACCAAGCCATGGGGCATCGGCAGAGTGCGCTGACGCATTTCCGGTCGTGCGCCGAGCTGATGGCCAGGTGGGGTGTCGACGCCACCGAGGTCGCGTCGAGGATGGAGTGGCACAGCCCGGACGCCACCCTTGCCACAGCCGACGGGCCTGCCCGGGTGGAGCCCGCTGCCGACCCGGGATGCGCCTTCGGCGTGAGCCGGGCCGATCGGCCGCCCGGGGCCGCCGCCGCGGTGGACAGCACCAAGCTCACGGACGCCGAGCAACGGGTCGCCGCGCTCGCCGCCGCCGGAAACACCAACCGGCAGATCGCCGCGCATCTCTGCATCACCGTCAGCACGGTCGAGCAGCACCTCACCAAGATCTACCGCAAACTCAACGTGCGCAGCCGCTCCGGATTGCGACGTTGCCGGCAGTGA	MTLRKQNSRLLLFEQVYAATTQGRGAVLLISGPVGTGKTALAQELAAHAGRQGALRFLVTASAGEREHPFGVLDRLIDSMHVAGLPRLLPDGTPHRSRDPHVLMDQTGAAIQQFAGGRPVLIGIDDVHFADEQSLRCLSYLIRRMEQSKLIIILNESTSYERDTADLRAEMLHLPYCHRIQLAPLTPADVAGQLTERLGGAVDDEFARLCTEVSGGNPLLMHALIDDRIAAPAQTSGEPGVSFRQAVLRILHRSAPATAAVARVMAVLGDYATPELVADLGGADTVLVRECMRDLHEVGLLDAEGAEGFRHGHIRSAVLASIPLGSLPALHSRAAELLHASGAPAIAVAEHLVTAQDGGKGTWRVAILCEAAREAMTEGDVDSAVNSLRYAVGASPDETQRAQAAVLAAAAQWHADPSRAARQLYGLMRDARAGLLTQPDALIVMNQLLWWGEFTDADELMRLTGVQDEVPSLAQLWRLYCQTGVGSERYAESGRPAEPSMAGSGPMASVTYLSSAATSAYDDTATEQVDQMLMGIRAGNLLTPALYALVVLVQTGRLDEVAAWCDSLLKEDWIARVPMRRVLIGTIKAVTALRGGDSGTALYEIREVFDAVPPPAWGVVAGLPLSVAVRAATDLGDTQSARMYLAVPVRAAMFDTPFVLPYLQALGRYHQAMGHRQSALTHFRSCAELMARWGVDATEVASRMEWHSPDATLATADGPARVEPAADPGCAFGVSRADRPPGAAAAVDSTKLTDAEQRVAALAAAGNTNRQIAAHLCITVSTVEQHLTKIYRKLNVRSRSGLRRCRQ	MQHTIARWVDRLREEYADAVAILLKGSYARGDAATWSDIDFDVLVSTQDVEDYRTWIEPVGDRLVHISAAVEWVTGWERDTVDPSSWSYGLPTQETTRLMWAINDETRRRMDRPYKTHPAAEPEVENTVEALGKIRNAIARGDDLGVYQSAQTVAKLVPTLLIPINPPVTVSHARQAIEAILAFPRVPVGFAADWLTCLGLVEERSARSTAAAAERMVRGVLEMLPTDPDLLGEDIARLMNAGLLEKYVQQ	321.51	gnl|BL_ORD_ID|1224|hsp_num:0	1329			99	471	amikacin; tobramycin; isepamicin
BGC0001178.1|UK-68,597_39 # 69519 # 71018 # 1 # ID=1_39;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.704	BGC0001178.1|UK-68,597_39 	69519	71018	+	Loose	1080	52.373	rosB	24.58	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGATGGGGTCGCACGTGTCCCTGTCGGCCCGGCCGATCAAGGCAGCGGCGAAACGGGCACCGGCCTGTCCGGGGAACGACTCTCACATGGCTTCTGTTCGATCAAGGCTGCTGTTTCGATCTGGGGGGAATCGTCAGATGGGGTTCACCACGCCGCCGCCGTCGCTCGGCGGGCACGCGCTGCTCGTATTCCTGATCGCGGTGGTGACGCTGCTGCTGGTCGCCCGTCTCCTCGCCGCCCTCGCGGAACGGGTGGGCATGCCGGCCATCGTGGGCGAGCTGGCCACCGGTGTCATCCTGGGGCCGTCGCTGCTGGGCCACCTCCTGCCCGGCCTGACCGACTGGATCTTTCCGCGCGCCGCCGAGCAGATGCACCTGCTGGACGCGGTCGGCCAGATCGGCATCCTGCTGCTGGTCGGGCTCACCGGAACCCACCTGGACGTCGCCATGATCCGGCGGCGTAAGGCCACCGCCGCCCGGATCAGCCTGGGCGGCATGCTCCTGCCGCTGGCTCTCGGCCTCATCGTCGGCTATCAGCTGGCGGACTGGATCAGCGGCACCCCGGTCGGGGACCGGCTCCTGTTCGCCGGCTTGATCGGCGTGGCGATGTGCGTGACGGCCATCCCGGTGATCGCCAAGACCCTCTCCGACATGCGGCTGCTGCACCGCGACACCGGCCAGATGATCATGGCGGCGGGAACGATCGACGACGCGGTCGGCTGGTTCCTGCTGTCGGTGGTGTCGATGGCCGCGACGGTCGGGCTGGCCACGGGGCACGTCGTGCTGGCGGCCGGCTACCTGCTCGGCTTCGTCGTCCTCGCCGTGCTCCTCGGCCGGCCGCTGGTGCGCCGGGCCATGCGGCTGGCCGACCGCAGCGAGGCACCCGGCCCCAGCATCGTGGCCGCTGTCGTCATCGTCCTGACCGGCGCGGTGATCACGCAGGCCCTGGGCATGGAACCGGTCTTCGGCGCCTTCGTCGCGGGCATCCTGGTGGGGCTGCCCCGGGCGGCGAACCAGGCGAAGCTGGCGGCCCTGCGTACGGTCGTGCTCAGCGTGCTGGCGCCGATCTTCCTGGCTACGGCCGGCTTCCGGATGGACCTGACCGCGCTGGCCGATCCCAAGGTCGCGCTCGCCGCGCTGGTCGTCCTGGCCGTCGCGATCCTCGGCAAGTTCGCCGGGGCGTACGCCGGTGCCCGCCTCAGCCGGCTGAGCCGATGGGAGGGTCTCGCCATCGGCGCGGGCATGAACTCCCGCGGTGTGGTCGAGGTGGTGGTGGCGCTCACCGGTCTGCGGCTGGGCATCCTGAACACCGCGAGCTACACGATCATCGTGCTGGTCGCCGTCGTCACCTCGGTCATGGCTCCGCCGATGCTGCGCTATGCCTGCGCCCGTATCACCGAGAACGAGGACGAGCGGCTCCGCAAGATCGACCACGACACCTGGAACGGTGTCCCCACCGCCCGGCAGCCCTCGTCAAACGCCGGAGAAAAATCCGCATGA	MMGSHVSLSARPIKAAAKRAPACPGNDSHMASVRSRLLFRSGGNRQMGFTTPPPSLGGHALLVFLIAVVTLLLVARLLAALAERVGMPAIVGELATGVILGPSLLGHLLPGLTDWIFPRAAEQMHLLDAVGQIGILLLVGLTGTHLDVAMIRRRKATAARISLGGMLLPLALGLIVGYQLADWISGTPVGDRLLFAGLIGVAMCVTAIPVIAKTLSDMRLLHRDTGQMIMAAGTIDDAVGWFLLSVVSMAATVGLATGHVVLAAGYLLGFVVLAVLLGRPLVRRAMRLADRSEAPGPSIVAAVVIVLTGAVITQALGMEPVFGAFVAGILVGLPRAANQAKLAALRTVVLSVLAPIFLATAGFRMDLTALADPKVALAALVVLAVAILGKFAGAYAGARLSRLSRWEGLAIGAGMNSRGVVEVVVALTGLRLGILNTASYTIIVLVAVVTSVMAPPMLRYACARITENEDERLRKIDHDTWNGVPTARQPSSNAGEKSA	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	88.63	gnl|BL_ORD_ID|466|hsp_num:0	507			42	1185	polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4
BGC0001178.1|UK-68,597_40 # 71113 # 72450 # 1 # ID=1_40;partial=00;start_type=TTG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.702	BGC0001178.1|UK-68,597_40 	71113	72450	+	Loose	500	27.335	mphI	41.27	3003991	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	TTGACCGGAGAAACTGTCGTGGAATCATCCGTGCTGCGTAAGTCGGAATTGCATGCGAGCGTTTCCGATCCGGTCCTGGACACGATGAATTTCCTCAACGAGGTGACCCTGCGCTATCCCGAGGCGATCTCATTCGCTCCGGGCCGGCCGTACGACGGCTTCTTCGAGACCGAAGAGGTCCTCGCTCACCTCCGCCGCTATCTCGACCATCTCGCCGATCAGGGCGCCTCGCCCGCGCAGGTCCGCACGGCGGTCTACCAGTACGGCCCGACCGCCGGCCAGATCCGCGAGATCATCGCGGACTCGCTGCGCCGGGACGAGCAGATCGACGTGCCGGCCGAGTCGATCGTGGTCACCGTCGGCGCGCAGGAGGCGATGATGCTGGTCGTCCGCGCGCTGATCCGTGACCCGGAGGACGTGCTGCTGGTCTCCAGCCCGTGCTACGTGGGCATCACCGGGGTGGCCCGGCTGCTCGACGTGACGCTCAGCCCGGTGGCCGAGCCGGCCGAGGGGTTCTCCCTGGCCAACCTGGCGGCGGCGATCCGGGCCGAGCGGGCCGCCGGGCGCCGGCCGCGGGCGTTCTACCTGGTGCCCGACCACGCCAACCCGTCCGGCTCCACGCTGTCGGTGACCGGCCGGGCCGAGTTGCTGGACCTCGCCGTACGGGAGGATCTGCTGATCCTGGAGGACACCCCGTACCGGCTGGTCAGTCCGGGTCAGCCGGCCCCGACGCTGAAGGCGATGGACCGGCACCGCTCGGTGGTGCACCTCGGGTCGTACTCAAAAACGATCTTCCCCGGTGCGCGGGTGGGCTTCGCCGTGGCCGACCAGACGGTGGTGGGTGACGACGGCCGGACCGGCCTGCTGGCCGACGAACTCTCGAAGATCAAGAGCATGGTGACGGTCAACACCTCGTCGCTGAGCCAGGCCGTGGTGGCCGGCGCGCTGCTGGCGGCCGGCGGCCGGGTCTCGGAACTGAACGCCAAGGCGGCCGGCCACTACGGCGACGCCATGCGGCGGGTGCTCGACCGGCTCGCCGACCGGCTGCCCGCATCGCGCCGCGCCGAGCTGGGCGTGCGCTGGAACGAGCCCAGCGGCGGCTTCTTCCTCAGCCTGACCGTGGGATTCGAGGTCGACGACGCGGCGCTCACCCGTTCCGCCGAGCAGTACGGCGTGATCTGGACCCCGATGCGTTACTTCCACCCGGACGACGGTGGCCGCGACGCCATCCGGCTCTCCGTCAGTTACCTGTCGCCCGAGGAGATCGACGAGGGCGTCACCCGCCTGGTCGCGTTCATCGAGGCCGAGACCGGCCGCCTCGCGATCGGACGGCACTGA	MTGETVVESSVLRKSELHASVSDPVLDTMNFLNEVTLRYPEAISFAPGRPYDGFFETEEVLAHLRRYLDHLADQGASPAQVRTAVYQYGPTAGQIREIIADSLRRDEQIDVPAESIVVTVGAQEAMMLVVRALIRDPEDVLLVSSPCYVGITGVARLLDVTLSPVAEPAEGFSLANLAAAIRAERAAGRRPRAFYLVPDHANPSGSTLSVTGRAELLDLAVREDLLILEDTPYRLVSPGQPAPTLKAMDRHRSVVHLGSYSKTIFPGARVGFAVADQTVVGDDGRTGLLADELSKIKSMVTVNTSSLSQAVVAGALLAAGGRVSELNAKAAGHYGDAMRRVLDRLADRLPASRRAELGVRWNEPSGGFFLSLTVGFEVDDAALTRSAEQYGVIWTPMRYFHPDDGGRDAIRLSVSYLSPEEIDEGVTRLVAFIEAETGRLAIGRH	MTIAKPNDDYTQVIQEMLEIAGKHGVNLIPEGIEMNESGMDFLVGFAEEAGTGARWILRKPRRPDVLDRADNEARVLKLIQSHLSVDVPDWRIYTPELIAYPLLSGQPAASVSMEGYAWNMDHENPGDGFIRSLAEALVALHGVDHDAARAAGLRVKSPQEVRDETARNMEDIKSRLGVSDALWERWQKWLEEDSYWPTHSALIHGDLHPPHILIDERVQVTGLLDWTESEVASPAKDFVLYYAIYGEHNLRVLLDRYEQAGGKVWPRMFDHIVEQHAAYPVLIAQFALLTGQEEYMTMARNALGLTE	144.48	gnl|BL_ORD_ID|2234|hsp_num:0	2527			654	834	erythromycin; telithromycin; tylosin
BGC0001178.1|UK-68,597_43 # 73916 # 75325 # 1 # ID=1_43;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.775	BGC0001178.1|UK-68,597_43 	73916	75325	+	Loose	750	28.8758	tet(54)	44.0	3004590	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGGTTCGCAGCCTGCTGGTGATCGGAACGGGGCTGGTGGGCACCTCGGTGGCCCTGGCCGCGCGGCGCGCCGGGGTCACCGTCTTCCTCGCCGATCGCGACGTCACGGCCGCCCGGGTGGCCGAGTCGCTCGGGGCGGGACTGGCCGAGACGCCCCGCCTCCCGGTGGACCTCGCGCTGATCGCGGTGCCGCCCGCCCAGGTCGGCCCGGTGCTGCGGGACGCGCAGGAACGGCGGTCGGCGCGGAGTTACACCGATGTGGCCGGGGTCAAGGGCGAGCCGGAGCGCGACGCGCTGCGGCTGGCGCCCGACCCGGTGGCGTACGTCGGCGGCCACCCGATGGCCGGCCGGGAGCGATCCGGCCCGCTGGCGGCCACCGCCGACCTGTTCACCGGCAAGACCTGGGTGCTGACCCCGTCCGAGCGGACCGGGGACGTGGCGCTGAGGAACGCCACCACCCTGGCCGAGATCTGCGGCGCGGTGCCGGTGCGGCTGAACAGCCGGGCGCACGACGCCATGGTGGCGGTGACCTCGCACGTCCCCCACCTGATGGCGAGCCTCACCGCGGCCCGGCTGCGCGACGCGCCGGCCGGCACGGAGGCGCTGGTCGGCCAGGGCGTGCGCGACGTCACCCGGATCGCGGCCGGCGACCCGGCGCTGTGGGCCGACATCGTCCGGTCGAATGCCCCGGCGGTGGCCGCGGTGCTCCGCGAGGTCCGCGGCGACCTCACCCGGCTGTCGGCCGCGGTCGACGCCCTGGCCGGGTCCGGGCCGGACGGCCACGACCGAGCCGTGCGCACGGTCACCGACGTGCTGGCGCGTGGCGTGGCCGGGGCGGTCCGGACCAGGCCATCCGGCGCAACCGCCCGGCTCCGGGCGGTGCTCGACCGAGATCCGGGCGCCCTGGGCCGTCTGCTGCACGCGGCGGCGCCGCACGGCGTCATCGCGGACCGGGCCGATGCGGTCCGCCCCGGCGACGAAGACCTGGTGGTTCACCTCGAGGTCCCGGCCGCCGCGGCCGATGCCGCGATGGCGGAGCTCGCCGCGGCCGGCTGGAATGTCAGCCGTCCCGAGCAGGCCCCGCCCGTCGCTGAGTCGGCCCGGGGCCGGCCGCCCGGTGCTGAGCCGGCCCGGGGCCGGTCGCCCGTCGCTGAGCCGGCCCGGGGCCGGTCGCCCGTCGCTGCCGGTCAACTACCTGGTGAGGAGCCGTCCATGCGAGTGGAGTTCGACGAGCCGAAATGCATCGCCGCCGGCCAGTGCGTCATGGCCGCGCCAGAGGTCTTCGACCAGCGCGACGAGGACGGCGTGGCGGTCGTCCTGGACCCCACGCCCGGCGCCGACCGGCACGAGATGGTGCGGCAGGCCGCCGCGGTGTGCCCGGGCACGGCGATCCGGCTGGTGGAGCGATGA	MVRSLLVIGTGLVGTSVALAARRAGVTVFLADRDVTAARVAESLGAGLAETPRLPVDLALIAVPPAQVGPVLRDAQERRSARSYTDVAGVKGEPERDALRLAPDPVAYVGGHPMAGRERSGPLAATADLFTGKTWVLTPSERTGDVALRNATTLAEICGAVPVRLNSRAHDAMVAVTSHVPHLMASLTAARLRDAPAGTEALVGQGVRDVTRIAAGDPALWADIVRSNAPAVAAVLREVRGDLTRLSAAVDALAGSGPDGHDRAVRTVTDVLARGVAGAVRTRPSGATARLRAVLDRDPGALGRLLHAAAPHGVIADRADAVRPGDEDLVVHLEVPAAAADAAMAELAAAGWNVSRPEQAPPVAESARGRPPGAEPARGRSPVAEPARGRSPVAAGQLPGEEPSMRVEFDEPKCIAAGQCVMAAPEVFDQRDEDGVAVVLDPTPGADRHEMVRQAAAVCPGTAIRLVER	MSTIKKILVIGAGIAGTAVCYWLRRFGFYPVLIEKSACIRKGGQGLDIRGVAIDIVKKMVIYEQICKMRTQVECGRYVDVVGKTLHEEKGEKFAFRQDEDVEILRGDLIEILMKTIDDVPCHFNQSIDSIEQNDDDVIVYFKDARVEHYDLIIGADGIHSSIRRMVFDKDEYRLVNLAEAYFSIFSIPNYLNLSHTEVQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQMQFLRDIFHDFGWEAQKILELMPNSHDFYFDSVTQVKMRSWTKGQVALVGDASYSASPLSGQGNNLALVGAYILAGELKAAEGNYRLAFNRYNELLHPFVEANQQLGAWVSESFLVPDAVSKEVAEERSNRILQKVQIISNAIKLPEYE	120.88	gnl|BL_ORD_ID|2726|hsp_num:0	3292			9	84	tetracycline; oxytetracycline
BGC0001178.1|UK-68,597_45 # 76600 # 77268 # 1 # ID=1_45;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=14bp;gc_cont=0.735	BGC0001178.1|UK-68,597_45 	76600	77268	+	Loose	700	26.5646	vanK gene in vanI cluster	30.0	3003727	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanK	GTGGTGACCGCGGCGGGCATCGGCGACCTGGTCCTGCGCGTCGACGGAAGCGAGCCGGTCTCACCGGCGGCCGTCGAGGCGCTGCTGAGAATCTGCGATCGGGCCGAGGACGAATACGGCTCCGGCCTGCTGATCGTGTACGCATCGGGCGCTCCGCGGCCCGGGTGGACGAAGGATCTCAGCGTCGGGCTGCTGACCAAGTGGGAACGCGCGGTGCGCCGGCTGGAACGCCTCGGCCTGGTCACCGTCGCCGTCACGGCGGGCCAATGCGGTGGCACGGCACTCGACGTGCTGCTGGCCACGGACGTCCGGATCGCCGTCGCGGGTGCGGGCTTCGTCGTGAGTTCGAGCGGCGATGCCACCTGGCCCGGCATGGCGCTGTACCGGCTCGCCCGGCAGGGGGCCAGGTGGCGCCTCCGGAAGGCGGGGCTGCTGGGCACGCCGATCGGTGCCGAGGAGGCCGCGGCGGCCGGGCTGATCGACGTCGTCGTCGACCACGCGGACGAGGTCCTCGCCGAGATCGCCGCCGTGGCGGGCACCATCACCGGCAAGGAACTGGCGATCCGGCGGCAGCTGATGCTCGACGCCCCCGAGCACAGCTTCGAGGAGGCTCTCGGCTCTCACCTGGCCGCCTGCGACCGCGCCCTGCGCCGGGCCGCCGCCTCATGA	MVTAAGIGDLVLRVDGSEPVSPAAVEALLRICDRAEDEYGSGLLIVYASGAPRPGWTKDLSVGLLTKWERAVRRLERLGLVTVAVTAGQCGGTALDVLLATDVRIAVAGAGFVVSSSGDATWPGMALYRLARQGARWRLRKAGLLGTPIGAEEAAAAGLIDVVVDHADEVLAEIAAVAGTITGKELAIRRQLMLDAPEHSFEEALGSHLAACDRALRRAAAS	MLNVDKISEETYYAFISQADLGNFMQYPSWAKVKTEWTSDLLGWFTPDNKLAGCGLILYRKMPCLNRYLAYCPRGPLIDWQSPNLREWFEPLVAYLRSKQVFSIKIDPPVVQAKWSAPTIKTFLGQAREQGSKGKVLRDLPPDEDYTTVQQVQQQLRQMGWRKQRGDTGFAATQPQYVYRLPLEGRSLEEVFAGFHTNWRRNVKKAERLGVKVRVGTEQDLPAFYELLKVTSERDHFKVRSFSYFSNLYRSLKAEAADRIALYLAEDEEELLAATLAVHSNAHSWYLYGASSNVKREKAPNHAIQWRMIQDAYQLKAYTYDFRGISPTLDESDPLFGLLRFKLGFGGEACEMISAWDYPLQPLLYRAFQLYLKRR	59.20	gnl|BL_ORD_ID|4747|hsp_num:0	2245			564	741	vancomycin; teicoplanin
BGC0001178.1|UK-68,597_47 # 78563 # 79363 # 1 # ID=1_47;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0001178.1|UK-68,597_47 	78563	79363	+	Loose	500	30.4166	cfrC	29.29	3004146	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGACCGGGCCGGCCCGGGTGCGCTACGAGAAGAAGGAGCACGTCGCCCAGGTCACGCTCGACCGTCCCGGCGTGCTCAACGCCATGGACCTGCGCATGCACGAGGAACTGGCGGAGATCTGGGACGACGTCGAGGCCGACGACGAGGTCAGGGTGGTGGTGCTCACCGGGGCGGGTGGCCGGGCCTTCTCCGTGGGTCAGGACCTGAAGGAGCGGGCCCGCCGCGATGCGGCGGGCACCCCGGCGTCGTCATTCGGCAGCCGGGGACAACCCGGCTGGCCGCGGCTCACCGAGCGGTTCGGCTTCAGCAAGCCGGTGGTCGCGCGGGTCGATGGGTACGCCCTCGGCGGCGGCTTCGAACTGGTCCTCGCCTGCGACGTGGTCGTCGCGTCCGACCAGTCGGTGTTCGGGTTGCCGGAGGTGCGGCTGGGGCTCGTGCCGGGCGCCGGCGGTGTGTTCCGGCTGATCCGGCAGCTGCCGCAGAAGGTGGCCATGGGCCTGCTGCTCACCGGCCGCCGGCTGGACGCGGCCACCGCCTATGCCTACGGGTTGGTCAATGAGGTGGTTCCGGCTGATCGGTTGGACGGGTGCGTCGACGGTTGGGTCGCGGAGCTGGTCGCGAGCGCGCCGCTGTCGGTGCGGGCGATCAAGGAAGCCGCGCTGCGTTCGGTCGACCTGCCGCTGCCTGACGCCTTCGCTGCCACGTACGGGTGGGAGGAACGGCGTCGGCGCAGCGCCGACGCCGTCGAAGGCCCGCGGGCCTTCGCGGAGAAGCGGGCGCCGATATGGACCGGGCAATGA	MTGPARVRYEKKEHVAQVTLDRPGVLNAMDLRMHEELAEIWDDVEADDEVRVVVLTGAGGRAFSVGQDLKERARRDAAGTPASSFGSRGQPGWPRLTERFGFSKPVVARVDGYALGGGFELVLACDVVVASDQSVFGLPEVRLGLVPGAGGVFRLIRQLPQKVAMGLLLTGRRLDAATAYAYGLVNEVVPADRLDGCVDGWVAELVASAPLSVRAIKEAALRSVDLPLPDAFAATYGWEERRRRSADAVEGPRAFAEKRAPIWTGQ	MKQTKTKYGKMKQIASNLKLPDYRYEQLTKAIFHQRIDNFHDMHILPKALRIALVNEFGKNVSSVTPIFSQDSKQAQKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCSFGCRFCATGSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGLSQRRITISTIGIIPGIQRLTKEFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLDEHIIHTGRRVFIAYIMLEGINDSKEHAEAIIGLLRNRGSWEHLYHIDLIPYNSTDKTTFKFQSSSAIKQFCSTLKKASISATVRTQFGSEISAACGQLCYENEL	77.33	gnl|BL_ORD_ID|2412|hsp_num:0	2800			333	615	chloramphenicol; florfenicol
BGC0001178.1|UK-68,597_48 # 79424 # 80287 # 1 # ID=1_48;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.715	BGC0001178.1|UK-68,597_48 	79424	80287	+	Loose	500	41.2022	PEDO-2	20.83	3003714	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	subclass B3 PEDO beta-lactamase	ATGTCTCCTCTCGCGAAGCCCTCCTCCTGGACGCGACCCCTGCCCGAAGCCCACCCACCCGCCGGCATGGCCCTCTACCACCTGCCCACCGGCACCTACGAGACCCGGGCGGCCCTCGCCTTCCGCGGCGGATCGTTTCGCGACAAGCGCGACTTCGCCGCGTCCGCGGTTCTGGTGCGGCACCCCAAGGGGGACCTGCTGATCGACGCGGGCTTCGGCGCCGGCGTCGCGGCGCACGTCGCGATGCTTCCCCGGTTCATGCGCGCCCCCTATCGGGTGGGCCGGACGGTCAGCGAGCAGCTCGACGCCGCCGGCTACGACCGCGGCAGGCTGCTGGGTGTGCTGCTGACCCACTCGCACTGGGACCACGCGAGCGGCCTCGACAGCCTCCGGGACACGCCGGTCTGGATCAACGCGAACGAACGGGAGTATGCCGCCGATGATCCGGACGGGAAGGTCTTCCGTCACGTTTCCCCGGGGCACGAGATCCACGAATACGGGTTCGACAGCCGGCCGTACCTCGGCTTTCCGTCGAGCTATGACGTCCACGGCGACGGCTCGGTGGTCATCGTCCTCGCGGGAGGCCACACGACCGGCTCCGTGATCGTCTTCGTGACCGTGCCCTCCGGCGAGCGGTACGCCTTCATCGGCGACCTGACCTGGCAGCTCGACGGCATCCGCCGGCGGGTGGAACGGCCGTGGCTGCTGAGCAGGCTCGCCGACAGCGACCCCGTCCAGCTGCGCCGGGACCTGCTCCGCATGATCGCCCTGGCGGGCCTGATCCGGATCGTCCCCGCGCACGACCTCGGCTCCTACGCCGGCATCCCCCGGCTGACGACCGAGGCCGCGGCGCCGTCCCGCTGA	MSPLAKPSSWTRPLPEAHPPAGMALYHLPTGTYETRAALAFRGGSFRDKRDFAASAVLVRHPKGDLLIDAGFGAGVAAHVAMLPRFMRAPYRVGRTVSEQLDAAGYDRGRLLGVLLTHSHWDHASGLDSLRDTPVWINANEREYAADDPDGKVFRHVSPGHEIHEYGFDSRPYLGFPSSYDVHGDGSVVIVLAGGHTTGSVIVFVTVPSGERYAFIGDLTWQLDGIRRRVERPWLLSRLADSDPVQLRRDLLRMIALAGLIRIVPAHDLGSYAGIPRLTTEAAAPSR	MKKIFLMVLFSCSLLGFAQTVTEPANNPKEWSQATEPFRIAGNLYYVGTYDLASYLIVTEKGNILINTGLANSLSIIKENIKALGFDYKSIKILLLTQAHFDHLGAMSEIKKETGAKLYVDEKDADALETGGKLDYELGKYGISFKPVKPDFLLKNNDKIKLGNTTLTMLHHPGHTKGSCSFIFDTKDKNSSYKILIANMPSIIVDRKFSEIASYKDIQKDYTETFKAMKKLDFDLWVASHASQFELHDKRKSGAPYNPKIFMDKSKFFKNLEDLENIFLEKIKN	100.70	gnl|BL_ORD_ID|2026|hsp_num:0	2229			156	588	
BGC0001178.1|UK-68,597_49 # 80305 # 80787 # 1 # ID=1_49;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.731	BGC0001178.1|UK-68,597_49 	80305	80787	+	Loose	270	45.0542	mgrA	26.83	3000815	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump	ATGCGAAGCCTGCCATCGCCGGTGCCCGAGATCGTCGGCCCCCGCCCCTCCGCCGAGTCCGAGATCACCTGGCTGCTGCACCGGGCGGCGCAGCGCATGCGCGGCGTGACCGGCGACGTGGCCGAGCAGCACGGCCTCGCGCTGCGCGACTACATCGTGCTGAGCGCCCTCGCCAAGACCCCCGGCCTCACCCAGGGCGAGCTCGGCCGATCCCTCGGGCTGGACAAGACCACCCTGATGAGCCAGCTGGACCGGCTTGAGCACCGGGGCCTCGTCGAGCGCCACCACGACCCGCGCGACCGCCGGCTGCGCCTCCCCGTGATCACCGAGGACGGCGAGGCCCTGCGCGCGACGGTGGCCGGCGCCTGCGCCGCCGTCGAGGAGTCGGTCCTGAACAGCTTCGGTCAGGACCAGGTCCAGGCCCTGCGCCGGATGCTCTTCACGATCATCGGCGACGCCGAGGACCGGGGATCCTGCTTGTGA	MRSLPSPVPEIVGPRPSAESEITWLLHRAAQRMRGVTGDVAEQHGLALRDYIVLSALAKTPGLTQGELGRSLGLDKTTLMSQLDRLEHRGLVERHHDPRDRRLRLPVITEDGEALRATVAGACAAVEESVLNSFGQDQVQALRRMLFTIIGDAEDRGSCL	MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK	108.84	gnl|BL_ORD_ID|133|hsp_num:0	154			51	414	methicillin; ciprofloxacin; acriflavine; tetracycline; daptomycin; moxifloxacin; cefotaxime; norfloxacin; sparfloxacin; moenomycin A1
